
<html lang="en"     class="pb-page"  data-request-id="de163e9f-75cd-4c0f-b68b-20a73040b53f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.1c00800;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2021.64.issue-14"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Optimization of a Screening Hit toward M2912, an Oral Tankyrase Inhibitor with Antitumor Activity in Colorectal Cancer Models" /></meta><meta name="dc.Creator" content="Hans-Peter  Buchstaller" /></meta><meta name="dc.Creator" content="Uwe  Anlauf" /></meta><meta name="dc.Creator" content="Dieter  Dorsch" /></meta><meta name="dc.Creator" content="Sarah  Kögler" /></meta><meta name="dc.Creator" content="Daniel  Kuhn" /></meta><meta name="dc.Creator" content="Martin  Lehmann" /></meta><meta name="dc.Creator" content="Birgitta  Leuthner" /></meta><meta name="dc.Creator" content="Sara  Lodholz" /></meta><meta name="dc.Creator" content="Djordje  Musil" /></meta><meta name="dc.Creator" content="Daniela  Radtki" /></meta><meta name="dc.Creator" content="Corinna  Rettig" /></meta><meta name="dc.Creator" content="Claudio  Ritzert" /></meta><meta name="dc.Creator" content="Felix  Rohdich" /></meta><meta name="dc.Creator" content="Richard  Schneider" /></meta><meta name="dc.Creator" content="Ansgar  Wegener" /></meta><meta name="dc.Creator" content="Stefan  Weigt" /></meta><meta name="dc.Creator" content="Kai  Wilkinson" /></meta><meta name="dc.Creator" content="Christina  Esdar" /></meta><meta name="dc.Description" content="Constitutive activation of the canonical Wnt signaling pathway, in most cases driven by inactivation of the tumor suppressor APC, is a hallmark of colorectal cancer. Tankyrases are druggable key re..." /></meta><meta name="Description" content="Constitutive activation of the canonical Wnt signaling pathway, in most cases driven by inactivation of the tumor suppressor APC, is a hallmark of colorectal cancer. Tankyrases are druggable key re..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 13, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00800" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00800" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00800" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00800" /></link>
        
    
    

<title>Optimization of a Screening Hit toward M2912, an Oral Tankyrase Inhibitor with Antitumor Activity in Colorectal Cancer Models | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00800" /></meta><meta property="og:title" content="Optimization of a Screening Hit toward M2912, an Oral Tankyrase Inhibitor with Antitumor Activity in Colorectal Cancer Models" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0018.jpeg" /></meta><meta property="og:description" content="Constitutive activation of the canonical Wnt signaling pathway, in most cases driven by inactivation of the tumor suppressor APC, is a hallmark of colorectal cancer. Tankyrases are druggable key regulators in these malignancies and are considered as attractive targets for therapeutic interventions, although no inhibitor has been progressed to clinical development yet. We continued our efforts to develop tankyrase inhibitors targeting the nicotinamide pocket with suitable drug-like properties for investigating effects of Wnt pathway inhibition on tumor growth. Herein, the identification of a screening hit series and its optimization through scaffold hopping and SAR exploration is described. The systematic assessment delivered M2912, a compound with an optimal balance between excellent TNKS potency, exquisite PARP selectivity, and a predicted human PK compatible with once daily oral dosing. Modulation of cellular Wnt pathway activity and significant tumor growth inhibition was demonstrated with this compound in colorectal xenograft models in vivo." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00800"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00800">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00800&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00800&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00800&amp;href=/doi/10.1021/acs.jmedchem.1c00800" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 10371-10392</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00793" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00810" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of a Screening Hit toward M2912, an Oral Tankyrase Inhibitor with Antitumor Activity in Colorectal Cancer Models</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Hans-Peter Buchstaller</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hans-Peter Buchstaller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#afc7cec1dc82dfcadbcadd81cddaccc7dcdbcec3c3caddefc2caddccc4c8ddc0dadf81ccc0c2"><span class="__cf_email__" data-cfemail="1d757c736e306d7869786f337f687e756e697c7171786f5d70786f7e767a6f72686d337e7270">[email protected]</span></a>. Phone: +49 6151-72-4092.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hans-Peter++Buchstaller">Hans-Peter Buchstaller</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-0577-8319" title="Orcid link">https://orcid.org/0000-0002-0577-8319</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Uwe Anlauf</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Uwe Anlauf</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Uwe++Anlauf">Uwe Anlauf</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dieter Dorsch</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dieter Dorsch</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dieter++Dorsch">Dieter Dorsch</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sarah Kögler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sarah Kögler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sarah++K%C3%B6gler">Sarah Kögler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Kuhn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Kuhn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Kuhn">Daniel Kuhn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martin Lehmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin Lehmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Lehmann">Martin Lehmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Birgitta Leuthner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Birgitta Leuthner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Birgitta++Leuthner">Birgitta Leuthner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sara Lodholz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sara Lodholz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sara++Lodholz">Sara Lodholz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Djordje Musil</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Djordje Musil</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Djordje++Musil">Djordje Musil</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniela Radtki</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniela Radtki</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniela++Radtki">Daniela Radtki</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Corinna Rettig</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Corinna Rettig</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Corinna++Rettig">Corinna Rettig</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claudio Ritzert</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claudio Ritzert</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claudio++Ritzert">Claudio Ritzert</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Felix Rohdich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Felix Rohdich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Felix++Rohdich">Felix Rohdich</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard Schneider</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard Schneider</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Schneider">Richard Schneider</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ansgar Wegener</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ansgar Wegener</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ansgar++Wegener">Ansgar Wegener</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefan Weigt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefan Weigt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Weigt">Stefan Weigt</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kai Wilkinson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kai Wilkinson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kai++Wilkinson">Kai Wilkinson</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Christina Esdar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christina Esdar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck KGaA, Global Research & Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christina++Esdar">Christina Esdar</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00800&amp;href=/doi/10.1021%2Facs.jmedchem.1c00800" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 10371–10392</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 13, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 May 2021</li><li><span class="item_label"><b>Published</b> online</span>13 July 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 July 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00800" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00800</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10371%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHans-Peter%2BBuchstaller%252C%2BUwe%2BAnlauf%252C%2BDieter%2BDorsch%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D14%26contentID%3Dacs.jmedchem.1c00800%26title%3DOptimization%2Bof%2Ba%2BScreening%2BHit%2Btoward%2BM2912%252C%2Ban%2BOral%2BTankyrase%2BInhibitor%2Bwith%2BAntitumor%2BActivity%2Bin%2BColorectal%2BCancer%2BModels%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10392%26publicationDate%3DJuly%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00800"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">594</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00800" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of a Screening Hit toward M2912, an Oral Tankyrase Inhibitor with Antitumor Activity in Colorectal Cancer Models&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hans-Peter&quot;,&quot;last_name&quot;:&quot;Buchstaller&quot;},{&quot;first_name&quot;:&quot;Uwe&quot;,&quot;last_name&quot;:&quot;Anlauf&quot;},{&quot;first_name&quot;:&quot;Dieter&quot;,&quot;last_name&quot;:&quot;Dorsch&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;Kögler&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Kuhn&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Lehmann&quot;},{&quot;first_name&quot;:&quot;Birgitta&quot;,&quot;last_name&quot;:&quot;Leuthner&quot;},{&quot;first_name&quot;:&quot;Sara&quot;,&quot;last_name&quot;:&quot;Lodholz&quot;},{&quot;first_name&quot;:&quot;Djordje&quot;,&quot;last_name&quot;:&quot;Musil&quot;},{&quot;first_name&quot;:&quot;Daniela&quot;,&quot;last_name&quot;:&quot;Radtki&quot;},{&quot;first_name&quot;:&quot;Corinna&quot;,&quot;last_name&quot;:&quot;Rettig&quot;},{&quot;first_name&quot;:&quot;Claudio&quot;,&quot;last_name&quot;:&quot;Ritzert&quot;},{&quot;first_name&quot;:&quot;Felix&quot;,&quot;last_name&quot;:&quot;Rohdich&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Schneider&quot;},{&quot;first_name&quot;:&quot;Ansgar&quot;,&quot;last_name&quot;:&quot;Wegener&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Weigt&quot;},{&quot;first_name&quot;:&quot;Kai&quot;,&quot;last_name&quot;:&quot;Wilkinson&quot;},{&quot;first_name&quot;:&quot;Christina&quot;,&quot;last_name&quot;:&quot;Esdar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;10371-10392&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00800&quot;},&quot;abstract&quot;:&quot;Constitutive activation of the canonical Wnt signaling pathway, in most cases driven by inactivation of the tumor suppressor APC, is a hallmark of colorectal cancer. Tankyrases are druggable key regulators in these malignancies and are considered as attractive targets for therapeutic interventions, although no inhibitor has been progressed to clinical development yet. We continued our efforts to develop tankyrase inhibitors targeting the nicotinamide pocket with suitable drug-like properties for investigating effects of Wnt pathway inhibition on tumor growth. Herein, the identification of a screening hit series and its optimization through scaffold hopping and SAR exploration is described. The systematic assessment delivered M2912, a compound with an optimal balance between excellent TNKS potency, exquisite PARP selectivity, and a predicted human PK compatible with once daily oral dosing. Modulation of cellular Wnt pathway activity and significant tumor growth inhibition was demonstrated with this compound in&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00800&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00800" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00800&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00800" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00800&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00800" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00800&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00800&amp;href=/doi/10.1021/acs.jmedchem.1c00800" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00800" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00800" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00800%26sid%3Dliteratum%253Aachs%26pmid%3D34255518%26genre%3Darticle%26aulast%3DBuchstaller%26date%3D2021%26atitle%3DOptimization%2Bof%2Ba%2BScreening%2BHit%2Btoward%2BM2912%252C%2Ban%2BOral%2BTankyrase%2BInhibitor%2Bwith%2BAntitumor%2BActivity%2Bin%2BColorectal%2BCancer%2BModels%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D14%26spage%3D10371%26epage%3D10392%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Constitutive activation of the canonical Wnt signaling pathway, in most cases driven by inactivation of the tumor suppressor APC, is a hallmark of colorectal cancer. Tankyrases are druggable key regulators in these malignancies and are considered as attractive targets for therapeutic interventions, although no inhibitor has been progressed to clinical development yet. We continued our efforts to develop tankyrase inhibitors targeting the nicotinamide pocket with suitable drug-like properties for investigating effects of Wnt pathway inhibition on tumor growth. Herein, the identification of a screening hit series and its optimization through scaffold hopping and SAR exploration is described. The systematic assessment delivered <b>M2912</b>, a compound with an optimal balance between excellent TNKS potency, exquisite PARP selectivity, and a predicted human PK compatible with once daily oral dosing. Modulation of cellular Wnt pathway activity and significant tumor growth inhibition was demonstrated with this compound in colorectal xenograft models <i>in vivo</i>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17151" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17151" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Constitutive activation of the canonical Wnt signaling pathway is a hallmark of colorectal cancer, which is in most cases (∼80%) driven by the inactivation of the tumor suppressor <i>adenomatous polyposis coli</i> (APC).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Different loss-of-function mutations within APC impair the β-catenin destruction complex, resulting in tumor-promoting and tumor-maintaining activation of Wnt/β-catenin signaling.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Tankyrase enzymes gained significant interest over recent years as druggable key regulators in APC mutant colorectal cancer.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> The two highly homologous human tankyrase isoforms, TNKS1 and TNKS2, are members of the poly(ADP-ribose) polymerase (PARP) superfamily. This unique class of enzymes consists of 17 members that catalyze ADP-ribosylation of their target proteins via a common catalytic PARP domain.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Mechanistically, tankyrases mark axin proteins, the concentration-limiting components of the β-catenin destruction complex, for degradation by PARsylation and subsequent ubiquitination.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Inhibition of tankyrase is suggested to block the Wnt signal transduction pathway by accumulation of axin proteins and thus triggering enhanced β-catenin degradation.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> Therefore, inhibition of tankyrase activity is considered as a promising strategy for the treatment of colorectal cancer, which is characterized by constitutive Wnt pathway activity.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11−14)</a></div><div class="NLM_p">Accordingly, in the ambition to discover novel anticancer agents, many research groups have worked on the development of tankyrase inhibitors. As a result, a plethora of diverse chemotypes have been identified that inhibit TNKS1/2 by binding to the substrate NAD<sup>+</sup> binding site. Depending on the cavity they were occupying, these compounds were classified as nicotinamide pocket inhibitors, adenosine binding pocket inhibitors, or dual inhibitors addressing both. Despite these tremendous efforts, the number of compounds exhibiting antitumor efficacy in preclinical mouse models after oral application is rather limited. For instance, a few nicotinamide pocket inhibitors (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) showed effects on tumor growth upon oral treatment as monotherapy (RK-287107, RK-582, AZ1366).<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> The number of reports about orally efficacious adenosine pocket binders or dual inhibitors in preclinical models is even less,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> indicating that optimization of chemotypes with these binding modes toward suitable candidates for <i>in vivo</i> studies seems to be very challenging. Moreover, pharmacokinetic characterization of these inhibitors in higher species and their assessment toward applicability as anticancer therapeutics in humans is limited. Hence, there is a continued need for the development of potent, orally available small molecule inhibitors directed toward TNKS1/2 and the WNT/β-catenin signaling pathway.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Nicotinamide pocket inhibitors of TNKS with activity in <i>in vivo</i> pharmacological models.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We recently described the identification of 2-aryl-quinazolin-4-one derivatives as active TNKS1 inhibitors in a biochemical high-throughput screen (HTS) and their optimization toward compound <b>1</b>, which was confirmed to bind to the nicotinamide pocket by X-ray crystallography. Owing to its low MW (316), this TNKS inhibitor had favorable drug-like properties and exhibited target modulation of tankyrase and subsequent reduction of Wnt pathway activity in a human xenograft tumor model.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Encouraged by these promising results, we reasoned if the biochemical potency and consequently the moderate cellular mechanistic activity of this quinazolin-4-one type inhibitor <b>1</b> (EC<sub>50</sub> = 319 nM) could be improved by exchanging the heterocyclic core while keeping the MW in the same range and maintaining the favorable selectivity over related PARP proteins. This could potentially decrease the efficacious dose in pharmacological studies and consequently have a beneficial impact on the predicted human dose. To this end, we surveyed the hit list obtained by the abovementioned biochemical screen to identify alternative core structures and selected a fragment-like hit series containing a 5,6-membered imidazo[1,2-<i>a</i>]pyrazin-8-one ring system as a starting point for an optimization campaign. Herein, the modification of the initial hit series by a scaffold hopping approach and subsequent exploration of the SAR of the discovered pyrrolo[1,2-<i>a</i>]pyrazin-1-one scaffold is described. These efforts yielded the highly potent and selective tankyrase inhibitor 3-[4-(1-hydroxy-1-methyl-ethyl)-phenyl]-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one <b>M2912</b> (<b>30g</b>) with favorable physicochemical and pharmacokinetic properties. Significant tumor growth inhibition in two colorectal xenograft models with APC mutations could be demonstrated for this compound.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05201" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05201" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Identification and <i>In Vitro</i> Characterization of the HTS Hit</h3><div class="NLM_p">In a biochemical HTS of the Merck screening collection against TNKS1 using a homogeneous TR-FRET assay, which monitored the inhibition of the physiological autoPARsylation activity of tankyrase,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> a small hit series with an imidazo[1,2-<i>a</i>]pyrazin-8-one scaffold was identified. The biochemical potency of the most potent series member <b>4a</b> was only moderate, which is in accordance with the findings of Shultz et al. that more polar alterations of the sulfur-containing ring of XAV-939 decreased activity.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> However, there are several attributes of screening hit <b>4a</b>, which made it an attractive starting point for further investigation including its fragment-like structure, polar nature (LogD = 1.6), and favorable binding efficiency (BEI = 25.9).</div><div class="NLM_p">Many nicotinamide pocket inhibitors described in the literature contain a pivotal lactam binding motif forming key hydrogen bonds with the protein and consequently leading to a similar orientation of the ligand in the binding cavity. Potency of this inhibitor type could significantly be improved by introducing a <i>tert</i>-butyl group in the para position of the distal phenyl residue, which fits very well into a small hydrophobic tunnel.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Accordingly, a <i>tert</i>-butyl residue was introduced to access the inhibitory potential of the hit scaffold. Indeed, biochemical activity of <b>4a</b> could significantly be improved by this structural modification and compound <b>4b</b> was a double digit nanomolar inhibitor of TNKS1. Further, despite its increased lipophilicity, compound <b>4b</b> showed decent aqueous solubility and metabolic stability in <i>in vitro</i> microsomal assays and was also active in the cellular mechanistic axin2 assay with low micromolar potency (EC<sub>50</sub> = 1.4 μM, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), which however was still far above the activity level required for a compound suitable for therapeutic pharmacology studies.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Nevertheless, biochemical potency of compound <b>4b</b> demonstrated that also the introduction of a 5,6-bicyclic core can result in a highly binding efficient tankyrase inhibitor (BEI = 28.7). This led us to perform a scaffold hopping approach and systematically study the impact of modifications of the central bicyclic core on TNKS1/2 inhibition and cellular potency. Thus, we introduced other 5-membered heterocycles to the nicotinamide mimetic bicyclic system and subsequently explored the SAR of the preferred scaffold to identify TNKS inhibitors with increased cellular potency, good selectivity, and drug-like properties.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Properties (Potency, Solubility, and Metabolic Stability) of Imidazo[1,2-<i>a</i>]Pyrazin-8-ones</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0013.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">FRET assay.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">ELISA assay. For experimental assay details, see ref <a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a>.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">ND = not determined.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">h, human liver microsomes; m, mouse liver microsomes.</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p">For the preparation of the different scaffolds, individual synthesis routes were established as depicted in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<named-content content-type="anchor" rid="sch2" type="simple"></named-content><a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Compound <b>4b</b>, the <i>tert</i>-butyl-substituted analog of the initial hit containing the imidazo[1,2-<i>a</i>]pyrazin-8-one core was obtained in two steps (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Imidazol-2-carboxylic acid ethyl ester <b>2</b> was alkylated with 2-bromo-1-(4-<i>tert</i>-butyl-phenyl)ethanone to give intermediate <b>3</b>. The ester moiety of <b>3</b> was transferred to the primary amide with ammonium acetate in acetic acid at elevated temperature, which cyclized spontaneously under these conditions affording <b>4b</b>. Synthesis of compounds <b>7a</b>–<b>c</b> with the isomeric imidazo[1,5-<i>a</i>]pyrazin-8-one scaffold is also illustrated in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. First, imidazole ester derivatives <b>5a</b>,<b>b</b><a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> were converted to their corresponding primary amides. Treatment of <b>6a</b> (R = H) with 2-bromo-1-(4-<i>tert</i>-butyl-phenyl)ethanone produced an imidazo-pyrazinium salt, which after benzyl deprotection with imidazole yielded compound <b>7a</b>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Alternatively, <b>7b</b> was obtained in one step by treatment of the primary amide <b>6b</b> with the same 2-bromoacetophenone derivative under microwave irradiation at high temperature. This method was also applied for the preparation of compound <b>7c</b>. In this case, reaction of <b>6b</b> with 2,4′-dibromoacetophenone afforded 6-(4-bromophenyl)-3-methyl-7<i>H</i>,8<i>H</i>-imidazo[1,5-<i>a</i>]pyrazin-8-one, which was converted to compound <b>7c</b> via Pd-catalyst carbonylation and the subsequent Grignard reaction of the methyl ester with methyl magnesium chloride. For the synthesis of the pyrazolo[1,5-<i>a</i>]pyrazin-4-one derivative <b>12</b>, the key intermediate <b>10</b> was also assembled by a two-step approach. In this example, pyrazole-3,5-dicarboxylic acid diethyl ester was alkylated with 2-bromo-1-(4-bromophenyl)ethanone and followed by cyclization under acidic conditions in the presence of ammonium acetate at high temperature. Transformation of the ester functionality of compound <b>10</b> into the methyl group of compound <b>11</b> was accomplished in three steps via lithium aluminum hydride reduction and conversion of the hydroxy group to the bromide using PBr<sub>3</sub> followed by removal of the bromo substituent with zinc in acetic acid. Finally, the methyl ester function was introduced via Pd-catalyst carbonylation and transformed into a 1-hydroxy-1-methyl-ethyl moiety via a Grignard reaction, leading to the pyrazolo[1,5-<i>a</i>]pyrazin-4-one derivative <b>12</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>4b</b>, <b>7a-c</b> and <b>12<sup><i>a</i></sup></b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-bromo-1-(4-<i>tert</i>-butyl-phenyl)ethanone, Na<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C; (b) NH<sub>4</sub>OAc, AcOH, 110 °C; (c) NH<sub>4</sub>Cl, NH<sub>4</sub>OH, MeOH, autoclave, 100 °C; (d) 2-bromo-1-(4-<i>tert</i>-butyl-phenyl)ethanone, DMF/MeCN, 90 °C; (e) imidazole 175 °C; (f) 2-bromo- or 2-chloro-acetophenone derivative, DMF/MeCN, MW, 160 °C; (g) Pd(dppf)<sub>2</sub>Cl<sub>2</sub>.CH<sub>2</sub>Cl<sub>2</sub>, dppf, Et<sub>3</sub>N, CO, methanol/toluene, 100 °C; (h) MeMgCl, CeCl<sub>3</sub>, THF, rt; (i) 2,4′-dibromoacetophenone, K<sub>2</sub>CO<sub>3</sub>, acetone, rt; (j) LiAlH<sub>4</sub>, THF, rt; (k) PBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (l) Zn, AcOH, 100 °C.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>16</b>, <b>21</b> and <b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DMF, KOt-Bu, NH<sub>2</sub>Cl; (b) 4-bromobenzoylchloride, pyridine, 60 °C; (c) NH<sub>4</sub>OH, MeOH; 80–100 °C; (d) PPA, 100 °C; (e) Pd(dppf)<sub>2</sub>Cl<sub>2</sub>.CH<sub>2</sub>Cl<sub>2</sub>, dppf, Et<sub>3</sub>N, CO, methanol/toluene, 100 °C; (f) MeMgCl, CeCl<sub>3</sub>, THF, rt; (g) NaH, O-(diphenylphosphoryl)hydroxylamine, DMF, 0 °C to rt; (h) 4-bromobenzoylchloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (i) NaOH, i-PrOH, 80 °C; (j) 4-bromobenzoylchloride, dioxane, 100 °C.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Pyrrolo[1,2-a]pyrazin-1-one Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,4′-dibromoacetophenone, K<sub>2</sub>CO<sub>3</sub>, DMF or acetone, rt; (b) K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O<sub>2</sub>, DMSO, MeOH, rt; (c) K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O<sub>2</sub>, DMSO, MeOH, rt; followed by TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) NH<sub>4</sub>OAc, AcOH, 110 °C; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (f) LiAlH<sub>4</sub>, THF, 0 °C to rt; (g) Pd(dppf)<sub>2</sub>Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, dppf, Et<sub>3</sub>N, CO, methanol/toluene, 100 °C; (h) MeMgCl, CeCl<sub>3</sub>, THF, rt; (i) ethylene glycole, TSA·H<sub>2</sub>O, rt; (j) Ti(Oi-Pr)<sub>4</sub>, EtMgCl, THF, rt; (k) oxetan-3-one, BuLi, THF, −75 °C; (l) 4,4,5,5-tetramethyl-2-(prop-1-en-2-yl)-1,3,2-dioxaborolane, K<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, dioxane/H<sub>2</sub>O, 90 °C; (m) BMIMPF<sub>6</sub>, DMAP, NMO, OsO<sub>4</sub>, t-BuOH/acetone, 60 °C; (n) Zn(CN)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, 100 °C; (o) MeMgCl, CuCl, THF, 60 °C; (p) Cp<sub>2</sub>TiCl<sub>2</sub>, Zn, ZnCl, dioxane, 90 °C; (q) LiAlH<sub>4</sub>, THF, rt.</p></p></figure><div class="NLM_p">The synthesis of the pyrrolo[2,1-<i>f</i>][1,2,4]triazin-4-one derivative <b>16</b> with a nitrogen in position 1 of the bicycle started with the introduction of an amino group onto 5-methyl-1<i>H</i>-pyrrole-2-carboxylic acid ethyl ester <b>13i</b> by N–N bond formation (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). This reaction was performed with freshly prepared chloramine solution and potassium <i>tert</i>-butylate. The primary amine was then acylated with 4-bromobenzoylchloride in pyridine followed by transformation of the ethyl ester to the primary amide <b>14</b> with ammonium hydroxide solution in methanol. Under these conditions, compound <b>14</b> did not cyclize spontaneously but required treatment with polyphosphoric acid to form key intermediate <b>15</b>, which was converted to the pyrrolo[2,1-<i>f</i>][1,2,4]triazin-4-one derivative <b>16</b> by functional group manipulations already described before. A similar synthesis strategy was applied for the preparation of pyrazolo[3,2-<i>f</i>][1,2,4]triazin-4-one derivative <b>21</b> containing in total 4 nitrogen atoms in the bicyclic core. For the introduction of the amino group onto the ring nitrogen of 5-methyl-2<i>H</i>-pyrazole-3-carboxylic acid ethyl ester <b>17</b>, <i>O</i>-(diphenylphosphoryl)hydroxylamine was the reagent of choice. This transformation was performed in dimethylformamide in the presence of sodium hydride. Compared to the synthesis of compound <b>14</b>, milder reaction conditions could be applied for the acylation of the primary amine with 4-bromobenzoylchloride. Interestingly, treatment of this intermediate with ammonium hydroxide solution in methanol not only provided the desired primary amide <b>19</b> but also delivered in parts the cyclized product <b>20</b>, which were not separated. Instead, cyclization of the remaining primary amide was driven to completion by treating the product mixture with sodium hydroxide in 2-propanol at elevated temperature. Introduction of the hydroxy-dimethyl residue at the para position of the phenyl residue via carbonylation followed by the Grignard reaction were performed as usual. A similar reaction sequence was used for the preparation of thieno[3,2-<i>d</i>]pyrimidin-4-one derivative <b>25</b>. Intermediate <b>23</b> was obtained by acylation of 3-amino-4-methyl-thiophene-2-carboxylic acid methyl ester <b>22</b> with 4-bromo-benzoyl chloride and then cyclized with ammonium hydroxide solution in methanol at elevated temperature. Finally, deployment of the established functional group transformations afforded the hydroxy-dimethyl-substituted compound <b>25</b>.</div><div class="NLM_p last">The various synthesis pathways for the preparation compounds <b>30a</b>–<b>g,i</b> and <b>31</b>–<b>35</b> containing the favorable pyrrolo[1,2-<i>a</i>]pyrazin-1-one scaffold are summarized in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The established routes assure the exploration of the structure activity and property relationship of the core substitution as well as diverse residues at the distal phenyl ring. Varying core substitution was achieved by either using substituted pyrrole-2-carbonitrile derivatives (<b>13a</b>,<b>f</b>–<b>h</b>) or pyrrole-2-carboxylic acid esters (<b>13b</b>–<b>e</b>) as starting materials, which were commercially available or prepared by literature methods.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> Compound <b>13e</b> was obtained from 4-fluoro-1<i>H</i>-pyrrole-2-carboxylic acid ethyl ester by fluorination with Selectfluor in acetonitrile under microwave irradiation. Alkylation of these starting materials was performed in DMF or acetone in the presence of potassium carbonate. While the yield of reactions with cyano-substituted pyrroles (<b>13a</b>,<b>f</b>–<b>h</b>) was low to moderate, conversion of pyrrole-2-carboxylic acid esters (<b>13b</b>–<b>e</b>) delivered intermediates <b>26</b> in high yield. Subsequent formation of the bicyclic key intermediates <b>28a</b>–<b>h</b> by cyclization required different conditions depending on the functional group involved in the ring formation. Treatment of the pyrrole-2-carboxylic acid esters <b>26b</b>–<b>e</b> with ammonium acetate in glacial acetic acid furnished the desired substituted pyrrolo[1,2-<i>a</i>]pyrazin-1-ones <b>28b</b>–<b>e</b> at elevated temperature and long reaction times. On the contrary, saponification of the cyano-substituted pyrroles <b>26a</b>,<b>f</b>–<b>h</b> in methanol in the presence of potassium carbonate, dimethylsulfoxide, and hydrogen peroxide at room temperature afforded the corresponding amides, which spontaneously cyclized under these conditions. It is worth noting that in the case of compounds <b>26a</b>,<b>f</b> even after extended reaction times, the expected products <b>28a</b>,<b>f</b> were accompanied by a non-aromatized impurity <b>27a</b>,<b>f</b>, which fortunately could be isolated and successfully dehydrated with TFA in dichloromethane. Hence, for the conversion of intermediates <b>26g</b>,<b>h</b>, a slightly modified procedure was used, which avoided the isolation of the individual cyclization products. Instead, the formation of the desired products was driven to completion by subsequent treatment of the obtained mixture after workup with TFA in dichloromethane and compounds <b>28g</b>,<b>h</b> were obtained in good yield. Reduction of <b>28h</b> (R<sup>1</sup> = CO<sub>2</sub>Me) with lithium aluminum hydride in THF delivered compound <b>28i</b> bearing a hydroxymethyl residue in position 6. The established reaction conditions for the carbonylation as well as the subsequent Grignard reaction were also applicable to the substrates <b>28a-g,i</b> and delivered the final compounds <b>30a</b>–<b>g</b>,<b>i</b> in moderate to good yields. As the substitution of the pyrrolo[1,2-<i>a</i>]pyrazin-1-one scaffold had been largely mapped out, subsequent efforts were focused on improving the solubility of the so far most favorable derivative <b>30g</b>. To this end, a set of diverse polar residues in the para position of the distal phenyl ring was introduced. Preparation of a close analog (<b>31</b>) of compound <b>30g</b> was accomplished by functionalization of the terminal hydroxy group with excess ethane-1,2-diol under acidic conditions. In this context, intermediates <b>28g</b> and <b>29g</b> proved to be versatile substrates for subsequent functional group manipulations, which allowed the facile evaluation of the SAR at the para position of the distal phenyl ring. For instance, the methyl ester function of <b>29g</b> could be transformed into a cyclopropanol moiety via a Kulinkovich reaction leading to compound <b>32</b>. Further, compound <b>33</b>, bearing a 3-hydroxy-oxetan-3-yl residue, was obtained though only in a low yield via lithiation of the bromo substituted intermediate <b>28g</b> and subsequent treatment with oxetan-3-one. The racemic mixture of the diol derivative <b>34a</b>,<b>b</b> was also prepared from intermediate <b>28g</b> via the Suzuki reaction using isopropenyl boronic acid pinacol ester followed by dihydroxylation of the alkene with <i>N</i>-methylmorpholine <i>N</i>-oxide and catalytic amounts of osmium tetroxide. Both enantiomers (<b>34a</b>, <b>34b</b>) were obtained by means of chiral separation. Finally, the racemic mixture of the homologous diol <b>35a</b>,<b>b</b> was prepared in four steps starting with the Pd-catalyst cyanation of intermediate <b>28g</b> in the presence of zinc cyanide. The nitrile was converted via the Grignard reaction to the corresponding methyl ketone, which was subjected to a Reformatzki reaction with excess ethyl bromoacetate and zinc in the presence of zinc iodide and bis(cyclopentadienyl)titanium(IV) dichloride in dioxane. The resulting β-hydroxyester was reduced to the racemic diol <b>35a/b</b>, which was separated into the enantiomers (<b>35a</b>, <b>35b</b>) by chiral separation.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structure–Activity Relationship of the Bicyclic Core</h3><div class="NLM_p">The aim of the SAR study was to identify a new core scaffold with optimized tankyrase potency and high selectivity over PARP1 as well as favorable physicochemical and pharmacokinetic properties to deliver a suitable compound for <i>in vivo</i> studies. To this end, novel TNKS inhibitors were profiled using ELISA assays (TNKS1 and TNKS2) and their selectivity was determined in a PARP-1 assay. Cellular potency was assessed by detection of axin2 accumulation using a quantitative antibody-based ELISA-like readout. Early assessment of drug-like properties was based on solubility measurement, assessment of metabolic stability in mice and human microsomes. Most nicotinamide pocket inhibitors share a lactam motif, which formed key hydrogen bonds to Gly1185 and Ser1221. In addition, a π–π stacking interaction of the central aromatic core with Tyr residue 1224 was observed in many crystal structures of ligands, for example in complex with TNKS1. While the lactam pharmacophore would be conserved when modifying the anellated five-membered heterocycles of compound <b>4b</b>, the impact on TNKS potency resulting from π–π stacking with Tyr and on selectivity within the PARP family was not easily predictable.</div><div class="NLM_p">Exploration of the SAR commenced with imidazo[1,5-<i>a</i>]pyrazin-8-one derivative <b>7a</b>, in which compared to the initial hit scaffold, the nitrogen atom was shifted to the adjacent position of the five-membered ring (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). This derivative was three times more potent in the biochemical assay than its matched pair compound <b>4b</b> and showed sub-micromolar activity in the cellular assay while favorable microsomal stability and solubility were retained. Several studies about nicotinamide pocket inhibitors revealed that small residues like the fluoro atom or methyl group on the opposite side of the lactam motif significantly enhanced potency.<a onclick="showRef(event, 'ref19 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref21">(19,21)</a> In order to prove the applicability to this scaffold, a methyl substituent was introduced in this part of the molecule. Indeed, gain of potency by this modification was remarkable and compound <b>7b</b> was about 10-fold more potent than <b>7a</b> inhibiting TNKS1 and TNKS2 in the single-digit nanomolar range (IC<sub>50</sub> = 2.9 and 3.8 nM, respectively). In addition, this derivative showed excellent selectivity over PARP 1 (>7000-fold) and a promising cellular EC<sub>50</sub> of 210 nM. However, an increase of lipophilicity (LogD = 3.3) by this methyl group deteriorated solubility and metabolic stability limiting further evaluation in pharmacology studies<i>.</i> In our optimization efforts of quinazoline type inhibitors, we discovered a hydroxy-dimethyl substituent at the distal phenyl ring as a key design feature resulting in potent TNKS inhibitors with a balanced activity and property profile.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In order to revoke the lipophilic nature of compound <b>7b</b>, this residue was introduced. Albeit potency was slightly diminished by this modification, compound <b>7c</b> remained a potent inhibitor of TNKS1 and TNKS2 with low double-digit nanomolar IC<sub>50</sub> values (IC<sub>50</sub> = 12 and 14 nM, respectively) and decent cellular activity. More importantly, lipophilicity was substantially decreased (LogD = 1.3) and solubility and metabolic stability liabilities of compound <b>7b</b> were overcome. Furthermore, selectivity over PARP1 was largely retained (>1600-fold). Hence, the beneficial impact on the overall activity and property profile of compound <b>7c</b> prompted us to preserve this hydroxy-dimethyl substituent as the distal phenyl decoration for all following examples of the scaffold hopping approach.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Properties (Potency, Solubility, and Metabolic Stability) of Examined Chemotypes</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0014.gif" alt="" id="gr13" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0015.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">All values are based at least on duplicate tests.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">ND = not determined.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">h, human liver microsomes; m, mouse liver microsomes.</p></div></div><div></div></div><div class="NLM_p">Next, the positions of the nitrogen atom and the Me-substituent of the five-membered ring were swapped, resulting in pyrazolo[1,5-<i>a</i>]pyrazin-4-one derivative <b>12</b>. By this modification, the inhibitory activities against both enzymes were slightly decreased, suggesting that this scaffold was in general well accommodated in the binding pocket, but the position of the CH<sub>3</sub> group was suboptimal. This was in accordance with the observation that introduction of this CH<sub>3</sub> substituent only slightly enhanced potency compared to the unsubstituted scaffold (data not shown). While <b>12</b> showed reasonable cellular potency and was metabolically as stable as compound <b>7c</b>, aqueous solubility was reduced, which however was still in an acceptable range. It is worth noting that selectivity of this compound over PARP1 was decreased and a 3-fold split between the IC<sub>50</sub> values of TNKS1 and TNKS2 inhibition was determined. In the fourth variant of the central scaffold, the nitrogen atom was introduced to the six-membered ring of the bicycle, providing a pyrrolotriazinone core. Given the fact that this version of the 5,6-fused ring system allowed the introduction of a methyl substituent in the favorable position, potent inhibition of both enzymes was anticipated. Encouragingly, compound <b>16</b> proved to be a tankyrase inhibitor with outstanding biochemical potency in the sub-nanomolar range (TNKS1 IC<sub>50</sub> = 0.8 and TNKS2 IC<sub>50</sub> = 0.9 nM) but more importantly also cellular potency was strikingly improved (EC<sub>50</sub> = 28 nM). Even though this structural modification was accompanied by an increase of lipophilicity (LogD = 2.9) compound properties remained in an acceptable range and therefore compound <b>16</b> represented a suitable inhibitor for further investigation. In contrast, formation of the pyrazolotriazinone core of derivative <b>21</b> by combining the substructures of compound <b>12</b> and <b>16</b> almost obliterates biochemical as well as cellular activity. Interestingly, like for compound <b>12</b>, a split between the IC<sub>50</sub> values of TNKS1 and TNKS2 inhibition was observed for this derivative. Compound <b>25</b>, which is structurally very similar to XAV939 comprising a thiophene ring, was determined to be a single digit nanomolar TNKS inhibitor with promising cellular potency (EC<sub>50</sub> = 96 nM) and acceptable solubility, but this compound was the least PARP1-selective example among the studied chemotypes. Moreover, introduction of the thiophene ring was accompanied by an increase in lipophilicity, impairing intrinsic clearance in mice liver microsomes, which was determined to be rather high. Finally, intrigued by the prediction of a reasonable lipophilicity (cLogD = 2.5) for the pyrrolo[1,2-<i>a</i>]pyrazin-1-one derivate <b>30g</b>, this compound was synthesized. Encouragingly, <b>30g</b> was determined to be another sub-nanomolar TNKS inhibitor (TNKS1 IC<sub>50</sub> = 0.6 and TNKS2 IC<sub>50</sub> = 0.9 nM) with the lowest EC<sub>50</sub> value of cellular axin2 induction (EC<sub>50</sub> = 16 nM) within the list of investigated scaffolds. Good selectivity over PARP1 (>1000-fold), acceptable solubility, decent lipophilicity (LogD = 2.3), and stability in mouse und human liver microsomes contributed to the overall favorable <i>in vitro</i> profile of this compound.</div><div class="NLM_p">In summary, the scaffold hopping approach yielded different chemotypes with a striking impact on biochemical TNKS potency (0.6–250 nM for TNKS1 and 0.9–2300 nM for TNKS2, respectively), cellular activity (16 nM–12 μM), and PARP1 selectivity. Due to its drug-like properties, compound <b>30g</b> was selected from this set of diverse TNKS1/2 inhibitors for further characterization and SAR exploration. To this end, close analogs of <b>30g</b> (<b>30a</b>–<b>f</b>,<b>i</b> and <b>31</b>–<b>35</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) were prepared. The initial focus was directed toward determining the impact of the substitution pattern at the pyrrolo[1,2-<i>a</i>]pyrazin-1-one core.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR Exploration of the Pyrrolo[1,2-<i>a</i>]pyrazin-1-one Scaffold</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0016.gif" alt="" id="gr15" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0017.gif" alt="" id="gr16" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">All values are based at least on duplicate tests.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">h, human liver microsomes; m, mouse liver microsomes.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Structure–Activity Relationship of Pyrrolo[1,2-<i>a</i>]pyrazin-1-ones</h3><div class="NLM_p">In general, small substituents at both investigated positions were well tolerated, resulting in inhibitors with consistently single digit nanomolar IC<sub>50</sub> values in the biochemical assays. Consequently, assessment of the potential of a compound for further characterization was focused on selectivity over PARP1, cellular activity, and property data. While solubility and metabolic stability were maintained, cellular activity of the unsubstituted derivative <b>30a</b> was 7-fold lower compared to compound <b>30g</b>, verifying the strong impact of the 6-CH<sub>3</sub> group on potency. The 7-Cl derivative <b>30b</b> was the least PARP1-selective example within this series, and in addition, solubility was marginal. Poor solubility of the 7-fluoro derivative (<b>30c</b>) and a drop of cellular potency (EC<sub>50</sub> = 230 nM) of the 7-CH<sub>3</sub> analog (<b>30f)</b> made these two compounds overall less attractive. Noteworthily, analogs with a substituent in position 7 of the bicyclic core consistently showed a split between the IC<sub>50</sub> values of TNKS1 and TNKS2 inhibition (about 3–4-fold), which was in agreement with data obtained for compounds <b>12</b> and <b>16</b> bearing a CH<sub>3</sub> group at the same position. A fluoro atom in position 6 (<b>30d</b>) was beneficial for selectivity and surprisingly also for solubility, but the cellular EC<sub>50</sub> was 7-fold higher (EC<sub>50</sub> = 113 nM) compared to the 6-CH<sub>3</sub> derivative <b>30g</b>. The 6,7-difluoro derivative <b>30e</b> exhibited an unfavorable profile primarily due to its poor solubility. Introduction of a polar CH<sub>2</sub>OH group in the 7-position (<b>30i</b>) was beneficial for the compound properties with a favorable microsomal stability and a substantial improvement in solubility, which however came at the expense of cellular potency (EC<sub>50</sub> = 580 nM). Further, residues at this position, e.g., a CF<sub>3</sub> group, were not tolerated, diminishing TNKS inhibitory activity (data not shown). As the SAR of the pyrrolo-pyrazinone scaffold had been mapped out, subsequent efforts were focused on further improving the solubility of compound <b>30g</b>, which remained the lead molecule of this series. To this end, the Me-substituted core was kept constant and a few substituents, partially with increased polarity, at the 4-position of the distal phenyl residue were surveyed. This endeavor commenced with compound <b>31</b>, a close analogue of <b>30g</b> functionalized with a hydroxyethyl group, which sparked our interest due to a similar cLogD value compared to <b>30g</b>. This modification delivered a very potent TNKS inhibitor with improved solubility and good selectivity, which was as potent as <b>30g</b> in the cellular assay. Only a decreased <i>in vitro</i> stability in mouse liver microsomes impeded further consideration of this derivative. While the profile of the hydroxy-cyclopropyl derivative <b>32</b> displayed some shortcomings (solubility, metabolic stability) compared to <b>30g</b>, compound <b>33</b> containing a hydroxy-oxethanyl residue exhibited an attractive profile. This compound potently induced axin2 in the cellular assay (EC<sub>50</sub> = 28 nM), showed acceptable stability in mouse und human liver microsomes and an improved solubility (60 μg/mL). Only, selectivity over PARP1 was reduced compared to <b>30g</b>. The common feature of the following analogs (<b>34a/b</b>, <b>35a/b</b>) was a second hydroxy group in a side chain of the substituent, by which lipophilicity was significantly decreased and excellent solubility was induced. The absolute configuration of these bis-hydroxylated analogs <b>34a/34b</b> and <b>35a/35b</b> is unknown and was therefore arbitrarily assigned. Although the optimization goal was achieved with both enantiomers of the 1,2-diol <b>34a/34b</b> (solubility = 784 and 826 μg/mL, respectively), further consideration of these analogs was hampered by their decreased cellular activity. It is worth noting that <i>in silico</i> prediction of metabolic transformations of compound <b>30g</b> using Metasite proposed an oxidation at the 6-methyl group and hence compound <b>30i</b> as the main metabolite. However, metabolite identification studies (<i>in vitro</i> and <i>in vivo</i>) using LC–MS/MS elucidated that primarily hydroxylation took place at one of the methyl groups of the substituent at the distal phenyl moiety resulting in the formation of the 1,2-diol <b>34a/34b</b>. Encouragingly, cellular activity of both enantiomers <b>35a</b>/<b>35b</b> containing the homologues 1,3-diol moiety was not impaired by their increased polarity and both analogs were as potent as <b>30g</b> in the axin2 induction assay (EC<sub>50</sub> = 18 nM and 16 nM, respectively). Excellent solubility and acceptable metabolic stability in liver microsomes contributed to their overall appealing profiles. Interestingly, one enantiomer (<b>35a</b>) was determined to be more selective over PARP1 (≥770-fold) than the other one (≥162-fold).</div><div class="NLM_p">The SAR of the pyrrolo[1,2-<i>a</i>]pyrazin-1-one scaffold had largely been explored and yielded molecules like <b>30g</b>, <b>33</b>, and <b>35a/35b</b> with promising potency, good selectivity, and drug-like properties (solubility and metabolic stability). For the ultimate selection of the most suitable inhibitor for <i>in vivo</i> studies, this set of optimized compounds was investigated in the Caco-2 assay and in mouse pharmacokinetic studies to assess their applicability for po dosing.</div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, compound <b>30g</b> was highly permeable and had a low efflux ratio in Caco-2 cells, indicating low affinity to drug transporters. The results for compounds with increased polarity (<b>33</b>, <b>35a</b>/<b>35b</b>) compared to <b>30g</b> revealed that their passive permeability was impaired whereas efflux was increased, which presumably can be attributed to the additional acceptor or donor motives, respectively. In addition, <b>30g</b> showed a reasonable <i>in vitro</i>–<i>in vivo</i> correlation of mouse CL predicted based on scaling of metabolic stability data obtained in liver microsomes. On the contrary, <b>33</b>, <b>35a</b>, and <b>35b</b> showed high CL in mouse PK studies and were significantly underpredicted by the <i>in vitro</i> data, suggesting Phase II and/or extrahepatic CL pathways for these compounds (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Hence, based on the PhysChem and ADME characteristics, <b>30g</b> was nominated as development candidate <b>M2912</b> and further characterized <i>in vitro</i> and <i>in vivo</i>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Comparison of PhysChem and ADME Characteristics of Candidate Molecules</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center"><b>30g</b></th><th class="colsep0 rowsep0" align="center"><b>33</b></th><th class="colsep0 rowsep0" align="center"><b>35a</b></th><th class="colsep0 rowsep0" align="center"><b>35b</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LogD pH 7.4</td><td class="colsep0 rowsep0" align="center">2.3</td><td class="colsep0 rowsep0" align="center">1.7</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="center">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S pH 7.4 (μg/mL)</td><td class="colsep0 rowsep0" align="center">21</td><td class="colsep0 rowsep0" align="center">60</td><td class="colsep0 rowsep0" align="center">369</td><td class="colsep0 rowsep0" align="center">847</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Mic Cl<sub>int</sub> h/m (μL/min/mg prot)</td><td class="colsep0 rowsep0" align="center"><10/39</td><td class="colsep0 rowsep0" align="center"><10/56</td><td class="colsep0 rowsep0" align="center"><10/45</td><td class="colsep0 rowsep0" align="center"><10/35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 AB (10<sup>–6</sup> cm/s)</td><td class="colsep0 rowsep0" align="center">28.6</td><td class="colsep0 rowsep0" align="center">11.8</td><td class="colsep0 rowsep0" align="center">8.1</td><td class="colsep0 rowsep0" align="center">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 efflux ratio</td><td class="colsep0 rowsep0" align="center">1.3</td><td class="colsep0 rowsep0" align="center">4.8</td><td class="colsep0 rowsep0" align="center">6.2</td><td class="colsep0 rowsep0" align="center">8.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Predicted mouse CL<sub>P</sub> (L/h/kg)</td><td class="colsep0 rowsep0" align="center">1.7</td><td class="colsep0 rowsep0" align="center">2.5</td><td class="colsep0 rowsep0" align="center">2.5</td><td class="colsep0 rowsep0" align="center">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Observed mouse CL<sub>P</sub> (L/h/kg)</td><td class="colsep0 rowsep0" align="center">2.72</td><td class="colsep0 rowsep0" align="center">5.04</td><td class="colsep0 rowsep0" align="center">7.85</td><td class="colsep0 rowsep0" align="center">5.66</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Co-crystal Structure of <b>M2912</b> (<b>30g</b>) and ITC Assessment</h3><div class="NLM_p">We were able to solve the X-ray structure of <b>M2912</b> (<b>30g</b>) in complex with TNKS1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) to a resolution of 1.95 Å (PDB code 7OCV). The observed interactions of the bicyclic core of this inhibitor are similar to known nicotinamide pocket binders containing a lactam moiety. Two hydrogen bonds to Gly1185 and an additional hydrogen bond to the side chain of Ser1221 by the lactam oxygen are formed. The pyrrolo[1,2-<i>a</i>]pyrazin-1-one scaffold shows π–π stacking interactions of the central aromatic core with Tyr residue 1224. The methyl group at the 6-position points toward a lipophilic subpocket and is in a van der Waals distance to the phenyl ring atoms of Tyr1203, Tyr1213, and Tyr1224, forming a sandwich-like orientation. The terminal 1-hydroxy-1-methyl-ethyl residue points toward the exit of the narrow nicotinamide pocket and the hydroxyl group does not make directed interactions to surrounding amino acids or water molecules. A detailed Watermap analysis of <b>M2912</b> (<b>30g</b>) in complex with TNKS1 was performed (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf" class="ext-link">Figure S1</a>), which interestingly revealed a high energy water site at the position where the 6-methyl group is located. It was predicted that filling this water site would result in an increase of Δ<i>G</i>, which prompted us to investigate this by isothermal calorimetry (ITC) measurements.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding mode of <b>M2912</b> (<b>30g</b>) in complex with TNKS1 (PDB code 7OCV). The pyrrolo[1,2-<i>a</i>]pyrazin-1-one scaffold core makes three hydrogen bonds to Gly1185 and Ser1221 (highlighted by red dashed lines) and engages in π–π-stacking interactions with Tyr1224 (highlighted by orange dashed lines). The phenyl ring pointing toward the solvent forms π–π interactions with Tyr1224 (highlighted by orange dashed line) and van der Waals interactions with Tyr1203. The methyl group exhibits van der Waals interactions to surrounding tyrosine residues (indicated by yellow dashed lines).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Substitution at the 6-position, especially introduction of a methyl substituent, was key for the substantial improvement of biochemical as well as cellular potency of compound <b>M2912</b> (<b>30g</b>). We investigated the thermodynamics of inhibitor binding to elucidate what factor contributes to the observed potency enhancement. To this end, binding affinities and thermodynamic signatures of selected pyrrolo[1,2-<i>a</i>]pyrazin-1-one derivatives from the optimization process were measured using isothermal calorimetry (ITC) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>; Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf" class="ext-link">Table S2</a>). In general, all compounds displayed low nanomolar binding affinities that are fully consistent with respect to absolute and relative affinities (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf" class="ext-link">Table S2</a>) with the biochemical potencies measured for TNKS1 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The binding affinity for <b>M2912</b> (<b>30g</b>) is too tight to be exactly resolved and could only be estimated to be <i>K</i><sub>D</sub> < 2 nM, matching with the sub-nanomolar biochemical potency. The thermodynamic signature for all compounds is dominated by the binding enthalpy in a range of −54 to −65 kJ/mol as driving force for the compound interaction. This observation is in line with the high number of direct interactions that the present scaffold is able to establish in the binding pocket. In <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, the impact of different substituents at the 6-position of the central core is compared.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Thermodynamic signature for the binding interaction of selected compounds with TNKS1 derived by ITC. Contributions from binding enthalpy represented by blue bars, entropic contributions represented by red bars, and over all free energy term depicted as green bar.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The slightly higher enthalpic contribution for the unsubstituted analog <b>30a</b> compared to the 6-F-substituted derivative <b>30d</b> is compensated for by a slight entropic penalty, resulting in an almost identical binding constant (<i>K</i><sub>D</sub> ≈ 6 nM) for both compounds. We surmised that the electron withdrawing effect of the 6-F substituent on the central core (<b>30d</b>) slightly attenuates binding enthalpy of this compound. In contrast, binding of the 6-CH<sub>3</sub>-substituted inhibitor <b>M2912</b> (<b>30g</b>) has a strongly enhanced enthalpic contribution (ΔΔH = −15.8 kJ/mol), which can likely be attributed to additional interactions of the Me group with amino acid side chains (Tyr1203, Tyr1213, and Tyr1224) in this region and an electron donating effect strengthening the observed π–π stacking interaction of the central aromatic core with Tyr1224. However, the enthalpic gain is partly compensated for by a strong entropic penalty for this compound, which is indicative of a loss of conformational degrees of freedom that is larger than a possible entropy gain from displacing a localized water molecule as identified in Watermap analysis. Thus, the additional methyl group of <b>M2912</b> (<b>30g</b>) may lead to a structural rigidification, e.g., by cooperative tethering interactions toward amino acid side chains. For the methyl substituted variant <b>35b</b>, we should expect a comparable binding interaction and indeed saw a similar trend for the thermodynamic signature as for <b>M2912</b> (<b>30g</b>) albeit with a smaller enthalpy gain. Docking analysis showed that the terminal dihydroxyl group of <b>35b</b> exhibits greater flexibility, and different binding poses were identified where the ethyl-hydroxyl group interacts with Ala1202 or His1201, respectively. This could contribute to the lower binding enthalpy of this compound if cooperativity between binding interactions to the protein is lost. By contrast, the hydroxymethyl-substituted <b>30i</b> has almost no enthalpy gain compared to <b>30a</b> but still a substantial entropic penalty leading to a loss in binding affinity.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vitro Characterization of <b>M2912</b> (<b>30g</b>)</h3><div class="NLM_p">To assess the target specificity of the development candidate, biochemical inhibition of a broad panel of human PARP enzymes was determined and IC<sub>50</sub> values for TNKS1 (1.3 nM) and TNKS2 (1.4 nM) were consistent with results from internal biochemical assays (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). While the most potently inhibited PARPs 1, 2, 3 and 11 enzymes showed a split of 50–100-fold against TNKS1 and TNKS2, all other tested PARP family members had a split of >300-fold or were not affected at all (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Overall, these data indicated exquisite selectivity of <b>M2912</b> (<b>30g</b>) for TNKS1 and TNKS2 within the PARP family.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Selectivity of <b>M2912</b> (<b>30g</b>) against Members of the PARP Family<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>TNKS1</b></th><th class="colsep0 rowsep0" align="center"><b>TNKS2</b></th><th class="colsep0 rowsep0" align="center"><b>PARP1</b></th><th class="colsep0 rowsep0" align="center"><b>PARP2</b></th><th class="colsep0 rowsep0" align="center"><b>PARP3</b></th><th class="colsep0 rowsep0" align="center"><b>PARP6</b></th><th class="colsep0 rowsep0" align="center"><b>PARP7</b></th><th class="colsep0 rowsep0" align="center"><b>PARP8</b></th><th class="colsep0 rowsep0" align="center"><b>PARP10</b></th><th class="colsep0 rowsep0" align="center"><b>PARP11</b></th><th class="colsep0 rowsep0" align="center"><b>PARP12</b></th><th class="colsep0 rowsep0" align="center"><b>PARP14</b></th><th class="colsep0 rowsep0" align="center"><b>PARP15</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.0013</td><td class="colsep0 rowsep0" align="left">0.0014</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">0.20</td><td class="colsep0 rowsep0" align="left">0.11</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">0.33</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">0.067</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">IC50 values in μM.</p></div></div></div><div class="NLM_p">Cellular potency of <b>M2912</b> (<b>30g</b>) was assessed by detection of axin2 accumulation (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Moreover, to further confirm the cellular mechanistic mode of action, cellular abundance of tankyrase levels were detected in DLD1 cells upon treatment with <b>M2912</b> (<b>30g</b>), since inhibition of tankyrase-mediated auto-PARsylation results in an accumulation of tankyrase protein.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> A dose-dependent increase of both markers indicated their stabilization due to impaired PARSylation and degradation as previously shown in Colo320 cells.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Consistent with its key role in the β-catenin destruction complex, increased axin2 levels translate into inhibition of Wnt pathway reporter activity in DLD1 cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cellular mode of action of <b>M2912</b> (<b>30g</b>) in DLD1 cells. Treatment with increasing concentrations of <b>M2912</b> (<b>30g</b>) for 24 h induced an accumulation of tankyrase and axin2 protein levels and reduced cellular Wnt reporter activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A small panel of APC mutant colorectal cancer cell lines was tested for sensitivity against <b>M2912</b> (<b>30g</b>) in softagar growth assays (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). A dose-dependent reduction of cell growth was observed in HT55 and Colo320 cells while DLD1, SW480, SW620, and HCT15 cells were not affected by treatment with <b>M2912</b> (<b>30g</b>). It is noteworthy that the two sensitive cell lines do not harbor any oncogenic driver mutation in KRAS or PIK3CA, which are however expressed in the resistant cell lines.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>M2912</b> (<b>30g</b>) on softagar growth of colorectal cancer cell lines. Cells were seeded in softagar and treated with different concentrations of <b>M2912</b> (<b>30g</b>) for 14 days. Cell growth was determined by resazurin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>M2912</b> (<b>30g</b>) was profiled against 146 safety relevant off-targets and demonstrated minimal activity, being only active on the dopamine transporter (IC<sub>50</sub> ≈ 19 μM) as well as on the A3 adenosine receptor (IC<sub>50</sub> ≈ 10 μM). Further, this inhibitor was completely inactive against a broad panel of kinases (243 kinases: no inhibition >50% @1 μM). Also, only minimal hERG inhibition (17%@30 μM) was determined. The favorable <i>in vitro</i> metabolic stability of this compound observed in incubations with mouse as well as human liver microsomes was further confirmed by stability testing with hepatocytes, demonstrating moderate stability in mouse hepatocytes (Cl<sub>int</sub> = 32.1 μL/min/10<sup>6</sup> cells) and high stability in human hepatocytes (Cl<sub>int</sub> = 1.19 μL/min/10<sup>6</sup> cells) against phase I and II metabolic reactions. Furthermore, <b>M2912</b> (<b>30g</b>) is moderately but still sufficiently soluble (thermodynamic solubilities: 0.021 mg/mL (PBS, pH 7.4), 0.029 mg/mL (FaSSIF, pH 6.5), and 0.064 mg/mL (FeSSIF, pH 5.0)) and does not inhibit (neither reversibly nor mechanism-based) any cytochrome P450 subtypes (Cyp IC<sub>50</sub>s > 50 μM).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> PK Profile and Prediction of Human PK</h3><div class="NLM_p">In light of these favorable, drug-like properties, <b>M2912</b> (<b>30g</b>) was investigated in <i>in vivo</i> pharmacokinetic studies. Overall, the compound showed acceptable <i>in vivo</i> pharmacokinetics (PK) in all tested preclinical species (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Profile of Compound <b>M2912</b> (<b>30g</b>)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">Fu<sub>p</sub> (%)</th><th class="colsep0 rowsep0" align="center" char=".">C<sub>B</sub>/C<sub>P</sub></th><th class="colsep0 rowsep0" align="center" char=".">Vd<sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">Plasma CL (L/h/kg)</th><th class="colsep0 rowsep0" align="center" char=".">Q<sub>h</sub> (%)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">Excretion (feces/urine)</th><th class="colsep0 rowsep0" align="center" char=".">F (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="center" char=".">16</td><td class="colsep0 rowsep0" align="center" char=".">0.98</td><td class="colsep0 rowsep0" align="center" char=".">2.43</td><td class="colsep0 rowsep0" align="center" char=".">2.72</td><td class="colsep0 rowsep0" align="center" char=".">50</td><td class="colsep0 rowsep0" align="center" char=".">0.976</td><td class="colsep0 rowsep0" align="center">6.4/–</td><td class="colsep0 rowsep0" align="center" char=".">77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="center" char=".">13</td><td class="colsep0 rowsep0" align="center" char=".">0.93</td><td class="colsep0 rowsep0" align="center" char=".">0.91</td><td class="colsep0 rowsep0" align="center" char=".">1.93</td><td class="colsep0 rowsep0" align="center" char=".">56</td><td class="colsep0 rowsep0" align="center" char=".">0.340</td><td class="colsep0 rowsep0" align="center">1.8/<1</td><td class="colsep0 rowsep0" align="center" char=".">41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="center" char=".">14</td><td class="colsep0 rowsep0" align="center" char=".">1.06</td><td class="colsep0 rowsep0" align="center" char=".">2.17</td><td class="colsep0 rowsep0" align="center" char=".">2.54</td><td class="colsep0 rowsep0" align="center" char=".">130</td><td class="colsep0 rowsep0" align="center" char=".">0.593</td><td class="colsep0 rowsep0" align="center">–/–</td><td class="colsep0 rowsep0" align="center" char=".">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="center" char=".">21</td><td class="colsep0 rowsep0" align="center" char=".">1.21</td><td class="colsep0 rowsep0" align="center" char=".">3.15</td><td class="colsep0 rowsep0" align="center" char=".">2.45</td><td class="colsep0 rowsep0" align="center" char=".">99</td><td class="colsep0 rowsep0" align="center" char=".">1.01</td><td class="colsep0 rowsep0" align="center">–/<1</td><td class="colsep0 rowsep0" align="center" char=".">6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="center" char=".">9.6</td><td class="colsep0 rowsep0" align="center" char=".">0.91</td><td class="colsep0 rowsep0" align="center" char=".">1.2<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center" char=".">0.12<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center" char=".">17</td><td class="colsep0 rowsep0" align="center" char=".">6.9</td><td class="colsep0 rowsep0" align="center">–/–</td><td class="colsep0 rowsep0" align="center" char=".">70<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Predicted by allometric scaling.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Predicted by PBPK modeling (Gastroplus, v9.5).</p></div></div></div><div class="NLM_p">Prediction of human PK was performed by 4-species allometric scaling corrected for protein binding and considering interspecies differences in intrinsic clearance in liver microsomes (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf" class="ext-link">Figures S3 and S4</a>). Metabolism studies in hepatocytes showed that <b>M2912</b> (<b>30g</b>) was metabolized mainly via phase I reactions. Further, these experiments revealed a good correlation (within 2-fold) of clearance values scaled from <i>in vitro</i> data as compared to observed <i>in vivo</i> clearance in the 4 nonclinical species tested. Triggered by these findings, human clearance was also scaled from such <i>in vitro</i> data (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Scaling of <i>in vivo</i> blood CL based on <i>in vitro</i> intrinsic CL data obtained in hepatocytes from mice, rats, dogs, and monkeys (dotted lines represent area within 2-fold prediction error; solid line represents 1:1 unity; predicted human value was correlated with the value predicted by allometric scaling).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Details of the scaling are summarized in the Supporting Information (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf" class="ext-link">Table S3</a>). Both approaches resulted in consistent values of the human clearance, i.e., 0.12 vs 0.17 L/h/kg, respectively. Overall, the predicted human PK parameters are compatible with once daily oral dosing, i.e., clearance and volume of distribution at the steady state (Vd<sub>ss</sub>) were estimated to be low (∼0.12 L/h/kg) and moderate (∼1.2 L/kg), respectively, resulting in a moderate predicted terminal half-life (∼7 h). Physiologically based pharmacokinetics (PBPK) simulations suggested that human oral bioavailability may be ≥70% up to a dose level of ∼200 mg daily.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>In Vivo</i> Studies with Compound <b>M2912</b> (<b>30g</b>)</h3><div class="NLM_p">The overall favorable profile of the selected candidate molecule prompted us to investigate pharmacodynamic (PD) effects in the colorectal cancer xenograft model DLD1. Tumor-bearing mice received a single oral administration of two different doses (10 and 30 mg/kg) of <b>M2912</b> (<b>30g</b>), and PD biomarkers were assessed at three different time points (2, 8, and 18 h) in tumor tissue. A time-dependent increase of tankyrase and axin2 abundance was observed at 2 and 8 h, while levels declined back to baseline at the later time point of 18 h. The observed PD modulation is in line with recently reported results in a Colo320 xenograft model.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Consistent with the increase of axin2 level, the active β-catenin level decreased with a maximum effect at 8 h, indicating inhibition of Wnt pathway activity (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <i>In vivo</i> pharmacodynamic biomarker modulation with <b>M2912</b> (<b>30g</b>) in the DLD1 xenograft model. DLD1 tumor-bearing mice received a single oral treatment with 10 or 30 mg/kg <b>M2912</b> (<b>30g</b>) and tumors were excised at 2, 8, and 18 h, respectively. Protein levels of (a) tankyrase, (b) axin2, and (c) active nuclear β-catenin were analyzed in <i>ex vivo</i> lysates and compared to untreated controls. Each group contained five mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on the cellular growth sensitivity data (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), we selected Colo320 and HT55 xenograft models to assess the tumor growth inhibition potential of <b>M2912</b> (<b>30g</b>). Mice bearing Colo320 (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>a) and HT55 (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>b) were treated orally bi-daily with 20 mg/kg, which resulted in simulated exposure levels above the cellular EC<sub>50</sub> for almost 18 h, suggesting sufficient target engagement (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf" class="ext-link">Figure S5</a>). <b>M2912</b> (<b>30g</b>) demonstrated significant tumor growth inhibition of both human colon cancer xenograft tumor models, Colo320 and HT55, respectively. The regimen of 20 mg/kg bi-daily was selected based on a tolerability study in mice treated with 15, 30, and 50 mg/kg bi-daily for 20 days (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf" class="ext-link">Figure S6a</a>). 15 mg/kg bi-daily was tolerated without any treatment-related histopathological findings. The dose of 20 mg/kg bi-daily was tolerated based on clinical signs and body weight (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf" class="ext-link">Figure S6b,c</a>). In addition, plasma levels of <span class="smallcaps smallerCapital">l</span>-citrulline, a well-characterized preclinical safety biomarker for gastrointestinal toxicity,<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> were not affected in mice treated for 17 days with 20 mg/kg bi-daily of <b>M2912</b> (<b>30g</b>) (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf" class="ext-link">Figure S7</a>). However, at higher doses of 50 mg/kg bi-daily, adverse histopathological findings were observed in the gastrointestinal tract, which was previously described as the key target organ for tankyrase inhibitors.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a></div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <i>In vivo</i> antitumor activity of <b>M2912</b> (<b>30g</b>) in two colorectal cancer xenograft models, Colo320 (a) and HT55 (b). 20 mg/kg <b>M2912</b> (<b>30g</b>) given per os in bi-daily schedule achieved significant tumor growth inhibition compared to vehicle control in both models.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11665" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11665" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A biochemical HTS against TNKS1 using a TR-FRET assay delivered a small series of imidazo[1,2-<i>a</i>]pyrazin-8-ones. Hit optimization through scaffold hopping yielded a potent tankyrase inhibitor with a pyrrolo[1,2-<i>a</i>]pyrazin-1-one scaffold, which was further investigated by SAR exploration around the central core and the 4′-position of the distal phenyl residue. The exchange of the heterocyclic core was key to improving cellular activity compared to 2-aryl-quinazolin-4-one <b>1</b> and was achieved while maintaining low MW (282) and high binding efficiency (32.7). The systematic study resulted in the discovery of 3-[4-(1-hydroxy-1-methyl-ethyl)-phenyl]-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one <b>M2912</b> (<b>30g</b>), a very potent TNKS1/TNKS2 inhibitor with exquisite selectivity over other PARP family enzymes and favorable compound properties. This inhibitor potently modulated the Wnt/β-catenin pathway by elevating the levels of axin2 and tankyrase in DLD1 cells in a dose-dependent manner resulting in reduced cellular Wnt reporter activity. Supported by its favorable rodent pharmacokinetic profiles, <b>M2912</b> (<b>30g</b>) exhibited statistically significant tumor growth inhibition in two APC mutant human colon cancer models after oral administration of a well-tolerated dose of 20 mg/kg twice daily. Overall, these findings together with a predicted human PK compatible with once daily oral dosing and the option of appropriate combination treatment regimens with other anticancer agents<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> qualify <b>M2912</b> (<b>30g</b>) as a candidate to explore the potential and utility of tankyrase inhibitors as cancer therapeutic agents for the treatment of patients with Wnt pathway-driven colorectal cancer.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50514" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50514" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemical Synthesis</h3><div class="NLM_p">All solvents and reagents were obtained from commercial suppliers and were used without further purification. Compounds <b>2</b>, <b>8</b>, <b>13a</b>–<b>c</b>, <b>13g</b>, <b>13h</b>, <b>13i</b>, <b>17</b>, and <b>22</b> were purchased from commercial suppliers. Compounds <b>5a</b>,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a><b>5b</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a><b>13d</b>,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and <b>13f</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> were prepared as described in the literature.</div><div class="NLM_p">HPLC/MS spectra of the products were recorded on an Agilent 1100 HPLC system (1100 high-pressure gradient pump, 1100 diode array detector, wavelength: 220 nm) interfaced to an Agilent 1100 mass spectrometer detector (positive mode). The following conditions were used: (A): column: Chromolith SpeedROD RP-18e, 50 × 4.6 mm<sup>2</sup>; gradient: A:B = 96:4 to 0:100 in 3.3 min; flow rate: 2.40 mL/min; eluent A: water + 0.05% formic acid, eluent B: acetonitrile + 0.04% formic acid; (B): column: Chromolith SpeedROD RP-18e, 50 × 4.6 mm<sup>2</sup>; gradient: A:B = 96:4 to 0:100 in 2.8 min; flow rate: 2.0 mL/min; eluent A: water + 0.05% formic acid, eluent B: acetonitrile + 0.04% formic acid; (C): column: Chromolith PerformanceROD RP-18e, 100 × 3 mm<sup>2</sup>; gradient: A:B = 99:1 to 0:100 in 3.5 min; flow rate: 2.0 mL/min; eluent A: water + 0.05% formic acid, eluent B: acetonitrile + 0.04% formic acid; (D): column: Chromolith PerformanceROD RP-18e, 100 × 3 mm<sup>2</sup>; gradient: A:B = 99:1 to 0:100 in 1.8 min; flow rate: 2.0 mL/min; eluent A: water + 0.05% formic acid, eluent B: acetonitrile + 0.04% formic acid. Proton magnetic resonance spectra (<sup>1</sup>H-NMR) were recorded on a Bruker Avance II 400 (400 MHz, 1H) spectrometer or a Bruker DRX 500 spectrometer (500 MHz, 1H) using DMSO-<i>d</i><sub>6</sub> as the solvent. Chemical shifts (δ) are reported in parts per million (ppm) relative to DMSO as the internal reference. High-resolution mass spectra were recorded on a Waters Micromass GCT Premier spectrometer (EI, 70 eV; accuracy, <3 mDa; mass range: 25–800 amu). Flash chromatography was performed on an Isco CombiFlash Companion system using prepacked reversed-phase flash columns and mixtures of water/acetonitrile containing 0.1% HCOOH. The combined fractions were concentrated <i>in vacuo</i>, and the aqueous residue was rendered basic and extracted with ethyl acetate. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated <i>in vacuo</i>. Preparative HPLC was performed on an Agilent system (1200 series) using a Chromolith prep RP-18e 100-25 column and mixtures of water/acetonitrile containing 0.1% HCOOH. The combined fractions were concentrated <i>in vacuo</i>, and the aqueous residue was rendered basic and extracted with ethyl acetate. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated <i>in vacuo</i>. Final compounds were found to be >95% pure by HPLC and HPLC/MS analyses. The absolute configuration of compounds <b>34a/b</b> and <b>35a/b</b> is unknown and was therefore arbitrarily assigned.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 1-[2-(4-<i>tert</i>-Butyl-phenyl)-2-oxo-ethyl]-1<i>H</i>-imidazole-2-carboxylic Acid Ethyl Ester (<b>3</b>)</h4><div class="NLM_p last">Imidazol-2-carboxylic acid ethyl ester <b>2</b> (100.0 mg, 0.714 mmol) was dissolved in DMF, sodium carbonate (151.3 mg, 1.427 mmol) and 2-bromo-1-(4-<i>tert</i>-butyl-phenyl)ethanone (218.5 mg, 0.857 mmol) were added, and the mixture was stirred for 4 d at 60 °C. The reaction mixture was filtered, the filtrate was evaporated, and the residue was purified by preparative HPLC. Yield: 114 mg (51%) of the title compound as a colorless solid. HPLC/MS <i>m/z</i>: 315.1 [M + H]<sup>+</sup>, Rt (A): 2.25 min.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 6-(4-<i>tert</i>-Butyl-phenyl)-7<i>H</i>-imidazo[1,2-<i>a</i>]pyrazin-8-one (<b>4b</b>)</h4><div class="NLM_p last">A suspension of compound <b>3</b> (55 mg, 0.188 mmol) in glacial acetic acid (2.0 mL) was treated with ammonium acetate (434.0 mg, 5.630 mmol) and stirred at 110 °C overnight. The reaction mixture was cooled to room temperature, diluted with water, neutralized with sodium bicarbonate, and extracted with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered, and evaporated to dryness. The residue was triturated with diethyl ether, filtered by suction, and dried under vacuum to afford the title compound (20 mg, 40%) as an off-white solid. HPLC/MS <i>m</i>/<i>z</i>: 268.1 [M + H]<sup>+</sup>, Rt (A): 1.97 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.36 (s, 1H), 7.87–7.73 (m, 2H), 7.62 (d, 2H), 7.54–7.46 (m, 3H), 1.32 (s, 9H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>16</sub>H<sub>17</sub>N<sub>3</sub>O: 267.1372; found: 267.1377.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-Benzyl-1<i>H</i>-imidazole-4-carboxylic Acid Amide (<b>6a</b>)</h4><div class="NLM_p last">1-Benzyl-1<i>H</i>-imidazole-4-carboxylic acid ethyl ester <b>5a</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (3.93 g, 17.07 mmol) and ammonium chloride (0.27 g, 5.12 mmol) were treated with ammonium hydroxide solution (32%, 45 mL) and stirred in an autoclave at 105 °C overnight. The reaction mixture was cooled to room temperature, the precipitate was filtered off, washed with water, and dried at 50 °C <i>in vacuo</i> to give compound <b>6a</b> (2.13 g, 61%) as an off-white solid. HPLC/MS <i>m</i>/<i>z</i>: 202.0 [M + H]<sup>+</sup>, Rt (A): 1.30 min.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-Benzyl-2-methyl-1<i>H</i>-imidazole-4-carboxylic Amide (<b>6b</b>)</h4><div class="NLM_p last">1-Benzyl-2-methyl-1<i>H</i>-imidazole-4-carboxylic acid ethyl ester <b>5b</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (1.28 g, 5.240 mmol) and ammonium chloride (112.1 mg, 2.096 mmol) were heated in an autoclave in a mixture of ammonium hydroxide solution (32%, 40 mL) and methanol (20 mL) at 100 °C and 6.6 bar overnight. The reaction mixture was cooled to room temperature and evaporated to dryness. The residue (1.02 g) was used in the next step without further purification.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-(4-<i>tert</i>-Butyl-phenyl)-7<i>H</i>-imidazo[1,5-<i>a</i>]pyrazin-8-one (<b>7a</b>)</h4><div class="NLM_p"><b>7a</b>.1: 1-Benzyl-1<i>H</i>-imidazole-4-carboxylic acid amide (200.0 mg, 0.994 mmol) and 2-bromo-1-(4-<i>tert</i>-butyl-phenyl)ethanone (304.3 mg, 1.193 mmol) were dissolved in 3/1 CH<sub>3</sub>CN/DMF (4 mL) and stirred at 90 °C overnight. The reaction mixture was cooled to room temperature, and the precipitate was filtered, washed with diethyl ether, and dried. The crude 2-benzyl-6-(4-<i>tert</i>-butyl-phenyl)-8-oxo-7,8-dihydro-imidazo[1,5-<i>a</i>]pyrazin-2-ium bromide (165 mg) was used in the next step without further purification.</div><div class="NLM_p last"><b>7a</b>.2: A mixture of 2-benzyl-6-(4-<i>tert</i>-butyl-phenyl)-8-oxo-7,8-dihydro-imidazo[1,5-<i>a</i>]pyrazin-2-ium bromide (165 mg, 0.376 mmol) and imidazole (1.60 g, 23.502 mmol) was heated under a nitrogen atmosphere to 175 °C and stirred for 5 h. The reaction mixture was cooled down and poured on ice. The precipitate was filtered by suction, washed with diethyl ether, dried, and purified by preparative HPLC to give compound <b>7a</b> (13.5 mg, 13%) as an off-white solid. HPLC/MS <i>m</i>/<i>z</i>: 268.1 [M + H]<sup>+</sup>, Rt (A): 1.97 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.92 (s, 1H), 8.27 (s, 1H), 7.78 (s, 1H), 7.75 (s, 1H), 7.64–7.58 (m, 2H), 7.53–7.47 (m, 2H), 1.31 (s, 9H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>16</sub>H<sub>17</sub>N<sub>3</sub>O: 267.1372; found: 267.1376.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 6-(4-<i>tert</i>-Butyl-phenyl)-3-methyl-7<i>H</i>-imidazo[1,5-<i>a</i>]pyrazin-8-one (<b>7b</b>)</h4><div class="NLM_p last">1-Benzyl-2-methyl-1<i>H</i>-imidazole-4-carboxylic acid amide (69.0 mg; 0.321 mmol) and 1-(4-<i>tert</i>-butyl-phenyl)-2-chloro-ethanone (81.0 mg; 0.385 mmol) were dissolved in 3/1 CH<sub>3</sub>CN/DMF (4 mL) and heated in a microwave apparatus (CEM) at 160 °C for 6 h. The reaction mixture was concentrated, diluted with water, and extracted with ethyl acetate. The combined organic layers were washed with water and brine, dried with sodium sulfate, filtered, and evaporated to dryness. The oily residue was purified by chromatography to give compound <b>7b</b> (11.0 mg, 12%) as a colorless solid. HPLC/MS <i>m/z</i>: 282.2 [M + H]<sup>+</sup>, Rt (A): 1.85 min. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.82 (s, 1H), 7.69–7.63 (m, 3H), 7.53–7.46 (m, 3H), 2.57 (s, 3H), 1.32 (s, 9H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>17</sub>H<sub>19</sub>N<sub>3</sub>O: 281.1528; found: 281.1532.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 6-[4-(1-Hydroxy-1-methyl-ethyl)-phenyl]-3-methyl-7<i>H</i>-imidazo[1,5-<i>a</i>]pyrazin-one (<b>7c</b>)</h4><div class="NLM_p"><b>7c</b>.1: Compound <b>6b</b> (200.0 mg; 0.929 mmol) and 2,4′-dibromoacetophenone (361.5 mg; 1.301 mmol) were dissolved in 3/1 CH<sub>3</sub>CN/DMF (4 mL) and heated in a microwave apparatus (CEM) for 3 h at 160 °C. The reaction mixture was concentrated, and the residue diluted with water and extracted with ethyl acetate. The combined organic layers were washed with water and brine, dried over sodium sulfate, filtered, evaporated to dryness, and purified by chromatography. The residue (80 mg) was used in the next step.</div><div class="NLM_p"><b>7d</b>.2: In an autoclave, a solution of the residue from the previous reaction (80 mg, 0.263 mmol) and triethylamine (53 mg, 0.526 mmol) in 1/1 methanol/toluene (10 mL) was flushed with nitrogen. (1,1′-bis(diphenylphosphino)ferrocene)dichloropalladium(II), dichloromethane (13.0 mg, 0.016 mmol), and 1,1-bis(diphenylphosphino)ferrocene (7.0 mg, 0.013 mmol) were added. The autoclave was filled with carbon monoxide, heated to 100 °C, and kept at this temperature for 8 h at a pressure of 4.4 bar. The autoclave was brought to atmospheric pressure. The reaction mixture was evaporated, and the residue was triturated with dichloromethane, filtered by suction, washed with dichloromethane, and dried under vacuum to yield 4-(3-methyl-8-oxo-7,8-dihydro-imidazo[1,5-<i>a</i>]pyrazin-6-yl)benzoic acid methyl ester (37 mg, 50%) as an off-white solid. HPLC/MS <i>m</i>/<i>z</i>: 284.1 [M + H]<sup>+</sup>, Rt (A): 1.40 min.</div><div class="NLM_p last"><b>7d</b>.3: 4-(3-Methyl-8-oxo-7,8-dihydro-imidazo[1,5-<i>a</i>]pyrazin-6-yl)benzoic acid methyl ester (37 mg, 0.131 mmol) was suspended in THF (2 mL), cerium chloride (35.4 mg, 0.144 mmol) was added, and the mixture was stirred for 1 h at ambient temperature. A solution of methyl magnesium chloride (3 M in THF, 0.13 mL, 0.392 mmol) was added, and the reaction mixture was stirred for 2 h at ambient temperature. The reaction mixture was quenched with a mixture of methanol/water and extracted with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered, and evaporated to dryness. The residue was purified by preparative HPLC to afford compound <b>7d</b> (15 mg, 40%) as a beige solid. HPLC/MS <i>m</i>/<i>z</i>: 284.2 [M + H]<sup>+</sup>, Rt (A): 1.24 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.82 (s, 1H), 7.72–7.62 (m, 3H), 7.60–7.46 (m, 3H), 5.07 (s, 1H), 2.57 (s, 3H), 1.45 (s, 6H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>16</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>: 283.1321; found: 283.1317.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-[2-(4-Bromophenyl)-2-oxo-ethyl]-1<i>H</i>-pyrazole-3,5-dicarboxylic Acid Diethyl Ester (<b>9</b>)</h4><div class="NLM_p last">1<i>H</i>-Pyrazole-3,5-dicarboxylic acid diethyl ester <b>8</b> (2.12 g, 10.0 mmol), 2-bromo-1-(4-bromophenyl)ethanone (2.78 g, 10.0 mmol), and potassium carbonate (1.66 g, 12.0 mmol) were diluted with acetone (20.0 mL), and the suspension was stirred for 70 h at ambient temperature. The reaction mixture was diluted with water (150 mL), and the formed precipitate was filtered by suction and washed with water. The residue was dissolved in dichloromethane, dried over sodium sulfate, filtered, and evaporated to dryness to give <b>9</b> (3.95 g, 97%) as a yellow solid. HPLC/MS <i>m</i>/<i>z</i>: 409.0/411.0 [M + H]<sup>+</sup>, Rt (A): 2.57 min.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 6-(4-Bromophenyl)-4-oxo-4,5-dihydro-pyrazolo[1,5-<i>a</i>]pyrazine-2-carboxylic Acid Ethyl Ester (<b>10</b>)</h4><div class="NLM_p last">Compound <b>9</b> (3.79 g, 9.265 mmol) and ammonium acetate (7.14 g, 92,654 mmol) were suspended in glacial acetic acid (11.0 mL), and the reaction mixture was stirred at 110 °C for 21 h. The reaction mixture was cooled down to ambient temperature, and the resulting suspension was diluted with water (100 mL). The precipitate was filtered by suction, washed with water and diethyl ether, and dried at 50 °C under vacuum to afford compound <b>10</b> (3.15 g, 93%) as an off-white solid. HPLC/MS <i>m</i>/<i>z</i>: 361.9/363.9 [M + H]<sup>+</sup>, Rt (A): 2.09 min.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 6-(4-Bromophenyl)-2-methyl-5<i>H</i>-pyrazolo[1,5-<i>a</i>]pyrazin-4-one (<b>11</b>)</h4><div class="NLM_p"><b>11</b>.1: To a suspension of compound <b>10</b> (6.24 g, 17.221 mmol) in THF (100.0 mL), lithiumaluminiumhydride (2 M solution in THF, 17.2 mL, 34.442 mmol) was added slowly under an argon atmosphere, and after complete addition, the reaction mixture was stirred for 1 h at room temperature. The reaction mixture was quenched in an ice bath with methanol (20 mL), acidified with 1 N HCl solution (20 mL), filtered, and washed thoroughly with water. The solid was suspended in 2 N HCl (250 mL), stirred for 20 min, filtered by suction, and washed with water. The solid was triturated with acetone (300 mL), filtered by suction, washed with acetone, and dried under vacuum at 50 °C overnight to give 6-(4-bromophenyl)-2-hydroxymethyl-5<i>H</i>-pyrazolo[1,5-<i>a</i>]pyrazin-4-one (4.60 g, 83%) as an off-white solid. HPLC/MS <i>m</i>/<i>z</i>: 320.0/322.0 [M + H]<sup>+</sup>, Rt (A): 1.68 min.</div><div class="NLM_p"><b>11</b>.2: 6-(4-Bromophenyl)-2-hydroxymethyl-5<i>H</i>-pyrazolo[1,5-<i>a</i>]pyrazin-4-one (1.30 g, 4.061 mmol) was suspended in dry dichloromethane (80.0 mL). Phosphorus tribromide (1.37 g, 5.076 mmol) was added dropwise at 20 °C under an argon atmosphere, and the resulting suspension was stirred overnight. Further, phosphorus tribromide (1.37 g, 5.076 mmol) was added at 20 °C under an argon atmosphere, and the reaction mixture was stirred for 1 d and quenched with water (100 mL). The resulting solid was filtered by suction and washed with water. The filtrate was extracted with dichloromethane, and the combined organic layers were washed with water and brine, dried over sodium sulfate, filtered, and evaporated to dryness. Both solids were combined (1.20 g) and used in the next step without further purification. HPLC/MS <i>m/z</i>: 383.8 [M + H]<sup>+</sup>, Rt (A): 2.21 min.</div><div class="NLM_p last"><b>11</b>.3: To the residue from the previous reaction (0.69 g, 1.801 mmol) in glacial acetic acid (35 mL), zinc powder (0.59 g, 9.007 mmol) was added and the mixture was stirred at 110 °C overnight. The reaction mixture was diluted with water and extracted with ethyl acetate. The combined organic layers were washed with 1 N NaOH, saturated NaHCO<sub>3</sub> solution, water, and brine, dried over sodium sulfate, filtered, and evaporated to dryness. The residue was purified by flash chromatography to give the title compound (383 mg, 70%) as a colorless solid. HPLC/MS <i>m/z</i>: 303.9/305.9 [M + H]<sup>+</sup>, Rt (A): 2.00 min.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 6-[4-(1-Hydroxy-1-methyl-ethyl)-phenyl]-2-methyl-5<i>H</i>-pyrazolo[1,5-<i>a</i>]pyrazin-4-one (<b>12</b>)</h4><div class="NLM_p"><b>12</b>.1: In an autoclave, a solution of compound <b>11</b> (315.0 mg, 1.036 mmol) and triethylamine (167.7 mg, 1.658 mmol) in 1/1 methanol/toluene (20 mL) was flushed with nitrogen. (1,1′-bis(diphenylphosphino)ferrocene)dichloropalladium(II), dichloromethane (25.4 mg, 0.031 mmol), and 1,1-bis(diphenylphosphino)ferrocene (23.0 mg, 0.041 mmol) were added. The autoclave was filled with carbon monoxide, heated to 100 °C, and kept at this temperature for 21 h at a pressure of 4.5 bar. The autoclave was brought to atmospheric pressure. The reaction mixture was evaporated to dryness, and the residue was purified by flash chromatography to give 4-(2-methyl-4-oxo-4,5-dihydro-pyrazolo[1,5-<i>a</i>]pyrazin-6-yl)benzoic acid methyl ester (173 mg, 59%) as a colorless solid. HPLC/MS <i>m</i>/<i>z</i>: 284.0 [M + H]<sup>+</sup>, Rt (A): 1.80 min.</div><div class="NLM_p last"><b>12</b>.2: 4-(2-Methyl-4-oxo-4,5-dihydro-pyrazolo[1,5-<i>a</i>]pyrazin-6-yl)-benzoic acid methyl ester (169.0 mg, 0.597 mmol) was suspended in THF (18.0 mL), cerium(III) chloride (161.7 mg, 0.656 mmol) was added, and the mixture was stirred for 1 h at ambient temperature under an argon atmosphere. A solution of methyl magnesium chloride (3 M in THF, 0.83 mL, 2.506 mmol) was added slowly, and the reaction mixture was stirred at room temperature overnight. The reaction mixture was quenched with water, citric acid (10%) was added, and the mixture was extracted with ethyl acetate. The combined organic layers were washed with water and brine, dried over sodium sulfate, filtered by suction, and evaporated to dryness. The residue was purified by preparative HPLC to yield compound <b>12</b> (91.0 mg, 54%) as a colorless solid. HPLC/MS <i>m</i>/<i>z</i>: 284.1 [M + H]<sup>+</sup>, Rt (A): 1.63 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.41 (s, 1H), 7.91 (s, 1H), 7.69–7.63 (m, 2H), 7.58–7.52 (m, 2H), 6.79 (s, 1H), 5.06 (s, 1H), 2.36 (s, 3H), 1.45 (s, 6H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>16</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>: 283.1321; found: 283.1302.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-(4-Bromo-benzoylamino)-5-methyl-1<i>H</i>-pyrrole-2-carboxylic Acid Amide (<b>14</b>)</h4><div class="NLM_p"><b>14</b>.1: To a solution of 5-methyl-1<i>H</i>-pyrrole-2-carboxylic acid ethyl ester <b>13i</b> (6.13 g, 40.000 mmol) in DMF (10 mL), potassium <i>tert</i>-butylate (8.98 g, 80.000 mmol) was added under nitrogen. After stirring at room temperature for 25 min, the reaction mixture was cooled to 15 °C, a solution of chloramine in diethyl ether (∼0.4 M, 300 mL, 120.000 mmol) was added slowly, and the mixture was stirred for 15 min at 15 °C. The reaction mixture was diluted with ethyl acetate and extracted with saturated sodium thiosulfate solution. The organic phase was dried over sodium sulfate, filtered, and evaporated to dryness. The residue was purified by flash chromatography to afford 1-amino-5-methyl-<i>1H</i>-pyrrole-2-carboxylic acid ethyl ester (5.59 g, 83%) as a yellow oil. HPLC/MS <i>m</i>/<i>z</i>: 169.1 [M + H]<sup>+</sup>, Rt (A): 1.93 min.</div><div class="NLM_p"><b>14</b>.2: To a solution of 1-amino-5-methyl-1<i>H</i>-pyrrole-2-carboxylic acid ethyl ester (884.50 mg, 5.259 mmol) in dry pyridine (7.7 mL), 4-bromobenzoylchloride (1.38 g, 6.310 mmol) was added and the reaction mixture stirred at 60 °C overnight. The reaction mixture was diluted with water (250 mL) and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated <i>in vacuo</i>. The residue was purified by flash chromatography to give 1-(4-bromo-benzoylamino)-5-methyl-1<i>H</i>-pyrrole-2-carboxylic acid ethyl ester (1.80 g, 98%) as a colorless, viscous oil. HPLC/MS <i>m</i>/<i>z</i>: 351.0/353.0 [M + H]<sup>+</sup>, Rt (A): 2.27 min.</div><div class="NLM_p last"><b>14</b>.3: To a solution of 1-(4-bromo-benzoylamino)-5-methyl-1<i>H</i>-pyrrole-2-carboxylic acid ethyl ester (212.0 mg, 0.604 mmol) in methanol (1.9 mL), ammonium hydroxide solution (32%, 7.52 mL) was added and the mixture was stirred at 60 °C for 3 d. Further, ammonium hydroxide solution (32%, 1.88 mL) was added, the mixture was stirred at 80 °C overnight and concentrated <i>in vacuo</i>, and the residue was purified by flash chromatography to give compound <b>14</b> (78 mg, 40%) as a pale-yellow oil. HPLC/MS <i>m</i>/<i>z</i>: 322.0/324.0 [M + H]<sup>+</sup>, Rt (A): 1.82 min.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-(4-Bromophenyl)-7-methyl-3<i>H</i>-pyrrolo[2,1-<i>f</i>][1,2,4]triazin-4-one (<b>15</b>)</h4><div class="NLM_p last">Compound <b>14</b> (78.0 mg, 0.242 mmol) was added to polyphosphoric acid (4.65 g, 19.360 mmol), and the resulting mixture was stirred at 100 °C for 4 h. The mixture was cooled to approximately 50 °C, diluted with warm water (50 mL), and neutralized with 2 N NaOH. After extraction with ethyl acetate, the combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated <i>in vacuo</i>. The residue was purified by flash chromatography to afford compound <b>15</b> (40 mg, 54%) as a colorless solid. HPLC/MS <i>m</i>/<i>z</i>: 304.0/306.0 [M + H]<sup>+</sup>, Rt (A): 2.14 min.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-[4-(1-Hydroxy-1-methyl-ethyl)-phenyl]-7-methyl-3<i>H</i>-pyrrolo[2,1-<i>f</i>][1,2,4]triazin-4-one (<b>16</b>)</h4><div class="NLM_p"><b>16</b>.1: 4-(7-Methyl-4-oxo-3,4-dihydro-pyrrolo[2,1-<i>f</i>][1,2,4]triazin-2-yl)benzoic acid methyl ester was obtained by carbonylation of compound <b>15</b> (71 mg, 0.233 mmol) as described for compound <b>12</b> (step <b>12</b>.1). Yield: 49 mg (74%) as a colorless solid. HPLC/MS <i>m</i>/<i>z</i>: 284.2 [M + H]<sup>+</sup>, Rt (C): 2.60 min.</div><div class="NLM_p last"><b>16</b>.2: 4-(7-Methyl-4-oxo-3,4-dihydro-pyrrolo[2,1-<i>f</i>][1,2,4]triazin-2-yl)benzoic acid methyl ester (49.0 mg, 0.173 mmol) was treated as described for the synthesis of compound <b>12</b> (step <b>12</b>.2) to give compound <b>16</b> (38 mg, 78%) as a colorless solid. HPLC/MS <i>m</i>/<i>z</i>: 284.1 [M + H]<sup>+</sup>, Rt (C): 2.39 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.78 (s, 1H), 7.98–7.90 (m, 2H), 7.65–7.57 (m, 2H), 6.86 (d, <i>J</i> = 4.2 Hz, 1H), 6.40 (d, <i>J</i> = 4.2 Hz, 1H), 5.13 (s, 1H), 2.46 (s, 3H), 1.46 (s, 6H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>16</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>: 283.1321; found: 283.1309.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-(4-Bromobenzoylamino)-5-methyl-2<i>H</i>-pyrazole-3-carboxylic Acid Ethyl Ester (<b>18</b>)</h4><div class="NLM_p"><b>18</b>.1: To a mixture of sodium hydride (60% dispersion in mineral oil) (0.61 g, 25.300 mmol) in DMF (35 mL) at 0 °C, 5-methyl-2<i>H</i>-pyrazole-3-carboxylic acid ethyl ester <b>17</b> (2.60 g, 16.867 mmol) was added in portions over 10 min. After stirring at 0 °C for 45 min, the mixture was charged with a suspension of <i>O</i>-(diphenylphosphoryl)hydroxylamine (4.72 g, 20.240 mmol) in DMF (47 mL) over 15 min. The reaction mixture was stirred at 0 °C for 2 h, quenched by the slow addition of saturated sodium thiosulfate solution, and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated <i>in vacuo</i>. The residue was purified with flash chromatography to give 2-amino-5-methyl-2<i>H</i>-pyrazole-3-carboxylic acid ethyl ester (915 mg, 32%) as a brown oil. HPLC/MS <i>m</i>/<i>z</i>: 170.1 [M + H]<sup>+</sup>, Rt (C): 1.82 min. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.72 (bs, 2H), 6.49 (s, 1H), 4.27 (q, <i>J</i> = 7.1 Hz, 2H), 2.13 (s, 3H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H).</div><div class="NLM_p last"><b>18</b>.2. To a solution of 2-amino-5-methyl-2<i>H</i>-pyrazole-3-carboxylic acid ethyl ester (310.0 mg, 1.832 mmol) in dichloromethane (4 mL), triethylamine (887 μL, 6.401 mmol) was added; thereafter, a solution of 4-bromobenzoyl chloride (803.0 mg, 3.659 mmol) in dichloromethane (2 mL) was added slowly, and the reaction mixture was stirred for 18 h at room temperature. The reaction mixture was partitioned between water and dichloromethane. The organic layer was washed with 1 N HCl solution, dried over sodium sulfate, filtered, and evaporated to dryness. The residue was purified by flash chromatography (eluent: cyclohexane/ethyl acetate) to afford compound <b>18</b> (450 mg, 70%) as a brown oil. HPLC/MS <i>m</i>/<i>z</i>: 352.0/354.0 [M + H]<sup>+</sup>, Rt (B): 2.10 min.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-(4-Bromophenyl)-6-methyl-3<i>H</i>,4<i>H</i>-pyrazolo[3,2-<i>f</i>][1,2,4]triazin-4-one (<b>20</b>)</h4><div class="NLM_p"><b>20</b>.1: To a solution of compound <b>18</b> (443.0 mg, 1.258 mmol) in methanol (6.0 mL), ammonium hydroxide solution (32%, 10 mL) was added and the resulting solution was stirred at 60 °C for 3 d. The reaction mixture was cooled to room temperature and evaporated. The residue was taken up in water, and the solids were filtered, washed with water, and dried under vacuum to afford a mixture (209 mg) of compound <b>19</b> (HPLC/MS <i>m</i>/<i>z</i>: 323.0/325.0 [M + H]<sup>+</sup>, Rt (C): 1.90 min) and compound <b>20</b> (HPLC/MS <i>m</i>/<i>z</i>: 305.0/307.0 [M + H]<sup>+</sup>, Rt (C): 2.40 min) as a colorless solid, which was used in the next step without further purification.</div><div class="NLM_p last"><b>20</b>.2. The mixture of the previous step (209 mg) was dissolved in 2-propanol (4.4 mL), 2 N NaOH solution (1.61 mL) was added, and the reaction mixture was stirred at 80 °C for 18 h. The reaction mixture was cooled to room temperature and neutralized with 2 N HCl solution. The resulting precipitate was filtered, washed with water, dried, and purified by flash chromatography (eluent: cyclohexane/ethyl acetate) to afford compound 20 (60 mg, 16%) as a colorless solid. HPLC/MS <i>m</i>/<i>z</i>: 305.0/307.0 [M + H]<sup>+</sup>, Rt (C): 2.40 min.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-[4-(2-Hydroxypropan-2-yl)phenyl]-6-methyl-3<i>H</i>,4<i>H</i>-pyrazolo[3,2-<i>f</i>][1,2,4]triazin-4-one (<b>21</b>)</h4><div class="NLM_p"><b>21</b>.1: 4-(6-Methyl-4-oxo-3<i>H</i>,4<i>H</i>-pyrazolo[3,2-<i>f</i>][1,2,4]triazin-2-yl)benzoic acid methyl ester was obtained by carbonylation of compound <b>20</b> (56 mg, 0.184 mmol) as described for compound <b>12</b> (step <b>12</b>.1). Yield: 40 mg (76%) as an off-white solid. HPLC/MS <i>m</i>/<i>z</i>: 285.1 [M + H]<sup>+</sup>, Rt (C): 2.19 min.</div><div class="NLM_p last"><b>21</b>.2: 4-(6-Methyl-4-oxo-3H,4H-pyrazolo[3,2-f][1,2,4]triazin-2-yl)benzoic acid methyl ester (39.0 mg, 0.137 mmol) was treated as described for the synthesis of compound <b>12</b> (step <b>12</b>.2) to give compound <b>21</b> (21 mg, 54%) as a colorless solid. HPLC/MS <i>m</i>/<i>z</i>: 285.1 [M + H]<sup>+</sup>, Rt (C): 2.00 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.55 (s, 1H), 7.99–7.91 (m, 2H), 7.69–7.61 (m, 2H), 6.86 (s, 1H), 5.18 (s, 1H), 2.38 (s, 3H), 1.48 (s, 6H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>15</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub>: 284.1273; found: 284.1259.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 3-(4-Bromobenzoylamino)-4-methyl-thiophene-2-carboxylic Acid Methyl Ester (<b>23</b>)</h4><div class="NLM_p last">A mixture of 3-amino-4-methyl-thiophene-2-carboxylic acid methyl ester <b>22</b> (294.0 mg, 1.717 mmol) and 4-bromo-benzoyl chloride (414.5 mg, 1.889 mmol) in dry dioxane (7 mL) was stirred under a nitrogen atmosphere at 100 °C overnight. The reaction mixture was evaporated, and the residue was dissolved in dichloromethane, washed with aqueous NaHCO<sub>3</sub> solution, dried over sodium sulfate, filtered, and concentrated <i>in vacuo</i> to give compound <b>23</b> (601 mg, 99%) as a colorless solid. HPLC/MS <i>m</i>/<i>z</i>: 354.0/356.0 [M + H]<sup>+</sup>, Rt (A): 2.39 min.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-(4-Bromophenyl)-7-methyl-3<i>H</i>-thieno[3,2-d]pyrimidin-4-one (<b>24</b>)</h4><div class="NLM_p last">A suspension of compound <b>23</b> (288.0 mg, 0.813 mmol) in ammonium hydroxide solution (25%, 5.0 mL) and methanol (3 mL) was stirred at 100 °C overnight. The reaction mixture was evaporated, and the residue was triturated with dichloromethane containing little methanol, filtered by suction, washed with dichloromethane, and dried under vacuum to yield compound <b>24</b> (168 mg, 64%) as a colorless solid. HPLC/MS <i>m</i>/<i>z</i>: 321.0/323.0 [M + H]<sup>+</sup>, Rt (A): 2.35 min.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-[4-(1-Hydroxy-1-methyl-ethyl)-phenyl]-7-methyl-3<i>H</i>-thieno[3,2-d]pyrimidin-4-one (<b>25</b>)</h4><div class="NLM_p"><b>25</b>.1: 4-(7-Methyl-4-oxo-3,4-dihydro-thieno[3,2-<i>d</i>]pyrimidin-2-yl)benzoic acid methyl ester was obtained by carbonylation of compound <b>24</b> (168 mg, 0.523 mmol) as described for compound <b>12</b> (step <b>12</b>.1). Yield: 127 mg (81%) as a colorless solid. HPLC/MS <i>m</i>/<i>z</i>: 301.1 [M + H]<sup>+</sup>, Rt (A): 2.11 min.</div><div class="NLM_p last"><b>25</b>.2: 4-(7-Methyl-4-oxo-3,4-dihydro-thieno[3,2-<i>d</i>]pyrimidin-2-yl)benzoic acid methyl ester (127.0 mg, 0.423 mmol) was treated as described for the synthesis of compound <b>12</b> (step <b>12</b>.2) to give compound <b>25</b> (50 mg, 39%) as a colorless solid. HPLC/MS <i>m</i>/<i>z</i>: 301.1 [M + H]<sup>+</sup>, Rt (A): 1.87 min. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.61 (s, 1H), 8.14–8.07 (m, 2H), 7.85 (d, <i>J</i> = 1.3 Hz, 1H), 7.66–7.59 (m, 2H), 5.14 (s, 1H), 2.38 (d, <i>J</i> = 1.2 Hz, 3H), 1.47 (s, 6H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>16</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>S: 300.0932; found: 300.0910.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-[2-(4-Bromophenyl)-2-oxo-ethyl]-1<i>H</i>-pyrrole-2-carbonitrile (<b>26a</b>)</h4><div class="NLM_p last">Potassium carbonate (5.53 g, 0.040 mol) was added to a solution of 1<i>H</i>-pyrrole-2-carbonitrile <b>13a</b> (1.70 mL, 0.020 mol) and 2-bromo-1-(4-bromophenyl)ethanone (8.34 g, 0.030 mol) in DMF (40 mL). The resulting suspension was stirred for 1 h at room temperature. The reaction mixture was diluted with dichloromethane and filtered by suction. The residue was washed with dichloromethane. The filtrate was evaporated, and the residue was purified by chromatography (silica gel column; eluent: cyclohexane/ethyl acetate) to afford compound <b>26a</b> (3.58 g, 61% yield) as a light orange solid. HPLC/MS <i>m/z</i>: 289.0/291.0 [M + H]<sup>+</sup>, Rt (C): 2.80 min.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-[2-(4-Bromophenyl)-2-oxo-ethyl]-4-chloro-1<i>H</i>-pyrrole-2-carboxylic Acid Methyl Ester (<b>26b</b>)</h4><div class="NLM_p last">4-Chloro-<i>1H</i>-pyrrole-2-carboxylic acid methyl ester <b>13b</b> (445.5 mg, 2.792 mmol) and 2-bromo-1-(4-bromophenyl)ethanone (1.0 g, 3.629 mmol) were dissolved in DMF, potassium carbonate (771.7 mg, 5.584 mmol) was added, and the reaction mixture was stirred at ambient temperature for 3 h. The reaction mixture was diluted with dichloromethane and filtered by suction. The residue was washed with dichloromethane, and the filtrate was evaporated to dryness. The residue was triturated with MeOH/THF (1:1), filtered by suction, and washed with a small amount of MeOH. From the filtrate further product was isolated by flash chromatography. Yield: 728 mg (73%) as a beige solid. HPLC/MS <i>m/z</i>: 355.9/357.8/359.7 [M + H]<sup>+</sup>, Rt (A): 2.59 min.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-[2-(4-Bromophenyl)-2-oxo-ethyl]-4-fluoro-1<i>H</i>-pyrrole-2-carboxylic Acid Methyl Ester (<b>26c</b>)</h4><div class="NLM_p last">4-Fluoro-1<i>H</i>-pyrrole-2-carboxylic acid methyl ester <b>13c</b> (0.72 g, 5.000 mmol) and 2-bromo-1-(4-bromophenyl)ethanone (1.39 g 5.000 mmol) were dissolved in acetone (7.0 mL), potassium carbonate (0.83 g, 6.000 mmol) was added, and the reaction mixture was stirred at ambient temperature overnight. The red suspension was evaporated to dryness, the residue was triturated with water, and the formed precipitate was filtered by suction, washed with water, and dried <i>in vacuo</i>. Yield: 1.51 g (89%) as an orange solid. HPLC/MS <i>m/z</i>: 340.0/342.0 [M + H]<sup>+</sup>, Rt (C): 3.00 min.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-[2-(4-Bromophenyl)-2-oxo-ethyl]-5-fluoro-1<i>H</i>-pyrrole-2-carboxylic Acid Ethyl Ester (<b>26d</b>)</h4><div class="NLM_p last">Preparation was performed as described for compound <b>26c</b> using 5-fluoro-1<i>H</i>-pyrrole-2-carboxylic acid ethyl ester <b>13d</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (409.2 mg, 2.600 mmol), 2-bromo-1-(4-bromophenyl)ethanone (722.5 mg, 2.600 mmol), and potassium carbonate (431.1 mg, 3.119 mmol) in acetone (5.0 mL). Yield: 776 mg (84%) as a brown solid. HPLC/MS <i>m/z</i>: 354.0/356.0 [M + H]<sup>+</sup>, Rt (D): 2.17 min.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 4,5-Difluoro-1<i>H</i>-pyrrole-2-carboxylic Acid Ethyl Ester (<b>13e</b>)</h4><div class="NLM_p last">4-Fluoro-1<i>H</i>-pyrrole-2-carboxylic acid ethyl ester (1.57 g, 10.000 mmol) was dissolved in acetonitrile (10.0 mL), Selectfluor (3.54 g, 10.000 mmol) was added, and the mixture was irradiated in a microwave for 5 min at 70 °C. The reaction mixture was quenched with water and extracted two times with dichloromethane, and the organic layer was washed once with water, dried over sodium sulfate, filtered, and evaporated to dryness. The residue was purified by flash chromatography. Yield: 436 mg (25%) as a colorless solid. HPLC/MS <i>m/z</i>: 176.0 [M + H]<sup>+</sup>, Rt (D): 1.78 min.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-[2-(4-Bromophenyl)-2-oxo-ethyl]-4,5-difluoro-1<i>H</i>-pyrrole-2-carboxylic Acid Ethyl Ester (<b>26e</b>)</h4><div class="NLM_p last">Preparation was performed as described for compound <b>26c</b> using 4,5-difluoro-1<i>H</i>-pyrrole-2-carboxylic acid ethyl ester <b>13e</b> (436.0 mg, 2.492 mmol), 2-bromo-1-(4-bromophenyl)ethanone (692.7 mg, 2.492 mmol), and potassium carbonate (413.4 mg, 2.961 mmol) in acetone (5.0 mL). Yield: 863 mg (93%) as a brown solid. HPLC/MS <i>m/z</i>: 372.0/374.0 [M + H]<sup>+</sup>, Rt (D): 2.21 min.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-[2-(4-Bromophenyl)-2-oxo-ethyl]-4-methyl-1<i>H</i>-pyrrole-2-carbonitrile (<b>26f</b>)</h4><div class="NLM_p last">Preparation was described as that for compound <b>26a</b> using 4-methyl-1<i>H</i>-pyrrole-2-carbonitrile <b>13f</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (0.74 g, 6.996 mmol), 2-bromo-1-(4-bromophenyl)ethanone (2.53 g, 9.095 mmol), and potassium carbonate (1.93 g, 13.993 mmol) in DMF (15.0 mL). Yield: 514 mg (24%) as a beige solid. HPLC/MS <i>m/z</i>: 302.9/304.9 [M + H]<sup>+</sup>, Rt (A): 2.44 min.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-[2-(4-Bromophenyl)-2-oxo-ethyl]-5-methyl-1<i>H</i>-pyrrole-2-carbonitrile (<b>26g</b>)</h4><div class="NLM_p last">Preparation was performed as described for compound <b>26c</b> using 5-methyl-1<i>H</i>-pyrrole-2-carbonitrile <b>13g</b> (0.48 g, 4.476 mmol), 2-bromo-1-(4-bromophenyl)ethanone (1.62 g, 5.819 mmol), and potassium carbonate (1.24 g, 8.952 mmol) in acetone (10.0 mL). The reaction mixture was diluted with acetone and filtered by suction. The residue was washed with acetone, the filtrate was evaporated to dryness, and the residue purified by flash chromatography. Yield: 636 mg (47%) as a yellow solid. HPLC/MS <i>m/z</i>: 303.0/305.0 [M + H]<sup>+</sup>, Rt (A): 2.41 min.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-[2-(4-Bromophenyl)-2-oxo-ethyl]-5-cyano-1<i>H</i>-pyrrole-2-carboxylic Acid Methyl Ester (<b>26h</b>)</h4><div class="NLM_p last">Preparation was performed as described for compound <b>26c</b> using 5-cyano-1<i>H</i>-pyrrole-2-carboxylic acid methyl ester <b>13h</b> (265.1 mg, 1.766 mmol), 2-bromo-1-(4-bromophenyl)ethanone (736.3 mg, 2.649 mmol), and potassium carbonate (244.1 mg; 1.766 mmol) in acetone (5.0 mL). The reaction mixture was diluted with ethyl acetate (50 mL), washed with water and brine, dried with sodium sulfate, filtered by suction, and evaporated to dryness. The residue was triturated with diethyl ether–ethyl acetate (9:1), filtered by suction, and dried. Yield: 510 mg (83%) as a colorless solid. HPLC/MS <i>m/z</i>: 347.0/349.0 [M + H]<sup>+</sup>, Rt (A): 2.48 min.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 3-(4-Bromophenyl)-3-hydroxy-3,4-dihydro-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>27a</b>) and 3-(4-Bromophenyl)-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>28a</b>)</h4><div class="NLM_p">Compound <b>26a</b> (6.10 g, 21.098 mmol) was suspended in methanol (45.0 mL), potassium carbonate (14.58 g, 105.490 mmol), dry dimethylsulfoxide (4.50 mL, 63.294 mmol), and hydrogen peroxide (30%, 6.47 mL, 63.294 mmol) were added (strongly exothermic reaction after the addition of hydrogen peroxide), and the suspension was stirred at room temperature for 2 d. The reaction mixture was diluted with water, and the solid was filtered by suction, washed with water and dried under vacuum at 50 °C to give compound <b>28a</b> (3.99 g, 65%) as a pale-yellow solid. The filtrate was extracted three times with ethyl acetate, and the combined organic layers were dried over sodium sulfate, filtered by suction, and evaporated to dryness to afford compound <b>27a</b> (2.36 g, 36%) as a yellow oil. HPLC/MS <i>m/z</i>: 307.0/309.0 [M + H]<sup>+</sup>, Rt (A): 1.91 min.</div><div class="NLM_p last">Compound <b>27a</b> (2.36 g, 7.684 mmol) was suspended in dichloromethane (15.0 mL), treated with trifluoroacetic acid (0.59 mL, 7.684 mmol), and stirred for 15 min at ambient temperature. The reaction mixture was evaporated, and the residue was diluted with water and rendered basic with saturated NaHCO<sub>3</sub> solution. The resulting precipitate was isolated by suction, washed with water, and dried under vacuum to give compound <b>28a</b> (1.78 g, 80%) as a pale-yellow solid. HPLC/MS <i>m/z</i>: 289.0/291.0 [M + H]<sup>+</sup>, Rt (A): 2.05 min.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3-(4-Bromophenyl)-7-chloro-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>28b</b>)</h4><div class="NLM_p last">Compound <b>26b</b> (0.63 g, 1.767 mmol) and ammonium acetate (3.00 g, 38.920 mmol) were treated with glacial acetic acid (2.50 mL), and the resulting mixture was stirred at 110 °C overnight. The reaction mixture was cooled to room temperature, diluted with water, and stirred for 5 min. The precipitate was filtered by suction, washed with water, and dried at 50 °C under vacuum overnight to give compound <b>28b</b> (508 mg, 89%) as a beige solid. HPLC/MS <i>m/z</i>: 322.9/324.9 [M + H]<sup>+</sup>, Rt (A): 2.28 min.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 3-(4-Bromophenyl)-7-fluoro-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>28c</b>)</h4><div class="NLM_p last">A mixture of <b>26c</b> (6.69 g, 18.511 mmol), ammonium acetate (35.67 g, 462.754 mmol), and glacial acetic acid (30.0 mL) was stirred at 110 °C for 2 d and worked up as described for compound <b>28b</b>. Yield: 4.63 g (81%) as a pale-brown solid. HPLC/MS <i>m/z</i>: 307.0/309.0 [M + H]<sup>+</sup>, Rt (A): 2.12 min.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 3-(4-Bromophenyl)-6-fluoro-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>28d</b>)</h4><div class="NLM_p last">A mixture of <b>26d</b> (776.0 mg, 2.191 mmol), ammonium acetate (4.22 g, 54.749 mmol), and glacial acetic acid (5.0 mL) was stirred at 110 °C for 5 d and worked up as described for compound <b>28b</b>, and the isolated solid was triturated with hot ethanol, filtered, and dried to yield compound <b>28d</b> (251 mg, 37%) as a brown solid. HPLC/MS <i>m/z</i>: 307.0/309.0 [M + H]<sup>+</sup>, Rt (D): 1.88.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 3-(4-Bromophenyl)-6,7-difluoro-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>28e</b>)</h4><div class="NLM_p last">A mixture of <b>26e</b> (863.0 mg, 2.319 mmol), ammonium acetate (4.47 g, 57.992 mmol), and glacial acetic acid (5.0 mL) was stirred at 110 °C for 2.5 d and worked up as described for compound <b>28b</b>, and the isolated solid was triturated with isopropyl acetate, filtered, and dried to give compound <b>28e</b> (486 mg, 64%) as a brown solid. HPLC/MS <i>m/z</i>: 325.0/327.0 [M + H]<sup>+</sup>, Rt (D): 1.94.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 3-(4-Bromophenyl)-3-hydroxy-7-methyl-3,4-dihydro-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>27f</b>) and 3-(4-Bromophenyl)-7-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>28f</b>)</h4><div class="NLM_p">Preparation was performed as described for compounds <b>27a</b> and <b>28a</b> using compound <b>26f</b> (510.0 mg, 1.682 mmol), potassium carbonate (1.16 g, 8.422 mmol), dry dimethylsulfoxide (0.36 mL, 5.047 mmol), and hydrogen peroxide (30%, 0.52 mL, 5.047 mmol). Yield: 253 mg (50%) <b>28f</b> as a pale-yellow solid; HPLC/MS <i>m/z</i>: 302.9/304.9 [M + H]<sup>+</sup>, Rt (A): 2.20. 91 mg (17%) <b>27f</b> as a yellow oil; HPLC/MS <i>m/z</i>: 321.0/322.9 [M + H]<sup>+</sup>, Rt (A): 1.95 min.</div><div class="NLM_p last">Compound <b>27f</b> (91 mg, 0.283 mmol) was treated with trifluoroacetic acid (22 μL, 0.283 mmol) in dichloromethane (0.7 mL) as described for <b>27a</b> to give 82 mg (95%) <b>28f</b> as a pale-yellow solid.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 3-(4-Bromophenyl)-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>28g</b>)</h4><div class="NLM_p last">Compound <b>26g</b> (636.0 mg, 2.098 mmol) was suspended in methanol (4.5 mL), potassium carbonate (1.45 g, 10.490 mmol), dry dimethylsulfoxide (0.45 mL, 6.294 mmol), and hydrogen peroxide (30%, 0.64 mL, 6.294 mmol) were added (strongly exothermic reaction after the addition of hydrogen peroxide), and the yellow suspension was stirred for 2 d at room temperature. The reaction mixture was diluted with water and extracted three times with ethyl acetate, and the combined organic layers were dried over sodium sulfate, filtered by suction, and evaporated to dryness. The residue was dissolved in dichloromethane (5.0 mL), treated with trifluoroacetic acid (0.5 mL), and stirred for 10 min at room temperature. The reaction mixture was diluted with dichloromethane, washed with water, saturated NaHCO<sub>3</sub> solution, and brine, dried over sodium sulfate, filtered by suction, and evaporated to dryness to give compound <b>28g</b> (559 mg, 88%) as a yellow solid. HPLC/MS <i>m/z</i>: 303.0/305.0 [M + H]<sup>+</sup>, Rt (A): 2.16 min.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 3-(4-Bromophenyl)-1-oxo-1,2-dihydro-pyrrolo[1,2-<i>a</i>]pyrazine-6-carboxylic Acid Methyl Ester (<b>28h</b>)</h4><div class="NLM_p last">Compound <b>26h</b> (510.4 mg, 1.470 mmol) was treated with potassium carbonate (1.02 g, 7.351 mmol), dry dimethylsulfoxide (0.31 mL, 4.411 mmol), and hydrogen peroxide (30%, 0.45 mL, 4.411 mmol) in methanol (6.0 mL) for 30 min and worked-up, and the resulting intermediate was treated with trifluoroacetic acid (3.0 mL) in dichloromethane (15.0 mL) as described for <b>28g</b>. Yield: 400 mg (78%) as a pale-brown solid. HPLC/MS <i>m/z</i>: 347.0/349.0 [M + H]<sup>+</sup>, Rt (A): 2.31 min.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 3-(4-Bromophenyl)-6-hydroxymethyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>28i</b>)</h4><div class="NLM_p last">To a suspension of compound <b>28h</b> (302.4 mg, 0.871 mmol) in THF (30.0 mL), lithium aluminum hydride (2 M in THF, 0.435 mL, 0.871 mmol) was added dropwise to 0 °C over a period of 5 min. The reaction mixture was stirred for 10 min at 0–5 °C, warmed to room temperature, and stirred for 30 min. The reaction mixture was cooled to 0–5 °C, quenched with citric acid solution (5%), diluted with water, and extracted three times with ethyl acetate. The combined organic layers were washed with brine, dried with sodium sulfate, filtered by suction, and evaporated to dryness to yield compound <b>28i</b> (258 mg, 93%) as a pale-yellow solid. HPLC/MS <i>m/z</i>: 319.0/321.0 [M + H]<sup>+</sup>, Rt (A): 1.76 min.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Synthesis of Compounds <b>29a</b>–<b>g,i</b> via Carbonylation of Intermediates <b>28a</b>–<b>g,i</b>: General Procedure</h3><div class="NLM_p">In an autoclave, a solution of intermediates <b>28a-g</b>,<b>i</b> (1 equiv) and triethylamine (1.3–1.6 equiv) in 1/1 methanol/toluene or 1/1 methanol/THF was flushed with nitrogen. Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (3 mol %) and 1,1-bis(diphenylphosphino)ferrocene (4 mol %) were added, and the autoclave was filled with carbon monoxide and heated to 70–100 °C. The autoclave was kept at this temperature for 10–18 h with a carbon monoxide pressure of 1.7–4.7 bar (max.). The autoclave was brought to atmospheric pressure, and the precipitate was filtered, washed with methanol and <i>tert</i>-butyl methyl ether or further purified by flash chromatography and dried under vacuum at 50 °C to give the title compounds.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 4-(1-Oxo-1,2-dihydro-pyrrolo[1,2-<i>a</i>]pyrazin-3-yl)benzoic Acid Methyl Ester (<b>29a</b>)</h4><div class="NLM_p last">Reaction at 100 °C and 4.7 bar (max.) for 10 h. Yield: 2.51 g (90%) as a pale-yellow solid. HPLC/MS <i>m/z</i>: 269.1 [M + H]<sup>+</sup>, Rt (A): 1.84 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.02 (s, 1H), 8.17 (d, <i>J</i> = 8.4 Hz, 2H), 8.07 (s, 1H), 7.99 (d , <i>J</i> = 8.4 Hz, 2H), 7.64 (s, 1H), 7.10 (d, <i>J</i> = 3.6 Hz, 1H), 6.76 (m, 1H), 4.03 (s, 3H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4-(7-Chloro-1-oxo-1,2-dihydro-pyrrolo[1,2-<i>a</i>]pyrazin-3-yl)benzoic Acid Methyl Ester (<b>29b</b>)</h4><div class="NLM_p last">Reaction at 70 °C and at 1.7 bar (max.) for 18 h. Yield: 231 mg (81%) as a beige solid. HPLC/MS <i>m/z</i>: 303.1/305.1 [M + H]<sup>+</sup>, Rt (A): 2.07 min.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 4-(7-Fluoro-1-oxo-1,2-dihydro-pyrrolo[1,2-<i>a</i>]pyrazin-3-yl)benzoic Acid Methyl Ester (<b>29c</b>)</h4><div class="NLM_p last">Reaction at 100 °C and 4.0 bar (max.) for 5 h. Yield: 976 mg (78%) as a beige solid. HPLC/MS <i>m/z</i>: 287.1 [M + H]<sup>+</sup>, Rt (A): 1.91 min.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 4-(6-Fluoro-1-oxo-1,2-dihydro-pyrrolo[1,2-<i>a</i>]pyrazin-3-yl)benzoic Acid Methyl Ester (<b>29d</b>)</h4><div class="NLM_p last">Reaction at 100 °C and 4.2 bar (max.) for 24 h. Yield: 188 mg (80%) as a brown solid. HPLC/MS <i>m/z</i>: 287.1 [M + H]<sup>+</sup>, Rt (D): 1.74 min.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 4-(6,7-Difluoro-1-oxo-1,2-dihydro-pyrrolo[1,2-<i>a</i>]pyrazin-3-yl)benzoic Acid Methyl Ester (<b>29e</b>)</h4><div class="NLM_p last">Reaction at 100 °C and 4.6 bar (max.) for 41 h. Yield: 170 mg (37%) as a brown solid. HPLC/MS <i>m/z</i>: 305.1 [M + H]<sup>+</sup>, Rt (D): 1.81 min.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 4-(7-Methyl-1-oxo-1,2-dihydro-pyrrolo[1,2-<i>a</i>]pyrazin-3-yl)benzoic Acid Methyl Ester (<b>29f</b>)</h4><div class="NLM_p last">Reaction at 100 °C and 3.8 bar (max.) for 23 h. Yield: 170 mg (37%) as a brown solid. HPLC/MS <i>m/z</i>: 283.1 [M + H]<sup>+</sup>, Rt (A): 1.98 min.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 4-(6-Methyl-1-oxo-1,2-dihydro-pyrrolo[1,2-<i>a</i>]pyrazin-3-yl)benzoic Acid Methyl Ester (<b>29g</b>)</h4><div class="NLM_p last">Reaction at 100 °C and 4.6 bar (max.) for 17 h. Yield: 105 mg (76%) as a beige solid. HPLC/MS <i>m/z</i>: 283.1 [M + H]<sup>+</sup>, Rt (A): 1.94 min.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 4-(6-Hydroxymethyl-1-oxo-1,2-dihydro-pyrrolo[1,2-<i>a</i>]pyrazin-3-yl)-benzoic Acid Methyl Ester (<b>29i</b>)</h4><div class="NLM_p last">Reaction with triethylamine (1.3 equiv) in 1/1 methanol/THF at 100 °C and 4.6 bar (max.) for 18 h. The reaction mixture was evaporated to dryness, and the residue was dissolved in ethyl acetate, washed with water, 10% citric acid solution, and brine, dried with sodium sulfate, filtered, and evaporated to dryness. The solid residue was triturated with acetonitrile and filtered by suction, washed with acetonitrile and diethyl ether, and dried. Yield: 177 mg (71%) as a pale-brown solid. HPLC/MS <i>m/z</i>: 299.1 [M + H], Rt (A): 1.59 min.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Synthesis of Compounds <b>30a</b>–<b>g,i</b>: General Procedure</h3><div class="NLM_p">Compounds <b>29a–g,i</b> (1 equiv) were suspended in THF, cerium(III) chloride (1.1 equiv) was added and the mixture was stirred for 1–2 h at ambient temperature under argon. Methyl magnesium chloride (3 M in THF; 4.2–5.2 equiv) was added, and the reaction mixture was stirred for 1–2 h at ambient temperature and quenched with water, whereupon a precipitate was formed. The mixture was treated with citric acid solution (10%) and filtered by suction, and the residue was washed with citric acid solution (10%), water, and dried. The aqueous filtrate was extracted three times with ethyl acetate. The combined organic layers were washed with water and brine, dried over sodium sulfate, filtered, and evaporated to dryness. Both product fractions were combined and either purified by flash chromatography or triturated with diethyl ether or <i>tert</i>-butyl methyl ether, filtered by suction, washed with diethyl ether or <i>tert</i>-butyl methyl ether, and dried under vacuum at 50 °C.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 3-[4-(1-Hydroxy-1-methyl-ethyl)-phenyl]-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>30a</b>)</h4><div class="NLM_p last">Preparation was according to the general procedure using compound <b>29a</b>. Yield: 2.04 g (81%) as a pale-yellow solid. HPLC/MS <i>m</i>/<i>z</i>: 269.0 [M + H]<sup>+</sup>, Rt (A): 1.66 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.69 (s, 1H), 7.70 (s, 1H), 7.64–7.50 (m, 4H), 7.48–7.42 (m, 1H), 6.94–6.86 (m, 1H), 6.61–6.53 (m, 1H), 5.05 (s, 1H), 1.45 (s, 6H); HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>16</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>: 268.1212; found: 268.1195.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 7-Chloro-3-[4-(1-hydroxy-1-methyl-ethyl)-phenyl]-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>30b</b>)</h4><div class="NLM_p last">Preparation was according to the general procedure using compound <b>29b</b>. Yield: 3.22 g (71%) as a pale-yellow solid. HPLC/MS <i>m/z</i>: 303.1/305.1 [M + H]<sup>+</sup>, Rt (A): 1.90 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.96 (s, 1H), 7.65–7.62 (m, 1H), 7.60–7.56 (m, 3H), 7.56–7.51 (m, 2H), 6.93–6.90 (m, 1H), 5.06 (s, 1H), 1.44 (s, 6H); HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>Cl: 302.0822; found: 302.0808.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 7-Fluoro-3-[4-(1-hydroxy-1-methyl-ethyl)-phenyl]-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>30c</b>)</h4><div class="NLM_p last">Preparation was according to the general procedure using compound <b>29c</b>. Yield: 4.78 g (83%) as a beige solid. HPLC/MS <i>m/z</i>: 287.1 [M + H]<sup>+</sup>, Rt (C): 2.15 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.97 (s, 1H), 7.61 (s, 1H), 7.59 (d, <i>J</i> = 8.5 Hz, 2H), 7.54 (d, <i>J</i> = 8.5 Hz, 2H), 7.47 (dd, <i>J</i> = 3.4, 1.9 Hz, 1H), 6.75 (d, <i>J</i> = 1.7 Hz, 1H), 5.06 (s, 1H), 1.45 (s, 6H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>F: 286.1118; found: 286.1122.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 6-Fluoro-3-[4-(1-hydroxy-1-methyl-ethyl)-phenyl]-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>30d</b>)</h4><div class="NLM_p last">Preparation was according to the general procedure using compound <b>29d</b>. Yield: 116 mg (62%) as a beige solid. HPLC/MS <i>m/z</i>: 287.1 [M + H]<sup>+</sup>, Rt (D): 1.63 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.78 (s, 1H), 7.69–7.61 (m, 2H), 7.58–7.49 (m, 2H), 7.44 (s, 1H), 6.86 (dd, <i>J</i> = 5.1, 4.3 Hz, 1H), 6.25 (t, <i>J</i> = 4.1 Hz, 1H), 5.08 (s, 1H), 1.45 (s, 6H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>F: 286.1118; found: 286.1102.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 6,7-Difluoro-3-[4-(1-hydroxy-1-methyl-ethyl)-phenyl]-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>30e</b>)</h4><div class="NLM_p last">Preparation was according to the general procedure using compound <b>29e</b>. Yield: 104 mg (61%) as a beige solid. HPLC/MS <i>m/z</i>: 305.1 [M + H]<sup>+</sup>, Rt (D): 1.70 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.04 (s, H), 7.69–7.61 (m, 2H), 7.57–7.51 (m, 2H), 7.50 (s, H), 6.90 (d, <i>J</i> = 4.7 Hz, 1H), 5.09 (s, H), 1.44 (s, 6H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>16</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>F<sub>2</sub>: 304.1023; found: 304.1006.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 3-[4-(1-Hydroxy-1-methyl-ethyl)-phenyl]-7-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>30f</b>)</h4><div class="NLM_p last">Preparation was according to the general procedure using compound <b>29f</b>. Yield: 12 mg (18%) as a pale-beige solid. HPLC/MS <i>m/z</i>: 283.1 [M + H]<sup>+</sup>, Rt (A): 1.81 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.62 (s, 1H), 7.63–7.56 (m, 3H), 7.54–7.50 (m, 2H), 7.25–7.21 (m, 1H), 6.73–6.69 (m, 1H), 5.22–4.80 (m, 1H), 2.18 (s, 3H), 1.44 (s, 6H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>17</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>: 282.1368; found: 282.1354.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 3-[4-(1-Hydroxy-1-methyl-ethyl)-phenyl]-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>30g</b>)</h4><div class="NLM_p last">Preparation was according to the general procedure using compound <b>29g</b>. Yield: 6.55 g (80%) as a yellow solid. HPLC/MS <i>m/z</i>: 283.2 [M + H]<sup>+</sup>, Rt (A): 1.79 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.64 (s, 1H), 7.69–7.63 (m, 2H), 7.57–7.50 (m, 2H), 7.38 (s, 1H), 6.85 (d, <i>J</i> = 3.8 Hz, 1H), 6.37–6.34 (m, 1H), 5.06 (s, 1H), 2.44 (s, 3H), 1.45 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.72, 151.53, 130.50, 128.01, 127.03, 126.12, 125.31, 122.61, 111.84, 109.06, 103.01, 71.08, 32.33, 11.74. HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>17</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>: 282.1368; found: 282.1355.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 6-Hydroxymethyl-3-[4-(1-hydroxy-1-methyl-ethyl)-phenyl]-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>30i</b>)</h4><div class="NLM_p last">Preparation was according to the general procedure using compound <b>29i</b>. Yield: 134 mg (77%) as a yellow solid. HPLC/MS <i>m/z</i>: 299.1 [M + H]<sup>+</sup>, Rt (A): 1.45 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.78 (s, 1H), 7.65–7.59 (m, 2H), 7.57–7.52 (m, 2H), 7.52–7.49 (m, 1H), 6.85 (d, <i>J</i> = 3.9 Hz, 1H), 6.50 (d, <i>J</i> = 3.9 Hz, 1H), 5.62–4.84 (m, 2H), 4.70 (s, 2H), 1.45 (s, 6H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>17</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>: 298.1317; found: 298.1291.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 3-{4-[1-(2-Hydroxy-ethoxy)-1-methyl-ethyl]-phenyl}-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>31</b>)</h4><div class="NLM_p last">Compound <b>30g</b> (100.0 mg, 0.354 mmol) was suspended in ethylene glycol (2.0 mL), toluene-4-sulfonic acid monohydrate (33.7 mg, 0.177 mmol) was added, and the reaction mixture was stirred at room temperature overnight. The reaction mixture was diluted with water, rendered basic by addition of saturated NaHCO<sub>3</sub> solution, and extracted with ethyl acetate. The combined organic layers were washed with water and brine, dried over sodium sulfate, filtered, and evaporated to dryness. The residue was purified by flash chromatography to afford compound <b>31</b> (47 mg, 41%) as a yellow solid. HPLC/MS <i>m/z</i>: 327.2 [M + H]<sup>+</sup>, Rt (A): 1.82 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.65 (s, 1H), 7.75–7.67 (m, 2H), 7.55–7.48 (m, 2H), 7.45–7.40 (m, 1H), 6.85 (d, <i>J</i> = 3.8, 1H), 6.38–6.34 (m, 1H), 4.54 (s, 1H), 3.53–3.46 (m, 2H), 3.18 (t, <i>J</i> = 5.6, 2H), 2.44 (s, 3H), 1.49 (s, 6H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>19</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub>: 326.1630; found: 326.1616.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 3-[4-(1-Hydroxy-cyclopropyl)-phenyl]-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>32</b>)</h4><div class="NLM_p last">To a suspension of compound <b>29g</b> (99.5 mg, 0.352 mmol) in THF (10.0 mL), titanium isopropoxide (108.1 μL, 0.352 mmol) was added under argon and the suspension was stirred for 5 min at room temperature. Ethyl magnesium chloride (2 M in THF, 528.7 μL, 1.057 mmol) was added dropwise over a period of 5 min (slightly exothermic). The resulting solution was stirred for 2 h at room temperature and thereafter ethyl magnesium chloride (2 M in THF, 528.7 μL, 1.057 mmol) was added dropwise within 2 min and the reaction mixture was stirred at room temperature overnight. Further, ethyl magnesium chloride (2 M in THF, 528.7 μL, 1.057 mmol) was added dropwise over a period of 2 min, and the solution was stirred for 1 h at room temperature. After addition of another portion of ethyl magnesium chloride (2 M in THF, 528.7 μL, 1.057 mmol), the solution was stirred for 2.5 h at room temperature, quenched with citric acid solution (10%, 2 mL), diluted with ethyl acetate (40 mL), washed with water and brine, dried over sodium sulfate, filtered, and evaporated to dryness. The residue was purified by preparative HPLC to give compound <b>32</b> (15.5 mg, 16%) as a yellow solid. HPLC/MS <i>m/z</i>: 281.1 [M + H]<sup>+</sup>, Rt (A): 1.78 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.65 (s, 1H), 7.80–7.56 (m, 2H), 7.40 (d, 1H), 7.37–7.18 (m, 2H), 6.85 (d, <i>J</i> = 3.8 Hz, 1H), 6.37 (dd, <i>J</i> = 3.9, 0.9 Hz, 1H), 5.98 (s, 1H), 2.45 (s, 3H), 1.18–1.12 (m, 2H), 1.03–0.97 (m, 2H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>17</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>: 280.1212; found: 280.1216.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 3-[4-(3-Hydroxy-oxetan-3-yl)-phenyl]-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>33</b>)</h4><div class="NLM_p last">Compound <b>28g</b> (300.0 mg, 0.989 mmol) was dissolved in THF (30.0 mL), the solution was cooled to −75 °C, and oxetan-3-one (63.7 μL, 1.087 mmol) was added under an argon atmosphere followed by the dropwise addition of <i>n</i>-butyllithium (15% solution in <i>n</i>-hexane, 1.30 mL, 2.076 mmol) over a period of 15 min. The reaction mixture was stirred for 3 h at −75 °C. Further, oxetan-3-one (0.12 mL, 1.977 mmol) dissolved in THF (1.0 mL) was added dropwise and the reaction mixture was stirred at −75 °C for 15 min. The reaction mixture was quenched at −75 °C with citric acid solution (5%, 5 mL). The mixture was warmed to 0 °C, diluted with water, and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and evaporated to dryness. The residue was purified by flash chromatography, and the resulting solid was dried under vacuum at 60 °C for 3 h to give compound <b>33</b> (27 mg, 9%) as a pale-yellow solid. HPLC/MS <i>m</i>/<i>z</i>: 297.1 [M + H]<sup>+</sup>, Rt (A): 1.61 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.71 (s, 1H), 7.77 (d, <i>J</i> = 8.5 Hz, 2H), 7.67 (d, <i>J</i> = 8.5 Hz, 2H), 7.44 (s, 1H), 6.85 (d, <i>J</i> = 3.8 Hz, 1H), 6.41 (s, 1H), 6.36 (d, <i>J</i> = 3.3 Hz, 1H), 4.80 (d, <i>J</i> = 6.7 Hz, 2H), 4.70 (d, <i>J</i> = 6.7 Hz, 2H), 2.45 (s, 3H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>17</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub>: 296.1161; found: 296.1141.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 3-[4-((<i>S</i>)-1,2-Dihydroxy-1-methyl-ethyl)-phenyl]-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>34a</b>) and 3-[4-((<i>R</i>)-1,2-Dihydroxy-1-methyl-ethyl)-phenyl]-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>34b</b>)</h4><div class="NLM_p"><b>34</b>.1: Compound <b>28g</b> (1.00 g, 3.226 mmol), 4,4,5,5-tetramethyl-2-(prop-1-en-2-yl)-1,3,2-dioxaborolane (596.3 mg, 3.549 mmol), potassium carbonate (1.34 g. 9.678 mmol), and bis(triphenylphosphine)palladium(II) chloride (226.4 mg, 0.323 mmol) were suspended in dioxane (8.0 mL) and water (2.0 mL). While stirring argon was bubbled through the reaction mixture for 5 min. The mixture was heated to 90 °C and stirred for 1 h, cooled to ambient temperature, diluted with water, and extracted with dichloromethane. The combined organic layers were dried over sodium sulfate, filtered, and evaporated to dryness. The residue was purified by flash chromatography (eluent: dichloromethane containing 0–2.5% MeOH) to give 6-methyl-3-[4-(prop-1-en-2-yl)phenyl]-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (586 mg, 69%) as a pale-brown solid. HPLC/MS <i>m</i>/<i>z</i>: 265.2 [M + H]<sup>+</sup>, Rt (A): 2.30 min.</div><div class="NLM_p"><b>34</b>.2: 6-Methyl-3-[4-(prop-1-en-2-yl)-phenyl]-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (147.0 mg, 0.564 mmol) and 4-(dimethylamino)pyridine (2.1 mg, 0.017 mmol) were suspended in 1-butyl-3-methylimidazolium hexafluorophosphate (1.0 mL), <i>tert</i>-butanol (2.0 mL), and acetone (3.0 mL). 4-Methyl-morpholine-4-oxide (50% solution in water, 140.5 μL, 0.677 mmol) and osmium tetroxide (4% solution in water, 72 μL, 0.011 mmol) were added, and the reaction mixture was stirred at 60 °C and for 21 h. Further, osmium tetroxide (4% solution in water, 72 μL, 0.011 mmol) was added and the reaction mixture was stirred at 60 °C for 5 h. The reaction mixture was cooled to ambient temperature, diluted with ethyl acetate, washed with water and brine, dried over sodium sulfate, filtered, and evaporated to dryness. The residue was purified by flash-chromatography to give (<i>rac</i>)-3-[4-(1,2-dihydroxy-1-methyl-ethyl)-phenyl]-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (111 mg, 66%) as a yellow solid, which was subjected to chiral separation by SFC (column: ChiralPak AD-H; eluent: CO<sub>2</sub>/2-propanol (containing 0.5% diethylamine) = 70/30).</div><div class="NLM_p">Compound <b>34a</b>: 31 mg, colorless solid. HPLC/MS <i>m</i>/<i>z</i>: 299.1 [M + H]<sup>+</sup>, Rt (A): 1.56 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.66 (s, 1H), 7.66 (d, <i>J</i> = 8.4 Hz, 2H), 7.52 (d, <i>J</i> = 8.4 Hz, 2H), 7.39 (s, 1H), 6.84 (d, <i>J</i> = 3.8 Hz, 1H), 6.36 (d, <i>J</i> = 3.8 Hz, 1H), 4.94 (s, 1H), 4.70 (t, <i>J</i> = 5.5 Hz, 1H), 3.43 (d, <i>J</i> = 5.1 Hz, 2H), 2.44 (s, 3H), 1.41 (s, 3H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>17</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>: 298.1317; found: 298.1307.</div><div class="NLM_p last">Compound <b>34b</b>: 32 mg, colorless solid. HPLC/MS <i>m</i>/<i>z</i>: 299.1 [M + H]<sup>+</sup>, Rt (A): 1.55 min. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.65 (s, 1H), 7.65 (d, <i>J</i> = 8.5 Hz, 2H), 7.52 (d, <i>J</i> = 8.5 Hz, 2H), 7.38 (d, <i>J</i> = 0.6 Hz, 1H), 6.84 (d, <i>J</i> = 3.8 Hz, 1H), 6.35 (dd, <i>J</i> = 3.8, 0.6 Hz, 1H), 4.91 (s, br, 1H), 4.68 (s, br, 1H), 3.44 (s, 2H), 2.44 (s, 3H), 1.41 (s, 3H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>17</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>: 298.1317; found: 298.1324.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 3-[4-((<i>R</i>)-1,3-Dihydroxy-1-methyl-propyl)-phenyl]-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>35a</b>) and 3-[4-((<i>S</i>)-1,3-Dihydroxy-1-methyl-propyl)-phenyl]-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (<b>35b</b>)</h4><div class="NLM_p"><b>35</b>.1: Compound <b>28g</b> (1.50 g, 4.943 mmol), zinc cyanide (580.4 mg, 4.943 mmol), and tetrakis(triphenylphosphine)palladium(0) (285.6 mg, 0.247 mmol) were suspended in DMF (30.0 mL), purged with argon for 5 min, and heated to 100 °C for 3 h. The reaction mixture was cooled to room temperature, diluted with 1 N NaOH solution, and extracted with dichloromethane. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and evaporated to dryness. The solid residue was suspended in acetonitrile, filtered by suction, washed with acetonitrile, and then dried under vacuum at 50 °C overnight to give 4-(6-methyl-1-oxo-1,2-dihydro-pyrrolo[1,2-<i>a</i>]pyrazin-3-yl)benzonitrile (1.10 g, 89%) as a pale-yellow solid. HPLC/MS <i>m</i>/<i>z</i>: 250.1 [M + H]<sup>+</sup>, Rt (A): 1.86 min.</div><div class="NLM_p"><b>35</b>.2: 4-(6-Methyl-1-oxo-1,2-dihydro-pyrrolo[1,2-<i>a</i>]pyrazin-3-yl)-benzonitrile (1.04 g, 4.172 mmol) and copper(I) iodide (39.7 mg, 0.209 mmol) were suspended in THF (25.0 mL) under argon and stirred for 15 min at room temperature. Methyl magnesium chloride (3 M in THF, 13.91 mL, 41.722 mmol) was added dropwise over a period of 20 min, and the mixture was subsequently stirred at 60 °C for 4 h. The reaction mixture was cooled to room temperature, then slowly quenched with saturated NH<sub>4</sub>Cl solution, and diluted with water (150 mL) and 2 N HCl (100 mL). Ethyl acetate (100 mL) was added and the mixture was stirred at room temperature for 15 min, while a yellow precipitate was formed between the layers, which was filtered by suction, washed with water, ethyl acetate and acetonitrile, and then dried under high vacuum at 60 °C overnight to afford 3-(4-acetyl-phenyl)-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (779 mg, 70%) as a yellow solid. HPLC/MS <i>m</i>/<i>z</i>: 267.1 [M + H]<sup>+</sup>, Rt (A): 1.83 min.</div><div class="NLM_p"><b>35</b>.3: 3-(4-Acetyl-phenyl)-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (500.0 mg, 1.878 mmol), bis(cyclopentadienyl)titanium(IV) dichloride (23.4 mg, 0.094 mmol), zinc powder (613.9 mg, 9.388 mmol), and zinc iodide (119.9 mg, 0.376 mmol) were suspended in dry dioxane (35.0 mL), and the mixture was heated to 90 °C. Ethyl bromoacetate (418.1 μL, 3.755 mmol) was added dropwise under argon over a period of 30 min. The suspension was stirred at 90 °C for 2 h. Further, zinc iodide (59.9 mg, 0.188 mmol) was added and the mixture was stirred for 3.5 h at 90 °C. The reaction mixture was filtered over Celite and washed with dioxane and ethyl acetate, and the filtrate was evaporated to dryness. The solid residue was suspended in DMSO (5 mL) and warmed to 70 °C, and the resulting brown solution was then cooled to room temperature. The formed precipitate was filtered by suction and washed with a small amount of DMSO and acetonitrile. The filtrate was evaporated to dryness, and the residue was purified by flash chromatography to give (<i>rac</i>)-3-hydroxy-3-[4-(6-methyl-1-oxo-1,2-dihydro-pyrrolo[1,2-<i>a</i>]pyrazin-3-yl)-phenyl]-butyric acid ethyl ester (122 mg, 18%) as a yellow semisolid. HPLC/MS <i>m</i>/<i>z</i>: 355.2 [M + H]<sup>+</sup>, Rt (A): 1.93 min.</div><div class="NLM_p"><b>35</b>.4: (<i>rac</i>)-3-Hydroxy-3-[4-(6-methyl-1-oxo-1,2-dihydro-pyrrolo[1,2-<i>a</i>]pyrazin-3-yl)-phenyl]-butyric acid ethyl ester (121.6 mg, 0.343 mmol) was suspended in dry THF (6.0 mL) under argon. Lithium aluminum hydride (2.0 M in THF, 343 μL, 0.686 mmol) was added dropwise over a period of 5 min, and the reaction mixture was stirred overnight at room temperature. The reaction mixture was cooled to 0–5 °C, quenched with 5% citric acid solution, diluted with water, and extracted with ethyl acetate. The combined organic layers were washed with brine, dried with sodium sulfate, filtered by suction, and evaporated to dryness. The oily residue was purified by preparative HPLC to afford (<i>rac</i>)-3-[4-(1,3-dihydroxy-1-methyl-propyl)-phenyl]-6-methyl-2<i>H</i>-pyrrolo[1,2-<i>a</i>]pyrazin-1-one (59 mg, 55%) as a colorless solid, which was subjected to chiral separation by SFC (column: ChiralCel OJ-H; eluent: CO<sub>2</sub>/methanol (containing 0.5% diethylamine) = 80/20).</div><div class="NLM_p">Compound <b>35a</b>: 18 mg, yellow solid. HPLC/MS <i>m</i>/<i>z</i>: 313.2 [M + H]<sup>+</sup>, Rt (A): 1.61 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.65 (s, 1H), 7.67 (d, <i>J</i> = 8.5 Hz, 2H), 7.49 (d, <i>J</i> = 8.5 Hz, 2H), 7.40 (s, 1H), 6.85 (d, <i>J</i> = 3.8 Hz, 1H), 6.36 (d, <i>J</i> = 3.8 Hz, 1H), 5.08 (s, 1H), 4.36 (t, <i>J</i> = 4.9 Hz, 1H), 3.55–3.39 (m, 1H), 3.30–3.21 (m, 1H), 2.44 (s, 3H), 1.94 (t, <i>J</i> = 7.3 Hz, 2H), 1.44 (s, 3H). HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>18</sub>H<sub>20</sub>N<sub>2</sub>O<sub>3</sub>: 312.1474; found: 312.1472.</div><div class="NLM_p last">Compound <b>35b</b>: 12 mg, pale-brown solid. HPLC/MS <i>m</i>/<i>z</i>: 313.1 [M + H]<sup>+</sup>, Rt (A): 1.61 min. HRMS (EI): <i>m</i>/<i>z</i> [M]<sup>+</sup> calcd for C<sub>18</sub>H<sub>20</sub>N<sub>2</sub>O<sub>3</sub>: 312.1474; found: 312.1453.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Cellular Studies</h3><div class="NLM_p last">Assays for detection of tankyrase and axin 2 have been described previously,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and experimental details are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf" class="ext-link">Supporting Information</a>. To assess Wnt pathway activity, an 8× Super Topflash reporter plasmid<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> was stably transfected into DLD1 cells. 8×STF_DLD1 cells were seeded with 14,000 cells per well in white 96-well cell culture plates. After one day, cells were treated with a serial dilution of test compounds with a final concentration of 0.3% DMSO for 24 h at 37 °C and 5% CO<sub>2</sub> in technical triplicates. Luciferase activity was assessed with the Steady Glo Luciferase Assay System (Promega, E2520) and luminescence was measured with an Envision 2104 Multilabel Reader (Perkin Elmer). For softagar growth assays, cells were seeded in a 0.35% softagar matrix onto a bottom matrix consisting of 0.7% softagar in 96-well plates. Compound treatment was performed every 3 days and viable cell colonies were determined after 14 days by the resazurin fluorescent assay (R&D systems, AR002) with an Envision 2104 Multilabel Reader (Perkin Elmer).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> <i>In Vivo</i> Xenograft Studies</h3><div class="NLM_p last">Animal experiments were performed under regulation of the German animal welfare act and in accordance with the EU laboratory animal directive for the area of animal experiments. For tumor growth inhibition studies, 6–8 week-old CB17 SCID female mice (CRL) were inoculated subcutaneously (100 μL/mice) with 5 m human colorectal tumor cells Colo320 suspended 1:1 in Matrigel (BD Bioscience) in the right flank. 6–8 week-old CD1 nude female mice (CRL) were inoculated subcutaneously (100 μL/mice) with 7 m human colorectal tumor cells HT55 in the right flank. Upon inoculation, the mice were randomized according body weight into groups of 15 animals (day 0) and treatment was initiated the same day of grouping. Administrations of the vehicle (0.5% Methocel/0.25% Tween20/water) or M2912 (<b>30g)</b> were orally given by gavage. Tumor growth and body weight were measured twice weekly using a caliper. Tumor volume was calculated using the formula TV = <i>L</i> × <i>W</i> × <i>W</i>/2. Statistical analysis of tumor volumes between treatment groups was done using a two-way ANOVA mixed effect model. For <i>in vivo</i> biomarker studies, 6–8 week-old HSD athymic mice (Envigo) were inoculated subcutaneously (100 μL/mice) with 5 m human colorectal tumor cells DLD1 in the right flank. Tumors were growing until a tumor volume range from 300–800 mm<sup>3</sup>. Mice with the appropriate tumor volume were stratified into control & treatment groups (<i>n</i> = 5/group). Administrations of the vehicle or <b>M2912</b> (<b>30g</b>) were orally given by gavage, and plasma and tumors were collected at the respective time points (2, 8, and 18 h) for subsequent biomarker analysis. Pharmacodynamic biomarker analyses of tankyrase, axin2, and active β-catenin levels were performed as described recently.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00800" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21576" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21576" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00800?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00800</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Assay protocols: activity ELISA of TNKS1 and TNKS2 and PARP-1 biochemical activity assay; PARP family biochemical assays; protocol for determination of microsomal stability (intrinsic clearance); protocol for the determination of Kv11.1 (hERG) ion channel activity; procedure for Caco-2 Papp determination; determination of thermodynamic solubility; information about cell lines; protocol for axin2 and tankyrase cellular assay; description of crystallization procedure and structure determination; description of WaterMap analysis; description of the Glide & WaterMap method; description of isothermal titration calorimetry with binding isotherms and tabulated binding parameters; prediction of human PK by 4 species allometric scaling; scaling of <i>in vivo</i> blood CL based on hepatocyte data; determination of the maximum tolerated dose (MTD); PK simulation (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf">jm1c00800_si_001.pdf (1.19 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_002.csv">jm1c00800_si_002.csv (1.17 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors are deposited at the Protein Data Bank with code 7OCV (<b>30g</b>). The authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.1c00800" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hans-Peter Buchstaller</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-0577-8319" title="Orcid link">https://orcid.org/0000-0002-0577-8319</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#395158574a14495c4d5c4b175b4c5a514a4d5855555c4b79545c4b5a525e4b564c49175a5654"><span class="__cf_email__" data-cfemail="c8a0a9a6bbe5b8adbcadbae6aabdaba0bbbca9a4a4adba88a5adbaaba3afbaa7bdb8e6aba7a5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Uwe Anlauf</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dieter Dorsch</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah Kögler</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Kuhn</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Lehmann</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Birgitta Leuthner</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sara Lodholz</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Djordje Musil</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniela Radtki</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Corinna Rettig</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudio Ritzert</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Felix Rohdich</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Schneider</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ansgar Wegener</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Weigt</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kai Wilkinson</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christina Esdar</span> - <span class="hlFld-Affiliation affiliation">Merck KGaA, Global Research
& Development, Frankfurter Strasse 250, 64293 Darmstadt, Germany</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21387" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21387" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank J. Welge, S. Gaus, T. Herd, U. Bauer, D. Wolf, and E.-M. Leibrock. for excellent experimental support. We would like to acknowledge the work of Cornelia Sommersdorf and Oliver Poetz (NMI, Reutlingen) for analyses of β-catenin expression in <i>ex vivo</i> lysates. The authors are grateful to Ingo Hartung for helpful suggestions and proofreading the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">APC</td><td class="NLM_def"><p class="first last">adenomatous polyposis coli</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal calorimetry</p></td></tr><tr><td class="NLM_term">NAD</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly(ADP-ribose) polymerase</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">TNKS</td><td class="NLM_def"><p class="first last">tankyrase</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved fluorescence resonance energy transfer</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62367" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62367" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fodde, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smits, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">APC, signal transduction and genetic instability in colorectal cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1038/35094067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1038%2F35094067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=11900252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A280%3ADC%252BD387mvVOhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=55-67&author=R.+Foddeauthor=R.+Smitsauthor=H.+Clevers&title=APC%2C+signal+transduction+and+genetic+instability+in+colorectal+cancer&doi=10.1038%2F35094067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">APC, signal transduction and genetic instability in colorectal cancer</span></div><div class="casAuthors">Fodde R; Smits R; Clevers H</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-67</span>
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    </div><div class="casAbstract">Colorectal cancer arises through a gradual series of histological changes, each of which is accompanied by a specific genetic alteration.  In general, an intestinal cell needs to comply with two essential requirements to develop into a cancer: it must acquire selective advantage to allow for the initial clonal expansion, and genetic instability to allow for multiple hits in other genes that are responsible for tumour progression and malignant transformation.  Inactivation of APC--the gene responsible for most cases of colorectal cancer--might fulfil both requirements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-LChZ0ggVnjMsgLhIoICsfW6udTcc2eYibCxRKkRqq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387mvVOhtA%253D%253D&md5=854e24b3b614308fd84ce6af493a3e31</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F35094067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35094067%26sid%3Dliteratum%253Aachs%26aulast%3DFodde%26aufirst%3DR.%26aulast%3DSmits%26aufirst%3DR.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DAPC%252C%2520signal%2520transduction%2520and%2520genetic%2520instability%2520in%2520colorectal%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D55%26epage%3D67%26doi%3D10.1038%2F35094067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maricevich, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucherlapatiet, R.</span></span> <span> </span><span class="NLM_article-title">Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1565</span>– <span class="NLM_lpage">1570</span>, <span class="refDoi"> DOI: 10.1073/pnas.0908682107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1073%2Fpnas.0908682107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=20080688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslOrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=1565-1570&author=K.+E.+Hungauthor=M.+A.+Maricevichauthor=L.+G.+Richardauthor=W.+Y.+Chenauthor=M.+P.+Richardsonauthor=A.+Kuninauthor=R.+T.+Bronsonauthor=U.+Mahmoodauthor=R.+Kucherlapatiet&title=Development+of+a+mouse+model+for+sporadic+and+metastatic+colon+tumors+and+its+use+in+assessing+drug+treatment&doi=10.1073%2Fpnas.0908682107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment</span></div><div class="casAuthors">Hung, Kenneth E.; Maricevich, Marco A.; Richard, Larissa Georgeon; Chen, Wei Y.; Richardson, Michael P.; Kunin, Alexandra; Bronson, Roderick T.; Mahmood, Umar; Kucherlapati, Raju</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1565-1570, S1565/1-S1565/2</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Most genetically engineered mouse (GEM) models for colon cancer are based on tissue-wide or germline gene modification, resulting in tumors predominantly of the small intestine.  Several of these models involve modification of the adenomatous polyposis coli (Apc) gene and are excellent models for familial cancer predisposition syndromes.  We have developed a stochastic somatic mutation model for sporadic colon cancer that presents with isolated primary tumors in the distal colon and recapitulates the entire adenoma-carcinoma-metastasis axis seen in human colon cancer.  Using this model, we have analyzed tumors that are either solely mutant in the Apc gene or in combination with another colon cancer-assocd. mutant gene, the Kras G12D allele.  Because of the restricted location in the distal colon, the natural history of the tumors can be analyzed by serial colonoscopy.  As the mammalian target of rapamycin (mTOR) pathway is a crit. component of the complex signaling network in colon cancer, we used this model to assess the efficacy of mTOR blockade through rapamycin treatment of mice with established tumors.  After treatment, Apc mutant tumors were more than 80% smaller than control tumors.  However, tumors that possessed both Apc and Kras mutations did not respond to rapamycin treatment.  These studies suggest that mTOR inhibitors should be further explored as potential colorectal cancer therapies in patients whose tumors do not have activating mutations in KRAS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvKInIvqqMHLVg90H21EOLACvtfcHk0limah14OZjrWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslOrs7g%253D&md5=64a0da835bca5b26274c0cf71fa773ee</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908682107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908682107%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DK.%2BE.%26aulast%3DMaricevich%26aufirst%3DM.%2BA.%26aulast%3DRichard%26aufirst%3DL.%2BG.%26aulast%3DChen%26aufirst%3DW.%2BY.%26aulast%3DRichardson%26aufirst%3DM.%2BP.%26aulast%3DKunin%26aufirst%3DA.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DMahmood%26aufirst%3DU.%26aulast%3DKucherlapatiet%26aufirst%3DR.%26atitle%3DDevelopment%2520of%2520a%2520mouse%2520model%2520for%2520sporadic%2520and%2520metastatic%2520colon%2520tumors%2520and%2520its%2520use%2520in%2520assessing%2520drug%2520treatment%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D1565%26epage%3D1570%26doi%3D10.1073%2Fpnas.0908682107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span> <span> </span><span class="NLM_article-title">APC mutations as a potential biomarker for sensitivity to tankyrase inhibitors in colorectal cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">752</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1158%2F1535-7163.MCT-16-0578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=28179481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltlOqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=752-762&author=N.+Tanakaauthor=T.+Mashimaauthor=A.+Mizutaniauthor=A.+Satoauthor=A.+Aoyamaauthor=B.+Gongauthor=H.+Yoshidaauthor=Y.+Muramatsuauthor=K.+Nakataauthor=M.+Matsuuraauthor=R.+Katayamaauthor=S.+Nagayamaauthor=N.+Fujitaauthor=Y.+Sugimotoauthor=H.+Seimiya&title=APC+mutations+as+a+potential+biomarker+for+sensitivity+to+tankyrase+inhibitors+in+colorectal+cancer&doi=10.1158%2F1535-7163.MCT-16-0578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer</span></div><div class="casAuthors">Tanaka, Noritaka; Mashima, Tetsuo; Mizutani, Anna; Sato, Ayana; Aoyama, Aki; Gong, Bo; Yoshida, Haruka; Muramatsu, Yukiko; Nakata, Kento; Matsuura, Masaaki; Katayama, Ryohei; Nagayama, Satoshi; Fujita, Naoya; Sugimoto, Yoshikazu; Seimiya, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">752-762</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In most colorectal cancers, Wnt/β-catenin signaling is activated by loss-of-function mutations in the adenomatous polyposis coli (APC) gene and plays a crit. role in tumorigenesis.  Tankyrases poly(ADP-ribosyl)ate and destabilize Axins, a neg. regulator of β-catenin, and upregulate β-catenin signaling.  Tankyrase inhibitors downregulate β-catenin and are expected to be promising therapeutics for colorectal cancer.  However, colorectal cancer cells are not always sensitive to tankyrase inhibitors, and predictive biomarkers for the drug sensitivity remain elusive.  Here we demonstrate that the short-form APC mutations predict the sensitivity of colorectal cancer cells to tankyrase inhibitors.  By using well-established colorectal cancer cell lines, we found that tankyrase inhibitors downregulated β-catenin in the drug-sensitive, but not resistant, colorectal cancer cells.  The drug-sensitive cells showed higher Tcf/LEF transcriptional activity than the resistant cells and possessed "short" truncated APCs lacking all seven β-catenin-binding 20-amino acid repeats (20-AARs).  In contrast, the drug-resistant cells possessed "long" APC retaining two or more 20-AARs.  Knockdown of the long APCs with two 20-AARs increased β-catenin, Tcf/LEF transcriptional activity and its target gene AXIN2 expression.  Under these conditions, tankyrase inhibitors were able to downregulate β-catenin in the resistant cells.  These results indicate that the long APCs are hypomorphic mutants, whereas they exert a dominant-neg. effect on Axin-dependent β-catenin degrdn. caused by tankyrase inhibitors.  Finally, we established 16 patient-derived colorectal cancer cells and confirmed that the tankyrase inhibitor-responsive cells harbor the short-form APC mutations.  These observations exemplify the predictive importance of APC mutations, the most common genetic alteration in colorectal cancers, for mol. targeted therapeutics.  Mol Cancer Ther; 16(4); 752-62. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9GIiKfM_5S7Vg90H21EOLACvtfcHk0limah14OZjrWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltlOqtbk%253D&md5=05fb7d3731f714d6f7212f72f26707ab</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0578%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DMashima%26aufirst%3DT.%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DAoyama%26aufirst%3DA.%26aulast%3DGong%26aufirst%3DB.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DNakata%26aufirst%3DK.%26aulast%3DMatsuura%26aufirst%3DM.%26aulast%3DKatayama%26aufirst%3DR.%26aulast%3DNagayama%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DN.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DSeimiya%26aufirst%3DH.%26atitle%3DAPC%2520mutations%2520as%2520a%2520potential%2520biomarker%2520for%2520sensitivity%2520to%2520tankyrase%2520inhibitors%2520in%2520colorectal%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2017%26volume%3D16%26spage%3D752%26epage%3D762%26doi%3D10.1158%2F1535-7163.MCT-16-0578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schatoff, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zafra, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foronda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shusterman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, L. E.</span></span> <span> </span><span class="NLM_article-title">Distinct colorectal cancer-associated APC mutations dictate response to tankyrase inhibition</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1358</span>– <span class="NLM_lpage">1371</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-19-0289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1158%2F2159-8290.CD-19-0289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=31337618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFOmtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1358-1371&author=E.+M.+Schatoffauthor=S.+Goswamiauthor=M.+P.+Zafraauthor=M.+Forondaauthor=M.+Shustermanauthor=B.+I.+Leachauthor=A.+Kattiauthor=B.+J.+Diazauthor=L.+E.+Dow&title=Distinct+colorectal+cancer-associated+APC+mutations+dictate+response+to+tankyrase+inhibition&doi=10.1158%2F2159-8290.CD-19-0289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct colorectal cancer-associated APC mutations dictate response to tankyrase inhibition</span></div><div class="casAuthors">Schatoff, Emma M.; Goswami, Sukanya; Zafra, Maria Paz; Foronda, Miguel; Shusterman, Michael; Leach, Benjamin I.; Katti, Alyna; Diaz, Bianca J.; Dow, Lukas E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1358-1371</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The majority of colorectal cancers show hyperactivated WNT signaling due to inactivating mutations in the adenomatous polyposis coli (APC) tumor suppressor.  Genetically restoring APC suppresses WNT and induces rapid and sustained tumor regression, implying that reengaging this endogenous tumor-suppressive mechanism may be an effective therapeutic strategy.  Here, using new animal models, human cell lines, and ex vivo organoid cultures, we show that tankyrase (TNKS) inhibition can control WNT hyperactivation and provide long-term tumor control in vivo, but that effective responses are critically dependent on how APC is disrupted.  Mutant APC proteins truncated within the mutation cluster region phys. engage the destruction complex and suppress the WNT transcriptional program, while APC variants with early truncations (e.g., ApcMin) show limited interaction with AXIN1 and β-catenin, and do not respond to TNKS blockade.  Together, this work shows that TNKS inhibition, like APC restoration, can reestablish endogenous control of WNT/β-catenin signaling, but that APC genotype is a crucial determinant of this response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFx49qB-z9GbVg90H21EOLACvtfcHk0limah14OZjrWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFOmtLrL&md5=c2b204d7f428b20b60c6b16b770065fb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-19-0289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-19-0289%26sid%3Dliteratum%253Aachs%26aulast%3DSchatoff%26aufirst%3DE.%2BM.%26aulast%3DGoswami%26aufirst%3DS.%26aulast%3DZafra%26aufirst%3DM.%2BP.%26aulast%3DForonda%26aufirst%3DM.%26aulast%3DShusterman%26aufirst%3DM.%26aulast%3DLeach%26aufirst%3DB.%2BI.%26aulast%3DKatti%26aufirst%3DA.%26aulast%3DDiaz%26aufirst%3DB.%2BJ.%26aulast%3DDow%26aufirst%3DL.%2BE.%26atitle%3DDistinct%2520colorectal%2520cancer-associated%2520APC%2520mutations%2520dictate%2520response%2520to%2520tankyrase%2520inhibition%26jtitle%3DCancer%2520Discovery%26date%3D2019%26volume%3D9%26spage%3D1358%26epage%3D1371%26doi%3D10.1158%2F2159-8290.CD-19-0289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palazzo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahel, I.</span></span> <span> </span><span class="NLM_article-title">PARPs in genome stability and signal transduction: implications for cancer therapy</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1681</span>– <span class="NLM_lpage">1695</span>, <span class="refDoi"> DOI: 10.1042/BST20180418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1042%2FBST20180418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=30420415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntVelsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=1681-1695&author=L.+Palazzoauthor=I.+Ahel&title=PARPs+in+genome+stability+and+signal+transduction%3A+implications+for+cancer+therapy&doi=10.1042%2FBST20180418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PARPs in genome stability and signal transduction: implications for cancer therapy</span></div><div class="casAuthors">Palazzo, Luca; Ahel, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1681-1695</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The poly(ADP-ribose) polymerase (PARP) superfamily of enzymes catalyzes the ADP-ribosylation (ADPr) of target proteins by using NAD (NAD+) as a donor.  ADPr reactions occur either in the form of attachment of a single ADP-ribose nucleotide unit on target proteins or in the form of ADP-ribose chains, with the latter called poly(ADP-ribosyl)ation.  PARPs regulate many cellular processes, including the maintenance of genome stability and signal transduction.  In this review, we focus on the PARP family members that possess the ability to modify proteins by poly(ADPribosyl) ation, namely PARP1, PARP2, Tankyrase-1, and Tankyrase-2.  Here, we detail the cellular functions of PARP1 and PARP2 in the regulation of DNA damage response and describe the function of Tankyrases in Wnt-mediated signal transduction.  Furthermore, we discuss how the understanding of these pathways has provided some major breakthroughs in the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGj0Tirya8TbVg90H21EOLACvtfcHk0liI0IWVUX7niA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntVelsb8%253D&md5=3904ef6d262be342a32b96f2f54f8a9f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1042%2FBST20180418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20180418%26sid%3Dliteratum%253Aachs%26aulast%3DPalazzo%26aufirst%3DL.%26aulast%3DAhel%26aufirst%3DI.%26atitle%3DPARPs%2520in%2520genome%2520stability%2520and%2520signal%2520transduction%253A%2520implications%2520for%2520cancer%2520therapy%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2018%26volume%3D46%26spage%3D1681%26epage%3D1695%26doi%3D10.1042%2FBST20180418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, P.</span></span> <span> </span><span class="NLM_article-title">New PARP targets for cancer therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1038/nrc3748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1038%2Fnrc3748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=24898058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptlKqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=502-509&author=S.+Vyasauthor=P.+Chang&title=New+PARP+targets+for+cancer+therapy&doi=10.1038%2Fnrc3748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">New PARP targets for cancer therapy</span></div><div class="casAuthors">Vyas, Sejal; Chang, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">502-509</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerases (PARPs) modify target proteins post-translationally with poly(ADP-ribose) (PAR) or mono(ADP-ribose) (MAR) using NAD+ as substrate.  The best-studied PARPs generate PAR modifications and include PARP1 and the tankyrase PARP5A, both of which are targets for cancer therapy with inhibitors in either clin. trials or preclin. development.  There are 15 addnl. PARPs, most of which modify proteins with MAR, and their biol. is less well understood.  Recent data identify potentially cancer-relevant functions for these PARPs, which indicates that we need to understand more about these PARPs to effectively target them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouf6CtI5GhsrVg90H21EOLACvtfcHk0liI0IWVUX7niA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptlKqsb0%253D&md5=24a3b64d2d0518e13c9540ee012e29ca</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrc3748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3748%26sid%3Dliteratum%253Aachs%26aulast%3DVyas%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DP.%26atitle%3DNew%2520PARP%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2014%26volume%3D14%26spage%3D502%26epage%3D509%26doi%3D10.1038%2Fnrc3748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickanin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlat, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, F.</span></span> <span> </span><span class="NLM_article-title">RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signaling</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1038/ncb2222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1038%2Fncb2222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=21478859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFGmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=623-629&author=Y.+Zhangauthor=S.+Liuauthor=C.+Mickaninauthor=Y.+Fengauthor=O.+Charlatauthor=G.+A.+Michaudauthor=M.+Schirleauthor=X.+Shiauthor=M.+Hildauthor=A.+Bauerauthor=V.+E.+Myerauthor=P.+M.+Finanauthor=J.+A.+Porterauthor=S.+M.+Huangauthor=F.+Cong&title=RNF146+is+a+poly%28ADP-ribose%29-directed+E3+ligase+that+regulates+axin+degradation+and+Wnt+signaling&doi=10.1038%2Fncb2222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling</span></div><div class="casAuthors">Zhang, Yue; Liu, Shanming; Mickanin, Craig; Feng, Yan; Charlat, Olga; Michaud, Gregory A.; Schirle, Markus; Shi, Xiaoying; Hild, Marc; Bauer, Andreas; Myer, Vic E.; Finan, Peter M.; Porter, Jeffery A.; Huang, Shih-Min A.; Cong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">623-629</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Wnt/β-catenin signalling pathway plays essential roles in embryonic development and adult tissue homeostasis, and deregulation of this pathway has been linked to cancer.  Axin is a concn.-limiting component of the β-catenin destruction complex, and its stability is regulated by tankyrase.  However, the mol. mechanism by which tankyrase-dependent poly(ADP-ribosyl)ation (PARsylation) is coupled to ubiquitylation and degrdn. of axin remains undefined.  Here, we identify RNF146, a RING-domain E3 ubiquitin ligase, as a pos. regulator of Wnt signalling.  RNF146 promotes Wnt signalling by mediating tankyrase-dependent degrdn. of axin.  Mechanistically, RNF146 directly interacts with poly(ADP-ribose) through its WWE domain, and promotes degrdn. of PARsylated proteins.  Using proteomics approaches, we have identified BLZF1 and CASC3 as further substrates targeted by tankyrase and RNF146 for degrdn.  Thus, identification of RNF146 as a PARsylation-directed E3 ligase establishes a mol. paradigm that links tankyrase-dependent PARsylation to ubiquitylation.  RNF146-dependent protein degrdn. may emerge as a major mechanism by which tankyrase exerts its function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgvUCNwxGZLrVg90H21EOLACvtfcHk0liI0IWVUX7niA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFGmurk%253D&md5=0029be867466c74516f1a7fbab62369d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fncb2222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2222%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DMichaud%26aufirst%3DG.%2BA.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DMyer%26aufirst%3DV.%2BE.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DCong%26aufirst%3DF.%26atitle%3DRNF146%2520is%2520a%2520poly%2528ADP-ribose%2529-directed%2520E3%2520ligase%2520that%2520regulates%2520axin%2520degradation%2520and%2520Wnt%2520signaling%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2011%26volume%3D13%26spage%3D623%26epage%3D629%26doi%3D10.1038%2Fncb2222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callow, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bheddah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hongo, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span> <span> </span><span class="NLM_article-title">Ubiquitin ligase RNF146 regulates tankyrase and axin to promote Wnt signaling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e22595</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0022595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1371%2Fjournal.pone.0022595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=21799911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKgt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=M.+G.+Callowauthor=H.+Tranauthor=L.+Phuauthor=T.+Lauauthor=J.+Leeauthor=W.+N.+Sandovalauthor=P.+S.+Liuauthor=S.+Bheddahauthor=J.+Taoauthor=J.+R.+Lillauthor=J.-A.+Hongoauthor=D.+Davisauthor=D.+S.+Kirkpatrickauthor=P.+Polakisauthor=M.+Costa&title=Ubiquitin+ligase+RNF146+regulates+tankyrase+and+axin+to+promote+Wnt+signaling&doi=10.1371%2Fjournal.pone.0022595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling</span></div><div class="casAuthors">Callow, Marinella G.; Tran, Hoanh; Phu, Lilian; Lau, Ted; Lee, James; Sandoval, Wendy N.; Liu, Peter S.; Bheddah, Sheila; Tao, Janet; Lill, Jennie R.; Hongo, Jo-Anne; Davis, David; Kirkpatrick, Donald S.; Polakis, Paul; Costa, Mike</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e22595</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Canonical Wnt signaling is controlled intracellularly by the level of β-catenin protein, which is dependent on Axin scaffolding of a complex that phosphorylates β-catenin to target it for ubiquitylation and proteasomal degrdn.  This function of Axin is counteracted through relocalization of Axin protein to the Wnt receptor complex to allow for ligand-activated Wnt signaling.  AXIN1 and AXIN2 protein levels are regulated by tankyrase-mediated poly(ADP-ribosyl)ation (PARsylation), which destabilizes Axin and promotes signaling.  Mechanistically, how tankyrase limits Axin protein accumulation, and how tankyrase levels and activity are regulated for this function, are currently under investigation.  By RNAi screening, we identified the RNF146 RING-type ubiquitin E3 ligase as a pos. regulator of Wnt signaling that operates with tankyrase to maintain low steady-state levels of Axin proteins.  RNF146 also destabilizes tankyrases TNKS1 and TNKS2 proteins and, in a reciprocal relationship, tankyrase activity reduces RNF146 protein levels.  We show that RNF146, tankyrase, and Axin form a protein complex, and that RNF146 mediates ubiquitylation of all 3 proteins to target them for proteasomal degrdn.  RNF146 is a cytoplasmic protein that also prevents tankyrase protein aggregation at a centrosomal location.  Tankyrase auto-PARsylation and PARsylation of Axin is known to lead to proteasome-mediated degrdn. of these proteins, and we demonstrate that, through ubiquitylation, RNF146 mediates this process to regulate Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBK_DIvtiDN7Vg90H21EOLACvtfcHk0li7SGoCNByUwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKgt7vO&md5=df9dc5d0f0fc70e5d9c81783a34ee10c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0022595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0022595%26sid%3Dliteratum%253Aachs%26aulast%3DCallow%26aufirst%3DM.%2BG.%26aulast%3DTran%26aufirst%3DH.%26aulast%3DPhu%26aufirst%3DL.%26aulast%3DLau%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSandoval%26aufirst%3DW.%2BN.%26aulast%3DLiu%26aufirst%3DP.%2BS.%26aulast%3DBheddah%26aufirst%3DS.%26aulast%3DTao%26aufirst%3DJ.%26aulast%3DLill%26aufirst%3DJ.%2BR.%26aulast%3DHongo%26aufirst%3DJ.-A.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DCosta%26aufirst%3DM.%26atitle%3DUbiquitin%2520ligase%2520RNF146%2520regulates%2520tankyrase%2520and%2520axin%2520to%2520promote%2520Wnt%2520signaling%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0022595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishina, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlat, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiellette, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiessner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickanin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serluca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouwmeester, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, F.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition stabilizes axin and antagonizes Wnt signaling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1038/nature08356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1038%2Fnature08356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=19759537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=614-620&author=S.-M.+A.+Huangauthor=Y.+M.+Mishinaauthor=S.+Liuauthor=A.+Cheungauthor=F.+Stegmeierauthor=G.+A.+Michaudauthor=O.+Charlatauthor=E.+Wielletteauthor=Y.+Zhangauthor=S.+Wiessnerauthor=M.+Hildauthor=X.+Shiauthor=C.+J.+Wilsonauthor=C.+Mickaninauthor=V.+Myerauthor=A.+Fazalauthor=R.+Tomlinsonauthor=F.+Serlucaauthor=W.+Shaoauthor=H.+Chengauthor=M.+Shultzauthor=C.+Rauauthor=M.+Schirleauthor=J.+Schleglauthor=S.+Ghidelliauthor=S.+Fawellauthor=C.+Luauthor=D.+Curtisauthor=M.+W.+Kirschnerauthor=C.+Lengauerauthor=P.+M.+Finanauthor=J.+A.+Tallaricoauthor=T.+Bouwmeesterauthor=J.+A.+Porterauthor=A.+Bauerauthor=F.+Cong&title=Tankyrase+inhibition+stabilizes+axin+and+antagonizes+Wnt+signaling&doi=10.1038%2Fnature08356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span></div><div class="casAuthors">Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Kirschner, Marc W.; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Bouwmeester, Tewis; Porter, Jeffery A.; Bauer, Andreas; Cong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7264</span>),
    <span class="NLM_cas:pages">614-620</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The stability of the Wnt pathway transcription factor β-catenin is tightly regulated by the multi-subunit destruction complex.  Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies.  However, the development of targeted Wnt pathway inhibitors has been hampered by the limited no. of pathway components that are amenable to small mol. inhibition.  Here, we used a chem. genetic screen to identify a small mol., XAV939, which selectively inhibits β-catenin-mediated transcription.  XAV939 stimulates β-catenin degrdn. by stabilizing axin, the concn.-limiting component of the destruction complex.  Using a quant. chem. proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2.  Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degrdn. through the ubiquitin-proteasome pathway.  Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom3c1M4OoOarVg90H21EOLACvtfcHk0li7SGoCNByUwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP&md5=6a76dfa7ed2a57b29e0c1ee367bd652c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnature08356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08356%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.-M.%2BA.%26aulast%3DMishina%26aufirst%3DY.%2BM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DMichaud%26aufirst%3DG.%2BA.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DWiellette%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWiessner%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BJ.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DMyer%26aufirst%3DV.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DGhidelli%26aufirst%3DS.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DCurtis%26aufirst%3DD.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26atitle%3DTankyrase%2520inhibition%2520stabilizes%2520axin%2520and%2520antagonizes%2520Wnt%2520signaling%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D614%26epage%3D620%26doi%3D10.1038%2Fnature08356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariotti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guettler, S.</span></span> <span> </span><span class="NLM_article-title">Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">4611</span>– <span class="NLM_lpage">4636</span>, <span class="refDoi"> DOI: 10.1111/bph.14038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1111%2Fbph.14038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2017&pages=4611-4636&author=L.+Mariottiauthor=K.+Pollockauthor=S.+Guettler&title=Regulation+of+Wnt%2F%CE%B2-catenin+signalling+by+tankyrase-dependent+poly%28ADP-ribosyl%29ation+and+scaffolding&doi=10.1111%2Fbph.14038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fbph.14038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14038%26sid%3Dliteratum%253Aachs%26aulast%3DMariotti%26aufirst%3DL.%26aulast%3DPollock%26aufirst%3DK.%26aulast%3DGuettler%26aufirst%3DS.%26atitle%3DRegulation%2520of%2520Wnt%252F%25CE%25B2-catenin%2520signalling%2520by%2520tankyrase-dependent%2520poly%2528ADP-ribosyl%2529ation%2520and%2520scaffolding%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D74%26spage%3D4611%26epage%3D4636%26doi%3D10.1111%2Fbph.14038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riffell, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, A.</span></span> <span> </span><span class="NLM_article-title">Tankyrase-targeted therapeutics: expanding opportunities in the PARP family</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.1038/nrd3868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1038%2Fnrd3868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=23197039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCntbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=923-936&author=J.+L.+Riffellauthor=C.+J.+Lordauthor=A.+Ashworth&title=Tankyrase-targeted+therapeutics%3A+expanding+opportunities+in+the+PARP+family&doi=10.1038%2Fnrd3868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase-targeted therapeutics: expanding opportunities in the PARP family</span></div><div class="casAuthors">Riffell, Jenna L.; Lord, Christopher J.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">923-936</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The poly(ADP-ribose) polymerase (PARP) protein superfamily has wide-ranging roles in cellular processes such as DNA repair and WNT signalling.  Efforts to pharmacol. target PARP enzymes have largely focused on PARP1 and the closely related PARP2, but recent work highlighting the role of another family member, tankyrase 1 (TANK1; also known as PARP5A and ARTD5), in the control of WNT signalling has fuelled interest in the development of addnl. inhibitors to target this enzyme class.  Tankyrase function is also implicated in other processes such as the regulation of telomere length, lung fibrogenesis and myelination, suggesting that tankyrase inhibitors could have broad clin. utility.  Here, we discuss the biol. of tankyrases and the discovery of tankyrase-specific inhibitors.  We also consider the challenges that lie ahead for the clin. development of PARP family inhibitors in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6R0zBQ42UELVg90H21EOLACvtfcHk0lhiOej9NCpIkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCntbvI&md5=510c523982433e4c22f06f8d1679e6f6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrd3868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3868%26sid%3Dliteratum%253Aachs%26aulast%3DRiffell%26aufirst%3DJ.%2BL.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DTankyrase-targeted%2520therapeutics%253A%2520expanding%2520opportunities%2520in%2520the%2520PARP%2520family%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D923%26epage%3D936%26doi%3D10.1038%2Fnrd3868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lehtiö, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Tankyrases as drug targets</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">3576</span>– <span class="NLM_lpage">3593</span>, <span class="refDoi"> DOI: 10.1111/febs.12320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1111%2Ffebs.12320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=23648170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A280%3ADC%252BC3snhtFOqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=3576-3593&author=L.+Lehti%C3%B6author=N.+Chiauthor=S.+Krauss&title=Tankyrases+as+drug+targets&doi=10.1111%2Ffebs.12320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrases as drug targets</span></div><div class="casAuthors">Lehtio Lari; Chi Nai-Wen; Krauss Stefan</div><div class="citationInfo"><span class="NLM_cas:title">The FEBS journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3576-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tankyrase 1 and tankyrase 2 are poly(ADP-ribosyl)ases that are distinguishable from other members of the enzyme family by the structural features of the catalytic domain, and the presence of a sterile α-motif multimerization domain and an ankyrin repeat protein-interaction domain.  Tankyrases are implicated in a multitude of cellular functions, including telomere homeostasis, mitotic spindle formation, vesicle transport linked to glucose metabolism, Wnt-β-catenin signaling, and viral replication.  In these processes, tankyrases interact with target proteins, catalyze poly(ADP-ribosyl)ation, and regulate protein interactions and stability.  The proposed roles of tankyrases in disease-relevant cellular processes have made them attractive drug targets.  Recently, several inhibitors have been identified.  The selectivity and potency of these small molecules can be rationalized by how they fit within the NAD(+)-binding groove of the catalytic domain.  Some molecules bind to the nicotinamide subsite, such as generic diphtheria toxin-like ADP-ribosyltransferase inhibitors, whereas others bind to a distinct adenosine subsite that diverges from other diphtheria toxin-like ADP-ribosyltransferases and confers specificity.  A highly potent dual-site inhibitor is also available.  Within the last few years, tankyrase inhibitors have proved to be useful chemical probes and potential lead compounds, especially for specific cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxqKZ7T5loVg20zIbnCCI3fW6udTcc2eZirWQWUE1wObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snhtFOqug%253D%253D&md5=9643c0f2d7ee877400bffcdc8ad44c85</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12320%26sid%3Dliteratum%253Aachs%26aulast%3DLehti%25C3%25B6%26aufirst%3DL.%26aulast%3DChi%26aufirst%3DN.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DTankyrases%2520as%2520drug%2520targets%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D3576%26epage%3D3593%26doi%3D10.1111%2Ffebs.12320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtiö, L.</span></span> <span> </span><span class="NLM_article-title">Tankyrases: Structure, function and therapeutic implications in cancer</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6472</span>– <span class="NLM_lpage">6488</span>, <span class="refDoi"> DOI: 10.2174/1381612820666140630101525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.2174%2F1381612820666140630101525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=24975604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=6472-6488&author=T.+Haikarainenauthor=S.+Kraussauthor=L.+Lehti%C3%B6&title=Tankyrases%3A+Structure%2C+function+and+therapeutic+implications+in+cancer&doi=10.2174%2F1381612820666140630101525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrases: Structure, Function and Therapeutic Implications in Cancer</span></div><div class="casAuthors">Haikarainen, Teemu; Krauss, Stefan; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">6472-6488</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Several cellular signaling pathways are regulated by ADP-ribosylation, a posttranslational modification catalyzed by members of the ARTD superfamily.  Tankyrases are distinguishable from the rest of this family by their unique domain organization, notably the sterile alpha motif responsible for oligomerization and ankyrin repeats mediating protein-protein interactions.  Tankyrases are involved in various cellular functions, such as telomere homeostasis, Wnt/β -catenin signaling, glucose metab., and cell cycle progression.  In these processes, Tankyrases regulate the interactions and stability of target proteins by poly (ADP-ribosyl)ation.  Modified proteins are subsequently recognized by the E3 ubiquitin ligase RNF146, poly-ubiquitinated and predominantly guided to 26S proteasomal degrdn.  Several small mol. inhibitors have been described for Tankyrases; they compete with the co-substrate NAD+ for binding to the ARTD catalytic domain.  The recent, highly potent and selective inhibitors possess several properties of lead compds. and can be used for proof-of-concept studies in cancer and other Tankyrase linked diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotYUovVf-x6LVg90H21EOLACvtfcHk0lhiOej9NCpIkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtLfN&md5=ced27d2889d245696043a8cfa891166c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1381612820666140630101525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666140630101525%26sid%3Dliteratum%253Aachs%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DLehti%25C3%25B6%26aufirst%3DL.%26atitle%3DTankyrases%253A%2520Structure%252C%2520function%2520and%2520therapeutic%2520implications%2520in%2520cancer%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D20%26spage%3D6472%26epage%3D6488%26doi%3D10.2174%2F1381612820666140630101525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riyaz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahim, A.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibitors as therapeutic targets for cancer</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1967</span>– <span class="NLM_lpage">1976</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.2174%2F1568026614666140929115831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=25262803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=1967-1976&author=A.+Kamalauthor=S.+Riyazauthor=A.+K.+Srivastavaauthor=A.+Rahim&title=Tankyrase+inhibitors+as+therapeutic+targets+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase Inhibitors as Therapeutic Targets for Cancer</span></div><div class="casAuthors">Kamal, Ahmed; Riyaz, S.; Srivastava, Ajay Kumar; Rahim, Abdul</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1967-1976</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tankyrase 1 and 2 belonging to the family of poly(ADP-ribosyl)ases play an important role in PARsylation by utilizing NAD+ as a substrate in order to generate ADP-ribose polymers.  Tankyrases are involved in a no. of cellular functions, that includes telomere homeostasis, mitotic spindle formation, vesicle transport linked to glucose metab., Wnt/β-catenin signalling, and viral replication.  These roles of tankyrases in disease-relevant cellular processes have made them attractive drug targets.  Recently, several inhibitors have been identified as potential clin. leads.  The current review covers the progress, mechanism and binding modes of recently known Tankyrase inhibitors and discusses the rational approaches that were used to identify the tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruFM_1i4ZP1LVg90H21EOLACvtfcHk0liyXXZJdiS0aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgt7vP&md5=41cdf01744936fa538ef8e7307180feb</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F1568026614666140929115831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026614666140929115831%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DRiyaz%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DA.%2BK.%26aulast%3DRahim%26aufirst%3DA.%26atitle%3DTankyrase%2520inhibitors%2520as%2520therapeutic%2520targets%2520for%2520cancer%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D1967%26epage%3D1976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span> <span> </span><span class="NLM_article-title">RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">4003</span>– <span class="NLM_lpage">4014</span>, <span class="refDoi"> DOI: 10.1111/cas.13805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1111%2Fcas.13805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=30238564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFKju7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=4003-4014&author=A.+Mizutaniauthor=Y.+Yashirodaauthor=Y.+Muramatsuauthor=H.+Yoshidaauthor=T.+Chikadaauthor=T.+Tsumuraauthor=M.+Okueauthor=F.+Shiraiauthor=T.+Fukamiauthor=M.+Yoshidaauthor=H.+Seimiya&title=RK-287107%2C+a+potent+and+specific+tankyrase+inhibitor%2C+blocks+colorectal+cancer+cell+growth+in+a+preclinical+model&doi=10.1111%2Fcas.13805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model</span></div><div class="casAuthors">Mizutani, Anna; Yashiroda, Yoko; Muramatsu, Yukiko; Yoshida, Haruka; Chikada, Tsubasa; Tsumura, Takeshi; Okue, Masayuki; Shirai, Fumiyuki; Fukami, Takehiro; Yoshida, Minoru; Seimiya, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4003-4014</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tankyrase poly(ADP-ribosyl)ates (PARylates) Axin, a neg. regulator of β-catenin.  This post-translational modification causes ubiquitin-dependent degrdn. of Axin, resulting in β-catenin accumulation.  Tankyrase inhibitors downregulate β-catenin and suppress the growth of APC-mutated colorectal cancer cells.  Herein, we report a novel tankyrase-specific inhibitor RK-287107, which inhibits tankyrase-1 and -2 four- and eight-fold more potently, resp., than G007-LK, a tankyrase inhibitor that has been previously reported as effective in mouse xenograft models.  RK-287107 causes Axin2 accumulation and downregulates β-catenin, T-cell factor/lymphoid enhancer factor reporter activity and the target gene expression in colorectal cancer cells harboring the shortly truncated APC mutations.  Consistently, RK-287107 inhibits the growth of APC-mutated (β-catenin-dependent) colorectal cancer COLO-320DM and SW403 cells but not the APC-wild (β-catenin-independent) colorectal cancer RKO cells.  I.p. or oral administration of RK-287107 suppresses COLO-320DM tumor growth in NOD-SCID mice.  Rates of tumor growth inhibition showed good correlation with the behavior of pharmacodynamic biomarkers, such as Axin2 accumulation and MYC downregulation.  These observations indicate that RK-287107 exerts a proof-of-concept antitumor effect, and thus may have potential for tankyrase-directed mol. cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zgbenLgRqbVg90H21EOLACvtfcHk0liyXXZJdiS0aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFKju7zI&md5=4e7bae4fa3689bd43abe0ea399024686</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fcas.13805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13805%26sid%3Dliteratum%253Aachs%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DChikada%26aufirst%3DT.%26aulast%3DTsumura%26aufirst%3DT.%26aulast%3DOkue%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DF.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DSeimiya%26aufirst%3DH.%26atitle%3DRK-287107%252C%2520a%2520potent%2520and%2520specific%2520tankyrase%2520inhibitor%252C%2520blocks%2520colorectal%2520cancer%2520cell%2520growth%2520in%2520a%2520preclinical%2520model%26jtitle%3DCancer%2520Sci.%26date%3D2018%26volume%3D109%26spage%3D4003%26epage%3D4014%26doi%3D10.1111%2Fcas.13805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washizuka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, M.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shitara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, H.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of an orally efficacious spiroindolinone-based tankyrase inhibitor for the treatment of colon cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">4183</span>– <span class="NLM_lpage">4204</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltl2mt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4183-4204&author=F.+Shiraiauthor=A.+Mizutaniauthor=Y.+Yashirodaauthor=T.+Tsumuraauthor=Y.+Kanoauthor=Y.+Muramatsuauthor=T.+Chikadaauthor=H.+Yukiauthor=H.+Niwaauthor=S.+Satoauthor=K.+Washizukaauthor=Y.+Kodaauthor=Y.+Mazakiauthor=M.-K.+Jangauthor=H.+Yoshidaauthor=A.+Nagamoriauthor=M.+Okueauthor=T.+Watanabeauthor=K.+Kitamuraauthor=E.+Shitaraauthor=T.+Honmaauthor=T.+Umeharaauthor=M.+Shirouzuauthor=T.+Fukamiauthor=H.+Seimiyaauthor=M.+Yoshidaauthor=H.+Koyama&title=Design+and+discovery+of+an+orally+efficacious+spiroindolinone-based+tankyrase+inhibitor+for+the+treatment+of+colon+cancer&doi=10.1021%2Facs.jmedchem.0c00045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer</span></div><div class="casAuthors">Shirai, Fumiyuki; Mizutani, Anna; Yashiroda, Yoko; Tsumura, Takeshi; Kano, Yuko; Muramatsu, Yukiko; Chikada, Tsubasa; Yuki, Hitomi; Niwa, Hideaki; Sato, Shin; Washizuka, Kenichi; Koda, Yasuko; Mazaki, Yui; Jang, Myung-Kyu; Yoshida, Haruka; Nagamori, Akiko; Okue, Masayuki; Watanabe, Takashi; Kitamura, Kouichi; Shitara, Eiki; Honma, Teruki; Umehara, Takashi; Shirouzu, Mikako; Fukami, Takehiro; Seimiya, Hiroyuki; Yoshida, Minoru; Koyama, Hiroo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4183-4204</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases (TNKS/TNKS2) belong to the poly(ADP-ribose) polymerase family.  Inhibition of their enzymic activities attenuates the Wnt/β-catenin signaling, which plays an important role in cancer pathogenesis.  We previously reported the discovery of RK-287107, a spiroindoline-based, highly selective, potent tankyrase inhibitor.  Herein we describe the optimization process of RK-287107 leading to RK-582, which exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered.  In addn. to the dose-dependent elevation and attenuation of the levels of biomarkers AXIN2 and β-catenin, resp., results of the TCF reporter and cell proliferation studies on COLO-320DM are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnxMuxDScpWLVg90H21EOLACvtfcHk0lga8q1tYEQdAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltl2mt7g%253D&md5=8c55fd054daf7ccc91975379c2d8085b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00045%26sid%3Dliteratum%253Aachs%26aulast%3DShirai%26aufirst%3DF.%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DTsumura%26aufirst%3DT.%26aulast%3DKano%26aufirst%3DY.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DChikada%26aufirst%3DT.%26aulast%3DYuki%26aufirst%3DH.%26aulast%3DNiwa%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DWashizuka%26aufirst%3DK.%26aulast%3DKoda%26aufirst%3DY.%26aulast%3DMazaki%26aufirst%3DY.%26aulast%3DJang%26aufirst%3DM.-K.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DNagamori%26aufirst%3DA.%26aulast%3DOkue%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DK.%26aulast%3DShitara%26aufirst%3DE.%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DSeimiya%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DKoyama%26aufirst%3DH.%26atitle%3DDesign%2520and%2520discovery%2520of%2520an%2520orally%2520efficacious%2520spiroindolinone-based%2520tankyrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520colon%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D4183%26epage%3D4204%26doi%3D10.1021%2Facs.jmedchem.0c00045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quackenbush, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagby, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messersmith, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitts, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatchford, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capasso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcaroli, J. J.</span></span> <span> </span><span class="NLM_article-title">The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">28273</span>– <span class="NLM_lpage">28285</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.8626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.18632%2Foncotarget.8626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=27070088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A280%3ADC%252BC28fpt1KqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=28273-28285&author=K.+S.+Quackenbushauthor=S.+Bagbyauthor=W.+M.+Taiauthor=W.+A.+Messersmithauthor=A.+Schreiberauthor=J.+Greeneauthor=J.+Kimauthor=G.+Wangauthor=A.+Purkeyauthor=T.+M.+Pittsauthor=A.+Nguyenauthor=D.+Gaoauthor=P.+Blatchfordauthor=A.+Capassoauthor=A.+G.+Schullerauthor=S.+G.+Eckhardtauthor=J.+J.+Arcaroli&title=The+novel+tankyrase+inhibitor+%28AZ1366%29+enhances+irinotecan+activity+in+tumors+that+exhibit+elevated+tankyrase+and+irinotecan+resistance&doi=10.18632%2Foncotarget.8626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance</span></div><div class="casAuthors">Quackenbush Kevin S; Bagby Stacey; Tai Wai Meng; Messersmith Wells A; Schreiber Anna; Greene Justin; Kim Jihye; Wang Guoliang; Purkey Alicia; Pitts Todd M; Nguyen Anna; Gao Dexiang; Blatchford Patrick; Capasso Anna; Eckhardt S Gail; Arcaroli John J; Tai Wai Meng; Schuller Alwin G</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">28273-85</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Dysregulation of the canonical Wnt signaling pathway has been implicated in colorectal cancer (CRC) development as well as incipient stages of malignant transformation.  In this study, we investigated the antitumor effects of AZ1366 (a novel tankyrase inhibitor) as a single agent and in combination with irinotecan in our patient derived CRC explant xenograft models.  RESULTS:  Six out of 18 CRC explants displayed a significant growth reduction to AZ1366.  There was one CRC explant (CRC040) that reached the threshold of sensitivity (TGII ≤ 20%) in this study.  In addition, the combination of AZ1366 + irinotecan demonstrated efficacy in 4 out of 18 CRC explants.  Treatment effects on the WNT pathway revealed that tankyrase inhibition was ineffective at reducing WNT dependent signaling.  However, the anti-tumor effects observed in this study were likely a result of alternative tankyrase effects whereby tankyrase inhibition reduced NuMA levels.  MATERIALS AND METHODS:  Eighteen CRC explants were treated with AZ1366 single agent or in combination for 28 days and treatment responses were assessed.  Pharmacokinetic (AZ1366 drug concentrations) and pharmacodynamic effects (Axin2 levels) were investigated over 48 hours.  Immunohistochemistry of nuclear β-catenin levels as well as western blot was employed to examine the treatment effects on the WNT pathway as well as NuMA.  CONCLUSIONS:  Combination AZ1366 and irinotecan achieved greater anti-tumor effects compared to monotherapy.  Activity was limited to CRC explants that displayed irinotecan resistance and increased protein levels of tankyrase and NuMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRANi51pzsdW1QKX3ooHxWjfW6udTcc2ead08URVXuQY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fpt1KqtQ%253D%253D&md5=bb51ae9892a3ec15cbb0f1f5a3e6ebca</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8626%26sid%3Dliteratum%253Aachs%26aulast%3DQuackenbush%26aufirst%3DK.%2BS.%26aulast%3DBagby%26aufirst%3DS.%26aulast%3DTai%26aufirst%3DW.%2BM.%26aulast%3DMessersmith%26aufirst%3DW.%2BA.%26aulast%3DSchreiber%26aufirst%3DA.%26aulast%3DGreene%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DPurkey%26aufirst%3DA.%26aulast%3DPitts%26aufirst%3DT.%2BM.%26aulast%3DNguyen%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DBlatchford%26aufirst%3DP.%26aulast%3DCapasso%26aufirst%3DA.%26aulast%3DSchuller%26aufirst%3DA.%2BG.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DArcaroli%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520novel%2520tankyrase%2520inhibitor%2520%2528AZ1366%2529%2520enhances%2520irinotecan%2520activity%2520in%2520tumors%2520that%2520exhibit%2520elevated%2520tankyrase%2520and%2520irinotecan%2520resistance%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D28273%26epage%3D28285%26doi%3D10.18632%2Foncotarget.8626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eide, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machonova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voronkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2822</span>– <span class="NLM_lpage">2832</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-3336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1158%2F0008-5472.CAN-11-3336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=22440753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2822-2832&author=J.+Waalerauthor=O.+Machonauthor=L.+Tumovaauthor=H.+Dinhauthor=V.+Korinekauthor=S.+R.+Wilsonauthor=J.+E.+Paulsenauthor=N.+M.+Pedersenauthor=T.+J.+Eideauthor=O.+Machonovaauthor=D.+Gradlauthor=A.+Voronkovauthor=J.+P.+von+Kriesauthor=S.+Krauss&title=A+novel+tankyrase+inhibitor+decreases+canonical+Wnt+signaling+in+colon+carcinoma+cells+and+reduces+tumor+growth+in+conditional+APC+mutant+mice&doi=10.1158%2F0008-5472.CAN-11-3336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice</span></div><div class="casAuthors">Waaler, Jo; Machon, Ondrej; Tumova, Lucie; Dinh, Huyen; Korinek, Vladimir; Wilson, Steven Ray; Paulsen, Jan Erik; Pedersen, Nina Marie; Eide, Tor J.; Machonova, Olga; Gradl, Dietmar; Voronkov, Andrey; von Kries, Jens Peter; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2822-2832</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This preclin. proof-of-concept study suggests a new strategy to treat colon cancer by increasing the degrdn. of β-catenin, which drives this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokQ3hrnF8gMLVg90H21EOLACvtfcHk0lga8q1tYEQdAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D&md5=9814ad25dc1d5da6d9babaff8df19327</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-3336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-3336%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DTumova%26aufirst%3DL.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DPaulsen%26aufirst%3DJ.%2BE.%26aulast%3DPedersen%26aufirst%3DN.%2BM.%26aulast%3DEide%26aufirst%3DT.%2BJ.%26aulast%3DMachonova%26aufirst%3DO.%26aulast%3DGradl%26aufirst%3DD.%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DA%2520novel%2520tankyrase%2520inhibitor%2520decreases%2520canonical%2520Wnt%2520signaling%2520in%2520colon%2520carcinoma%2520cells%2520and%2520reduces%2520tumor%2520growth%2520in%2520conditional%2520APC%2520mutant%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2822%26epage%3D2832%26doi%3D10.1158%2F0008-5472.CAN-11-3336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anlauf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radtki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of 2-arylquinazolin-4-ones into a potent and selective tankyrase inhibitor modulating Wnt pathway activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7897</span>– <span class="NLM_lpage">7909</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7897-7909&author=H.-P.+Buchstallerauthor=U.+Anlaufauthor=D.+Dorschauthor=D.+Kuhnauthor=M.+Lehmannauthor=B.+Leuthnerauthor=D.+Musilauthor=D.+Radtkiauthor=C.+Ritzertauthor=F.+Rohdichauthor=R.+Schneiderauthor=C.+Esdar&title=Discovery+and+optimization+of+2-arylquinazolin-4-ones+into+a+potent+and+selective+tankyrase+inhibitor+modulating+Wnt+pathway+activity&doi=10.1021%2Facs.jmedchem.9b00656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity</span></div><div class="casAuthors">Buchstaller, Hans-Peter; Anlauf, Uwe; Dorsch, Dieter; Kuhn, Daniel; Lehmann, Martin; Leuthner, Birgitta; Musil, Djordje; Radtki, Daniela; Ritzert, Claudio; Rohdich, Felix; Schneider, Richard; Esdar, Christina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7897-7909</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. targets which recently gained interest for anticancer therapy in Wnt pathway dependent tumors.  2-Aryl-quinazolinones were identified and optimized into potent tankyrase inhibitors through SAR exploration around the quinazolinone core and the 4'-position of the Ph residue.  These efforts were supported by anal. of TNKS X-ray and Watermap structures and resulted in compd. 5k(I), a potent, selective tankyrase inhibitor with favorable pharmacokinetic properties.  The X-ray structure of I in complex with TNKS1 was solved and confirmed the design hypothesis.  Modulation of Wnt pathway activity was demonstrated with this compd. in a colorectal xenograft model in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl6p_xrETB-bVg90H21EOLACvtfcHk0lhcFQ4fQVZ4Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7bI&md5=7fcc6c91c6e614482386af2094675837</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00656%26sid%3Dliteratum%253Aachs%26aulast%3DBuchstaller%26aufirst%3DH.-P.%26aulast%3DAnlauf%26aufirst%3DU.%26aulast%3DDorsch%26aufirst%3DD.%26aulast%3DKuhn%26aufirst%3DD.%26aulast%3DLehmann%26aufirst%3DM.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DRadtki%26aufirst%3DD.%26aulast%3DRitzert%26aufirst%3DC.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DEsdar%26aufirst%3DC.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25202-arylquinazolin-4-ones%2520into%2520a%2520potent%2520and%2520selective%2520tankyrase%2520inhibitor%2520modulating%2520Wnt%2520pathway%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7897%26epage%3D7909%26doi%3D10.1021%2Facs.jmedchem.9b00656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dipietro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochala, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touré, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span> <span> </span><span class="NLM_article-title">Identification of NVP-TNKS656: The use of structure-efficiency relationships to generate a highly potent, selective, and orally active tankyrase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6495</span>– <span class="NLM_lpage">6511</span>, <span class="refDoi"> DOI: 10.1021/jm400807n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400807n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2msbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6495-6511&author=M.+D.+Shultzauthor=A.+K.+Cheungauthor=C.+A.+Kirbyauthor=B.+Firestoneauthor=J.+Fanauthor=C.+H.+Chenauthor=Z.+Chenauthor=D.+N.+Chinauthor=L.+Dipietroauthor=A.+Fazalauthor=Y.+Fengauthor=P.+D.+Fortinauthor=T.+Gouldauthor=B.+Laguauthor=H.+Leiauthor=F.+Lenoirauthor=D.+Majumdarauthor=E.+Ochalaauthor=M.+G.+Palermoauthor=L.+Phamauthor=M.+Puauthor=T.+Smithauthor=T.+Stamsauthor=R.+C.+Tomlinsonauthor=B.+B.+Tour%C3%A9author=M.+Visserauthor=R.+M.+Wangauthor=N.+J.+Watersauthor=W.+Shao&title=Identification+of+NVP-TNKS656%3A+The+use+of+structure-efficiency+relationships+to+generate+a+highly+potent%2C+selective%2C+and+orally+active+tankyrase+inhibitor&doi=10.1021%2Fjm400807n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of NVP-TNKS656: The Use of Structure-Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor</span></div><div class="casAuthors">Shultz, Michael D.; Cheung, Atwood K.; Kirby, Christina A.; Firestone, Brant; Fan, Jianmei; Chen, Christine Hiu-Tung; Chen, Zhouliang; Chin, Donovan N.; DiPietro, Lucian; Fazal, Aleem; Feng, Yun; Fortin, Pascal D.; Gould, Ty; Lagu, Bharat; Lei, Huangshu; Lenoir, Francois; Majumdar, Dyuti; Ochala, Etienne; Palermo, M. G.; Pham, Ly; Pu, Minying; Smith, Troy; Stams, Travis; Tomlinson, Ronald C.; Toure, B. Barry; Visser, Michael; Wang, Run Ming; Waters, Nigel J.; Shao, Wenlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6495-6511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase 1 and 2 have been shown to be redundant, druggable nodes in the Wnt pathway.  As such, there has been intense interest in developing agents suitable for modulating the Wnt pathway in vivo by targeting this enzyme pair.  By utilizing a combination of structure-based design and LipE-based structure efficiency relationships, the core of XAV939 was optimized into a more stable, more efficient, but less potent dihydropyran motif 7.  This core was combined with elements of screening hits 2, 19, and 33 and resulted in highly potent, selective tankyrase inhibitors that are novel three pocket binders.  NVP-TNKS656 (43) was identified as an orally active antagonist of Wnt pathway activity in the MMTV-Wnt1 mouse xenograft model.  With an enthalpy-driven thermodn. signature of binding, highly favorable physicochem. properties, and high lipophilic efficiency, NVP-TNKS656 is a novel tankyrase inhibitor that is well suited for further in vivo validation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDGWOimaJ0I7Vg90H21EOLACvtfcHk0lhcFQ4fQVZ4Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2msbfE&md5=db3f1a471ca757e0219a5175c5017e9b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm400807n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400807n%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DCheung%26aufirst%3DA.%2BK.%26aulast%3DKirby%26aufirst%3DC.%2BA.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DDipietro%26aufirst%3DL.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DOchala%26aufirst%3DE.%26aulast%3DPalermo%26aufirst%3DM.%2BG.%26aulast%3DPham%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DTomlinson%26aufirst%3DR.%2BC.%26aulast%3DTour%25C3%25A9%26aufirst%3DB.%2BB.%26aulast%3DVisser%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DR.%2BM.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DShao%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520NVP-TNKS656%253A%2520The%2520use%2520of%2520structure-efficiency%2520relationships%2520to%2520generate%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520tankyrase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6495%26epage%3D6511%26doi%3D10.1021%2Fjm400807n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of 2-arylquinazolin-4-ones as potent and selective inhibitors of tankyrases</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.1021/ml400260b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400260b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aht7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1173-1177&author=A.+Nathubhaiauthor=P.+J.+Woodauthor=M.+D.+Lloydauthor=A.+S.+Thompsonauthor=M.+D.+Threadgill&title=Design+and+discovery+of+2-arylquinazolin-4-ones+as+potent+and+selective+inhibitors+of+tankyrases&doi=10.1021%2Fml400260b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Discovery of 2 Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases</span></div><div class="casAuthors">Nathubhai, Amit; Wood, Pauline J.; Lloyd, Matthew D.; Thompson, Andrew S.; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1173-1177</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases (TNKSs) are poly-(ADP-ribose)-polymerases (PARPs) that are overexpressed in several clin. cancers.  They regulate elongation of telomeres, regulate the Wnt system, and are essential for the function of the mitotic spindle.  A set of 2-arylquinazolin-4-ones has been designed and identified as potent and selective TNKS inhibitors, some being more potent and selective than the lead inhibitor XAV939, with IC50 = 3 nM vs.  TNKS-2.  Me was preferred at the 8-position and modest bulk at the 4-position of the 2-Ph group; electronic effects and H-bonding were irrelevant, but charge in the 4'-substituent must be avoided.  Mol. modeling facilitated initial design of the compds. and rationalization of the SAR of binding into the nicotinamide-binding site of the target enzymes.  These compds. have potential for further development into anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxfmX1o7LIsrVg90H21EOLACvtfcHk0lhcFQ4fQVZ4Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aht7nM&md5=23eb9a910b7952c76392bb1ae3b1185b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fml400260b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400260b%26sid%3Dliteratum%253Aachs%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DP.%2BJ.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BS.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DDesign%2520and%2520discovery%2520of%25202-arylquinazolin-4-ones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520tankyrases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1173%26epage%3D1177%26doi%3D10.1021%2Fml400260b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukaiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oonota, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusama, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.10.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1016%2Fj.bmc.2006.10.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=17095233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtleisL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=868-885&author=H.+Mukaiyamaauthor=T.+Nishimuraauthor=S.+Kobayashiauthor=T.+Ozawaauthor=N.+Kamadaauthor=Y.+Komatsuauthor=S.+Kikuchiauthor=H.+Oonotaauthor=H.+Kusama&title=Synthesis+and+c-Src+inhibitory+activity+of+imidazo%5B1%2C5-a%5Dpyrazine+derivatives+as+an+agent+for+treatment+of+acute+ischemic+stroke&doi=10.1016%2Fj.bmc.2006.10.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke</span></div><div class="casAuthors">Mukaiyama, Harunobu; Nishimura, Toshihiro; Kobayashi, Satoko; Ozawa, Tomonaga; Kamada, Noboru; Komatsu, Yoshimitsu; Kikuchi, Shinji; Oonota, Hideki; Kusama, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">868-885</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We synthesized and evaluated a series of C-5 substituted imidazo[1,5-a]pyrazine derivs. to identify potent c-Src inhibitors as potential therapeutic agents for acute ischemic stroke.  Among these compds., compd. 14c (I) demonstrated remarkable central nervous system (CNS) penetration and significant neuroprotective efficacy in vivo in rat models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi4kukCwyq8LVg90H21EOLACvtfcHk0ljz12v0WrTWrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtleisL3O&md5=5a86ce3af0d088c9aefcb61080a4ac11</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.10.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.10.041%26sid%3Dliteratum%253Aachs%26aulast%3DMukaiyama%26aufirst%3DH.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DOzawa%26aufirst%3DT.%26aulast%3DKamada%26aufirst%3DN.%26aulast%3DKomatsu%26aufirst%3DY.%26aulast%3DKikuchi%26aufirst%3DS.%26aulast%3DOonota%26aufirst%3DH.%26aulast%3DKusama%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520c-Src%2520inhibitory%2520activity%2520of%2520imidazo%255B1%252C5-a%255Dpyrazine%2520derivatives%2520as%2520an%2520agent%2520for%2520treatment%2520of%2520acute%2520ischemic%2520stroke%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D868%26epage%3D885%26doi%3D10.1016%2Fj.bmc.2006.10.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, J. C.</span></span> <span> </span><span class="NLM_article-title">A concise and regioselective synthesis of 1-alkyl-4-imidazolecarboxylates</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">4133</span>– <span class="NLM_lpage">4134</span>, <span class="refDoi"> DOI: 10.1021/ol026892k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol026892k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFCnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=4133-4134&author=C.+J.+Helalauthor=J.+C.+Lucas&title=A+concise+and+regioselective+synthesis+of+1-alkyl-4-imidazolecarboxylates&doi=10.1021%2Fol026892k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A Concise and Regioselective Synthesis of 1-Alkyl-4-imidazolecarboxylates</span></div><div class="casAuthors">Helal, Christopher J.; Lucas, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4133-4134</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Reaction between Et 3-N,N-(dimethylamino)-2-isocyanoacrylate (I) and a primary amine regioselectively affords 1-alkyl-4-imidazolecarboxylates, e.g., II in good yields (52-89%).  The method is applicable to unhindered and hindered amine substrates, as well as those contg. reactive functionality such as alcs. and secondary and tertiary amines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs4Fz_aWB47rVg90H21EOLACvtfcHk0ljz12v0WrTWrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFCnur8%253D&md5=39b59fd4bbb930a5031c678d57241c90</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fol026892k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol026892k%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLucas%26aufirst%3DJ.%2BC.%26atitle%3DA%2520concise%2520and%2520regioselective%2520synthesis%2520of%25201-alkyl-4-imidazolecarboxylates%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D4133%26epage%3D4134%26doi%3D10.1021%2Fol026892k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H.-P.</span>; <span class="NLM_string-name">Dorsch, D.</span></span> <span> </span><span class="NLM_article-title">Imidazopyrazinone derivatives</span>. <span class="NLM_patent">WO 15096884</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.-P.+Buchstaller&author=D.+Dorsch&title=Imidazopyrazinone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBuchstaller%26aufirst%3DH.-P.%26atitle%3DImidazopyrazinone%2520derivatives%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heeran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandford, G.</span></span> <span> </span><span class="NLM_article-title">Fluorination of pyrrole derivatives by Selectfluor<sup>TM</sup></span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2456</span>– <span class="NLM_lpage">2463</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2016.03.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1016%2Fj.tet.2016.03.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVagur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2016&pages=2456-2463&author=D.+Heeranauthor=G.+Sandford&title=Fluorination+of+pyrrole+derivatives+by+SelectfluorTM&doi=10.1016%2Fj.tet.2016.03.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorination of pyrrole derivatives by Selectfluor</span></div><div class="casAuthors">Heeran, Darren; Sandford, Graham</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2456-2463</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Fluorination of a range of pyrrole substrates bearing various electron donating and withdrawing substituents at the 1-, 2- and 3-positions using Selectfluor was assessed in order to develop effective methodol. for the synthesis of corresponding fluoropyrrole derivs.  The synthesis of some novel fluorinated pyrrole derivs. were achieved in reasonable quantities although many pyrrole substrates were oxidatively polymd. by the fluorinating reagent, reducing the scope of a selective fluorination approach for the prepn. of fluoropyrrole products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhM4VzyaQiRbVg90H21EOLACvtfcHk0ljz12v0WrTWrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVagur4%253D&md5=24a342a6dc8da028a99dab08edeb76b5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2016.03.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2016.03.067%26sid%3Dliteratum%253Aachs%26aulast%3DHeeran%26aufirst%3DD.%26aulast%3DSandford%26aufirst%3DG.%26atitle%3DFluorination%2520of%2520pyrrole%2520derivatives%2520by%2520SelectfluorTM%26jtitle%3DTetrahedron%26date%3D2016%26volume%3D72%26spage%3D2456%26epage%3D2463%26doi%3D10.1016%2Fj.tet.2016.03.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gagliardi, S.</span>; <span class="NLM_string-name">Le Poul, E.</span>; <span class="NLM_string-name">Lingard, L.</span>; <span class="NLM_string-name">Palombi, G.</span>; <span class="NLM_string-name">Poli, S. M.</span>; <span class="NLM_string-name">Rocher, J.-P.</span></span> <span> </span><span class="NLM_article-title">Pyrrole derivatives as positive allosteric modulators of metabotropic receptors</span>. <span class="NLM_patent">WO 06123257</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=S.+Gagliardi&author=E.+Le+Poul&author=L.+Lingard&author=G.+Palombi&author=S.+M.+Poli&author=J.-P.+Rocher&title=Pyrrole+derivatives+as+positive+allosteric+modulators+of+metabotropic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGagliardi%26aufirst%3DS.%26atitle%3DPyrrole%2520derivatives%2520as%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520receptors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafiq, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa-Cabral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munkonge, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinidade, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, C. J.</span></span> <span> </span><span class="NLM_article-title">A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">201</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-36447-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1038%2Fs41598-018-36447-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=30655555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A280%3ADC%252BB3cjis1Gjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=201&author=M.+Menonauthor=R.+Elliottauthor=L.+Bowersauthor=N.+Balanauthor=R.+Rafiqauthor=S.+Costa-Cabralauthor=F.+Munkongeauthor=I.+Trinidadeauthor=R.+Porterauthor=A.+D.+Campbellauthor=E.+R.+Johnsonauthor=C.+Esdarauthor=H.-P.+Buchstallerauthor=B.+Leuthnerauthor=F.+Rohdichauthor=R.+Schneiderauthor=O.+Sansomauthor=D.+Wienkeauthor=A.+Ashworthauthor=C.+J.+Lord&title=A+novel+tankyrase+inhibitor%2C+MSC2504877%2C+enhances+the+effects+of+clinical+CDK4%2F6+inhibitors&doi=10.1038%2Fs41598-018-36447-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors</span></div><div class="casAuthors">Menon Malini; Elliott Richard; Bowers Leandra; Balan Nicolae; Rafiq Rumana; Costa-Cabral Sara; Munkonge Felix; Trinidade Ines; Ashworth Alan; Lord Christopher J; Porter Roderick; Campbell Andrew D; Johnson Emma R; Sansom Owen; Esdar Christina; Buchstaller Hans-Peter; Leuthner Birgitta; Rohdich Felix; Schneider Richard; Wienke Dirk; Ashworth Alan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">201</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inhibition of the PARP superfamily tankyrase enzymes suppresses Wnt/β-catenin signalling in tumour cells.  Here, we describe here a novel, drug-like small molecule inhibitor of tankyrase MSC2504877 that inhibits the growth of APC mutant colorectal tumour cells.  Parallel siRNA and drug sensitivity screens showed that the clinical CDK4/6 inhibitor palbociclib, causes enhanced sensitivity to MSC2504877.  This tankyrase inhibitor-CDK4/6 inhibitor combinatorial effect is not limited to palbociclib and MSC2504877 and is elicited with other CDK4/6 inhibitors and toolbox tankyrase inhibitors.  The addition of MSC2504877 to palbociclib enhances G1 cell cycle arrest and cellular senescence in tumour cells.  MSC2504877 exposure suppresses the upregulation of Cyclin D2 and Cyclin E2 caused by palbociclib and enhances the suppression of phospho-Rb, providing a mechanistic explanation for these effects.  The combination of MSC2504877 and palbociclib was also effective in suppressing the cellular hyperproliferative phenotype seen in Apc defective intestinal stem cells in vivo.  However, the presence of an oncogenic Kras p.G12D mutation in mice reversed the effects of the MSC2504877/palbociclib combination, suggesting one molecular route that could lead to drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsCECdrvD2BkewzGPswiWOfW6udTcc2eYDyAWqKDkdvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjis1Gjtg%253D%253D&md5=34ac002987c951a0ebd2f34f256ed21c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-36447-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-36447-4%26sid%3Dliteratum%253Aachs%26aulast%3DMenon%26aufirst%3DM.%26aulast%3DElliott%26aufirst%3DR.%26aulast%3DBowers%26aufirst%3DL.%26aulast%3DBalan%26aufirst%3DN.%26aulast%3DRafiq%26aufirst%3DR.%26aulast%3DCosta-Cabral%26aufirst%3DS.%26aulast%3DMunkonge%26aufirst%3DF.%26aulast%3DTrinidade%26aufirst%3DI.%26aulast%3DPorter%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DA.%2BD.%26aulast%3DJohnson%26aufirst%3DE.%2BR.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DBuchstaller%26aufirst%3DH.-P.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DSansom%26aufirst%3DO.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DAshworth%26aufirst%3DA.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26atitle%3DA%2520novel%2520tankyrase%2520inhibitor%252C%2520MSC2504877%252C%2520enhances%2520the%2520effects%2520of%2520clinical%2520CDK4%252F6%2520inhibitors%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D201%26doi%3D10.1038%2Fs41598-018-36447-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mouradov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloggett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorissen, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strausberg, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wormald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, L.</span></span> <span> </span><span class="NLM_article-title">Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">3238</span>– <span class="NLM_lpage">3247</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-0013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1158%2F0008-5472.CAN-14-0013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=24755471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1CmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=3238-3247&author=D.+Mouradovauthor=C.+Sloggettauthor=R.+N.+Jorissenauthor=C.+G.+Loveauthor=S.+Liauthor=A.+W.+Burgessauthor=D.+Arangoauthor=R.+L.+Strausbergauthor=D.+Buchananauthor=S.+Wormaldauthor=L.+O%E2%80%99Connor&title=Colorectal+cancer+cell+lines+are+representative+models+of+the+main+molecular+subtypes+of+primary+cancer&doi=10.1158%2F0008-5472.CAN-14-0013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer</span></div><div class="casAuthors">Mouradov, Dmitri; Sloggett, Clare; Jorissen, Robert N.; Love, Christopher G.; Li, Shan; Burgess, Antony W.; Arango, Diego; Strausberg, Robert L.; Buchanan, Daniel; Wormald, Samuel; O'Connor, Liam; Wilding, Jennifer L.; Bicknell, David; Tomlinson, Ian P. M.; Bodmer, Walter F.; Mariadason, John M.; Sieber, Oliver M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3238-3247</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Human colorectal cancer cell lines are used widely to investigate tumor biol., exptl. therapy, and biomarkers.  However, to what extent these established cell lines represent and maintain the genetic diversity of primary cancers is uncertain.  In this study, we profiled 70 colorectal cancer cell lines for mutations and DNA copy no. by whole-exome sequencing and SNP microarray analyses, resp.  Gene expression was defined using RNA-Seq.  Cell line data were compared with those published for primary colorectal cancers in The Cancer Genome Atlas.  Notably, we found that exome mutation and DNA copy-no. spectra in colorectal cancer cell lines closely resembled those seen in primary colorectal tumors.  Similarities included the presence of two hypermutation phenotypes, as defined by signatures for defective DNA mismatch repair and DNA polymerase ε proofreading deficiency, along with concordant mutation profiles in the broadly altered WNT, MAPK, PI3K, TGFβ, and p53 pathways.  Furthermore, we documented mutations enriched in genes involved in chromatin remodeling (ARID1A, CHD6, and SRCAP) and histone methylation or acetylation (ASH1L, EP300, EP400, MLL2, MLL3, PRDM2, and TRRAP).  Chromosomal instability was prevalent in nonhypermutated cases, with similar patterns of chromosomal gains and losses.  Although paired cell lines derived from the same tumor exhibited considerable mutation and DNA copy-no. differences, in silico simulations suggest that these differences mainly reflected a preexisting heterogeneity in the tumor cells.  In conclusion, our results establish that human colorectal cancer lines are representative of the main subtypes of primary tumors at the genomic level, further validating their utility as tools to investigate colorectal cancer biol. and drug responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEgggXY2lyLbVg90H21EOLACvtfcHk0lhbAMqsOIaVrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1CmtLo%253D&md5=070b70d23cea1eaa4333d95df2f57245</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0013%26sid%3Dliteratum%253Aachs%26aulast%3DMouradov%26aufirst%3DD.%26aulast%3DSloggett%26aufirst%3DC.%26aulast%3DJorissen%26aufirst%3DR.%2BN.%26aulast%3DLove%26aufirst%3DC.%2BG.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DBurgess%26aufirst%3DA.%2BW.%26aulast%3DArango%26aufirst%3DD.%26aulast%3DStrausberg%26aufirst%3DR.%2BL.%26aulast%3DBuchanan%26aufirst%3DD.%26aulast%3DWormald%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DL.%26atitle%3DColorectal%2520cancer%2520cell%2520lines%2520are%2520representative%2520models%2520of%2520the%2520main%2520molecular%2520subtypes%2520of%2520primary%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D3238%26epage%3D3247%26doi%3D10.1158%2F0008-5472.CAN-14-0013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crenn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messing, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynober, L.</span></span> <span> </span><span class="NLM_article-title">Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction</span>. <i>Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1016/j.clnu.2008.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1016%2Fj.clnu.2008.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=18440672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1OqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=328-339&author=P.+Crennauthor=B.+Messingauthor=L.+Cynober&title=Citrulline+as+a+biomarker+of+intestinal+failure+due+to+enterocyte+mass+reduction&doi=10.1016%2Fj.clnu.2008.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction</span></div><div class="casAuthors">Crenn, Pascal; Messing, Bernard; Cynober, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Nutrition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">328-339</span>CODEN:
                <span class="NLM_cas:coden">CLNUDP</span>;
        ISSN:<span class="NLM_cas:issn">0261-5614</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In human, citrulline (plasma concn. about 40 μmol/L) is an amino acid involved in intermediary metab. and that is not incorporated in proteins.  Circulating citrulline is mainly produced by enterocytes of the small bowel.  For this reason plasma or serum citrulline concn. has been proposed as a biomarker of remnant small bowel mass and function.  This article reviews this concept and its metabolic basis.  Conditions in which there is a significantly reduced small bowel enterocyte mass and function and a plasma or serum citrulline were measured in adults and children.  These studies included patients with a short bowel syndrome, villous atrophy states, Crohn's disease, during monitoring of digestive toxicity of chemotherapy and radiotherapy or follow-up of patients after small bowel transplantation.  In all these situations, with more than 500 studied patients a decreased level of plasma citrulline correlated with the reduced enterocyte mass independently of nutritional and inflammatory status.  A close correlation between small bowel remnant length and citrullinemia was found.  In addn., diagnosis of intestinal failure was assessed through plasma citrulline levels in severe small bowel diseases in which there is a marked enterocyte mass redn.  The threshold for establishing a diagnosis of intestinal failure is lower in villous atrophy disease (10 μmol/L) than in short bowel syndrome (20 μmol/L).  Compromised renal function is an important factor when considering plasma citrulline levels as a marker of intestinal failure as this potentially can increase circulating citrulline values.  Reduced plasma citrulline levels are an innovative quant. biomarker of significantly reduced enterocyte mass and function in different disease states in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDSG-b8a5N2rVg90H21EOLACvtfcHk0lhbAMqsOIaVrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1OqsLg%253D&md5=3bcbcd6185d2fd15a5fbca6cb790335d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.clnu.2008.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clnu.2008.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DCrenn%26aufirst%3DP.%26aulast%3DMessing%26aufirst%3DB.%26aulast%3DCynober%26aufirst%3DL.%26atitle%3DCitrulline%2520as%2520a%2520biomarker%2520of%2520intestinal%2520failure%2520due%2520to%2520enterocyte%2520mass%2520reduction%26jtitle%3DClin.%2520Nutr.%26date%3D2008%26volume%3D27%26spage%3D328%26epage%3D339%26doi%3D10.1016%2Fj.clnu.2008.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jäckel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pipp, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanschke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddharta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czasch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, M. W.</span></span> <span> </span><span class="NLM_article-title">L-citrulline: A preclinical safety biomarker for the small intestine in rats and dogs in repeat dose toxicity studies</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">107068</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1016%2Fj.vascn.2021.107068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=33940165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A280%3ADC%252BB3sbpsFeitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2021&pages=107068&author=S.+J%C3%A4ckelauthor=F.+C.+Pippauthor=B.+Emdeauthor=S.+Weigtauthor=E.+Vignaauthor=B.+Hanschkeauthor=L.+Kasperauthor=A.+Siddhartaauthor=J.+Hellmannauthor=S.+Czaschauthor=M.+W.+Schmitt&title=L-citrulline%3A+A+preclinical+safety+biomarker+for+the+small+intestine+in+rats+and+dogs+in+repeat+dose+toxicity+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">l-citrulline: A preclinical safety biomarker for the small intestine in rats and dogs in repeat dose toxicity studies</span></div><div class="casAuthors">Jackel Sven; Pipp Frederic Christian; Emde Barbara; Weigt Stefan; Kasper Lena; Hellmann Jurgen; Czasch Stephanie; Schmitt Michael W; Vigna Enrico; Hanschke Bettina; Siddharta Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107068</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Gastrointestinal (GI) toxicity is still an issue within drug development, especially for novel oncology drugs.  The identification of GI mucosal damage at an early stage with high sensitivity and specificity across preclinical species and humans remains difficult.  To date, in preclinical studies, no qualified mechanistic, diagnostic or prognostic biomarkers exist for GI mucosal toxicity. l-citrulline is one of the most promising biomarker candidates used in clinical settings to quantify enterocyte integrity in various small intestinal diseases. l-citrulline is an intermediate metabolic amino acid produced mainly by functional enterocytes of the small intestine, whereby enterocyte loss will cause a drop in circulating l-citrulline.  METHODS:  In several repeat-dose toxicity studies, plasma l-citrulline has been evaluated as a potential safety biomarker for intestinal toxicity in beagle dogs and Wistar (Han) rats treated with different oncological drug candidates in drug development.  Clinical observations and body weight determinations were performed during the pretreatment, treatment and treatment-free recovery period as well as toxicokinetic, gross and histopathology examinations.  The quantitative determination of plasma l-citrulline levels during the pretreatment (only dogs), treatment and treatment-free recovery period were performed using an HPLC MS/MS assay.  In cynomolgus monkeys, the first investigations on baseline l-citrulline levels were performed.  RESULTS:  In dogs, a dose- and exposure-dependent decrease of up to 50% in plasma l-citrulline was seen without histopathological alterations.  However, a decrease of more than 50% in comparison to the individual animal pretreatment value of l-citrulline correlated very well with histopathological findings (intestinal crypt necrosis, villus atrophy, enterocyte loss) and clinical signs (bloody faeces and diarrhoea).  During a treatment-free recovery period, a trend of increasing levels was observed in dogs.  In rats, absolute l-citrulline plasma levels of treated animals decreased compared to the values of the concurrent control group.  This decrease also correlated with the histopathological findings in the small intestine (single cell necrosis and mucosa atrophy).  Because of a large physiological variation in l-citrulline plasma levels in dogs and rats, a clear cut-off value for absolute l-citrulline levels predictive of intestinal mucosal toxicity was difficult to establish.  However, a > 50% decrease in l-citrulline plasma levels during the treatment period strongly correlated with histopathological findings.  DISCUSSION:  Based on the performed analysis, a longitudinal investigation of l-citrulline plasma levels for individual animals in the control and treatment groups is essential and pretreatment values of l-citrulline levels in rodents would be highly informative.  Overall, further cross-species comparison (Cynomolgus monkey, mouse) and implementation in clinical trials as exploratory biomarker is essential to foster the hypothesis and to understand completely the clinical relevance of l-citrulline as a small intestine biomarker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnvm1YrGpJ1Ebxh97K6Vt6fW6udTcc2eZleP3MWFJe87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3sbpsFeitw%253D%253D&md5=588202c50174e81604e0f574e53d08d2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2021.107068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2021.107068%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25A4ckel%26aufirst%3DS.%26aulast%3DPipp%26aufirst%3DF.%2BC.%26aulast%3DEmde%26aufirst%3DB.%26aulast%3DWeigt%26aufirst%3DS.%26aulast%3DVigna%26aufirst%3DE.%26aulast%3DHanschke%26aufirst%3DB.%26aulast%3DKasper%26aufirst%3DL.%26aulast%3DSiddharta%26aufirst%3DA.%26aulast%3DHellmann%26aufirst%3DJ.%26aulast%3DCzasch%26aufirst%3DS.%26aulast%3DSchmitt%26aufirst%3DM.%2BW.%26atitle%3DL-citrulline%253A%2520A%2520preclinical%2520safety%2520biomarker%2520for%2520the%2520small%2520intestine%2520in%2520rats%2520and%2520dogs%2520in%2520repeat%2520dose%2520toxicity%2520studies%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2021%26volume%3D110%26spage%3D107068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsworth, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span> <span> </span><span class="NLM_article-title">A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3132</span>– <span class="NLM_lpage">3144</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-4562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1158%2F0008-5472.CAN-12-4562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=23539443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3132-3144&author=T.+Lauauthor=E.+Chanauthor=M.+Callowauthor=J.+Waalerauthor=J.+Boggsauthor=R.+A.+Blakeauthor=S.+Magnusonauthor=A.+Sambroneauthor=M.+Schuttenauthor=R.+Firesteinauthor=O.+Machonauthor=V.+Korinekauthor=E.+Chooauthor=D.+Diazauthor=M.+Merchantauthor=P.+Polakisauthor=D.+D.+Holsworthauthor=S.+Kraussauthor=M.+Costa&title=A+novel+tankyrase+small-molecule+inhibitor+suppresses+APC+mutation-driven+colorectal+tumor+growth&doi=10.1158%2F0008-5472.CAN-12-4562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation-Driven Colorectal Tumor Growth</span></div><div class="casAuthors">Lau, Ted; Chan, Emily; Callow, Marinella; Waaler, Jo; Boggs, Jason; Blake, Robert A.; Magnuson, Steven; Sambrone, Amy; Schutten, Melissa; Firestein, Ron; Machon, Ondrej; Korinek, Vladimir; Choo, Edna; Diaz, Dolores; Merchant, Mark; Polakis, Paul; Holsworth, Daniel D.; Krauss, Stefan; Costa, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3132-3144</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Most colorectal cancers (CRC) are initiated by mutations of APC, leading to increased β-catenin-mediated signaling.  However, continued requirement of Wnt/P-catenin signaling for tumor progression in the context of acquired KRAS and other mutations is less well-established.  To attenuate Wnt/β-catenin signaling in tumors, we have developed potent and specific small-mol. tankyrase inhibitors, G007-LK and G244-LM, that reduce Wnt./p-catenin signaling by preventing poly(ADP-ribosyl)ation-dependent AXIN degrdn., thereby promoting β-catenin destabilization.  We show that novel tankyrase inhibitors completely block ligand-driven Wnt/β-catenin signaling in cell culture and display approx. 50% inhibition of APC mutation-driven signaling in most CRC cell lines.  It was previously unknown whether the level of AXIN protein stabilization by tankyrase inhibition is sufficient to impact tumor growth in the absence of normal APC activity.  Compd. G007-LK displays favorable pharmacokinetic properties and inhibits in vivo tumor growth in a subset of APC-mutant CRC xenograft models.  In the xenograft model most sensitive to tankyrase inhibitor, COLO-320DM, G007-LK inhibits cell-cycle progression, reduces colony formation, and induces differentiation, suggesting that β-catenin-dependent maintenance of an undifferentiated state may be blocked by tankyrase inhibition.  The full potential of the antitumor activity of G007-LK may be limited by intestinal toxicity assocd. with inhibition of Wnt/β-catenin signaling and cell proliferation in intestinal crypts.  These results establish proof-of-concept antitumor efficacy for tankyrase inhibitors in APC-mutant CRC models and uncover potential diagnostic and safety concerns to be overcome as tankyrase inhibitors are advanced into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbDZ01XGjOaLVg90H21EOLACvtfcHk0ljqbiGFw3j5wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D&md5=9f1d7b05b92ba8df593ccca9e7ea2cdf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-4562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-4562%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DCallow%26aufirst%3DM.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DSchutten%26aufirst%3DM.%26aulast%3DFirestein%26aufirst%3DR.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DM.%26atitle%3DA%2520novel%2520tankyrase%2520small-molecule%2520inhibitor%2520suppresses%2520APC%2520mutation-driven%2520colorectal%2520tumor%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D3132%26epage%3D3144%26doi%3D10.1158%2F0008-5472.CAN-12-4562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katavolos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harstad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutten, M.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition causes reversible intestinal toxicity in mice with a therapeutic index < 1</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1177/0192623315621192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1177%2F0192623315621192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=26692561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWgsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=267-278&author=Y.+Zhongauthor=P.+Katavolosauthor=T.+Nguyenauthor=T.+Lauauthor=J.+Boggsauthor=A.+Sambroneauthor=D.+Kanauthor=M.+Merchantauthor=E.+Harstadauthor=D.+Diazauthor=M.+Costaauthor=M.+Schutten&title=Tankyrase+inhibition+causes+reversible+intestinal+toxicity+in+mice+with+a+therapeutic+index+%3C+1&doi=10.1177%2F0192623315621192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition causes reversible intestinal toxicity in mice with a therapeutic index < 1</span></div><div class="casAuthors">Zhong, Yu; Katavolos, Paula; Nguyen, Trung; Lau, Ted; Boggs, Jason; Sambrone, Amy; Kan, David; Merchant, Mark; Harstad, Eric; Diaz, Dolores; Costa, Mike; Schutten, Melissa</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-278</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Activated Wnt/β-catenin signaling is frequently assocd. with colorectal cancer.  Wnt inhibitors, including tankyrase inhibitors, are being explored as potential anticancer agents.  Wnt signaling is also crit. for intestinal tissue homeostasis, and Wnt inhibitors have been shown to cause intestinal toxicity in mice by affecting intestinal stem cells.  This study sought to characterize the intestinal toxicity of tankyrase inhibitors, including reversibility, and to assess their therapeutic index.  Novel tankyrase inhibitor G-631 caused dose-dependent intestinal toxicity with a therapeutic index < 1 after 14 days of dosing in mice.  At a tolerated subtherapeutic dose level, the intestinal toxicity was composed of enteritis characterized by villus blunting, epithelial degeneration, and inflammation, which fully reversed after 14 days of recovery.  Doubled exposure showed weak antitumor activity in a xenograft colorectal cancer model but also caused more severe intestinal toxicity characterized by multifocal-regionally extensive necrotizing and ulcerative enteritis leading to morbidity or moribundity in some animals.  This toxicity was only partially reversed after 14 days of recovery, with evidence of crypt and villus regeneration, mildly blunted villi, and/or scarring in assocn. with chronic inflammation of the submucosa.  Therefore, the clin. utility of tankyrase inhibitors is likely limited by the on-target intestinal toxicity and a therapeutic index < 1 in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE6KF-WKDKTrVg90H21EOLACvtfcHk0lgrWB208XOvKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWgsLvF&md5=b4276e4b15fae2aa0bbc53d0f9f1f680</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1177%2F0192623315621192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623315621192%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DKatavolos%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DLau%26aufirst%3DT.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DKan%26aufirst%3DD.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DCosta%26aufirst%3DM.%26aulast%3DSchutten%26aufirst%3DM.%26atitle%3DTankyrase%2520inhibition%2520causes%2520reversible%2520intestinal%2520toxicity%2520in%2520mice%2520with%2520a%2520therapeutic%2520index%2520%253C%25201%26jtitle%3DToxicol.%2520Pathol.%26date%3D2016%26volume%3D44%26spage%3D267%26epage%3D278%26doi%3D10.1177%2F0192623315621192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veeman, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusarski, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaykas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span> <span> </span><span class="NLM_article-title">Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">680</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1016/S0960-9822(03)00240-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1016%2FS0960-9822%2803%2900240-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=12699626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtVKhu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=680-685&author=M.+T.+Veemanauthor=D.+C.+Slusarskiauthor=A.+Kaykasauthor=S.+H.+Louieauthor=R.+T.+Moon&title=Zebrafish+prickle%2C+a+modulator+of+noncanonical+Wnt%2FFz+signaling%2C+regulates+gastrulation+movements&doi=10.1016%2FS0960-9822%2803%2900240-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements</span></div><div class="casAuthors">Veeman, Michael T.; Slusarski, Diane C.; Kaykas, Ajamete; Louie, Sarah Hallagan; Moon, Randall T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">680-685</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In addn. to the canonical Wnt/β-catenin signaling pathway, at least two noncanonical Wnt/Fz pathways have been described: the planar cell polarity (PCP) pathway in Drosophila and the Wnt/calcium pathway in vertebrate embryos.  Recent work suggests that a vertebrate pathway homologous to the PCP pathway acts to regulate the convergent extension movements of gastrulation.  To further test this hypothesis, we have identified two zebrafish homologs of the Drosophila PCP gene prickle (pk) , both of which show discrete and dynamic expression patterns during gastrulation.  Both gain and loss of pk1 function cause defects in convergent extension.  Pk1 localizes to both the cytoplasm and the cell membrane, and its normal localization is partially dependent on its C-terminal prenylation motif.  At the cell membrane, Pk1 is frequently localized asym. around the cell and can colocalize with the signaling mol. Dishevelled (Dsh).  In overexpression assays, Pk1 is able to activate AP-1-mediated transcription and inhibit activation of Wnt/β-catenin signaling.  Like noncanonical Wnts , overexpression of Pk1 increases the frequency of calcium transients in zebrafish blastulae.  Our results support the idea that a vertebrate PCP pathway regulates gastrulation movements and suggest that there is overlap between the PCP and Wnt/calcium pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCHsICitWVAbVg90H21EOLACvtfcHk0lgrWB208XOvKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtVKhu7s%253D&md5=9f4718000ceeb7fb5958e0f0679fa61c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2803%2900240-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252803%252900240-9%26sid%3Dliteratum%253Aachs%26aulast%3DVeeman%26aufirst%3DM.%2BT.%26aulast%3DSlusarski%26aufirst%3DD.%2BC.%26aulast%3DKaykas%26aufirst%3DA.%26aulast%3DLouie%26aufirst%3DS.%2BH.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26atitle%3DZebrafish%2520prickle%252C%2520a%2520modulator%2520of%2520noncanonical%2520Wnt%252FFz%2520signaling%252C%2520regulates%2520gastrulation%2520movements%26jtitle%3DCurr.%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D680%26epage%3D685%26doi%3D10.1016%2FS0960-9822%2803%2900240-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Nicotinamide pocket inhibitors of TNKS with activity in <i>in vivo</i> pharmacological models.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>4b</b>, <b>7a-c</b> and <b>12<sup><i>a</i></sup></b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-bromo-1-(4-<i>tert</i>-butyl-phenyl)ethanone, Na<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C; (b) NH<sub>4</sub>OAc, AcOH, 110 °C; (c) NH<sub>4</sub>Cl, NH<sub>4</sub>OH, MeOH, autoclave, 100 °C; (d) 2-bromo-1-(4-<i>tert</i>-butyl-phenyl)ethanone, DMF/MeCN, 90 °C; (e) imidazole 175 °C; (f) 2-bromo- or 2-chloro-acetophenone derivative, DMF/MeCN, MW, 160 °C; (g) Pd(dppf)<sub>2</sub>Cl<sub>2</sub>.CH<sub>2</sub>Cl<sub>2</sub>, dppf, Et<sub>3</sub>N, CO, methanol/toluene, 100 °C; (h) MeMgCl, CeCl<sub>3</sub>, THF, rt; (i) 2,4′-dibromoacetophenone, K<sub>2</sub>CO<sub>3</sub>, acetone, rt; (j) LiAlH<sub>4</sub>, THF, rt; (k) PBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (l) Zn, AcOH, 100 °C.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>16</b>, <b>21</b> and <b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DMF, KOt-Bu, NH<sub>2</sub>Cl; (b) 4-bromobenzoylchloride, pyridine, 60 °C; (c) NH<sub>4</sub>OH, MeOH; 80–100 °C; (d) PPA, 100 °C; (e) Pd(dppf)<sub>2</sub>Cl<sub>2</sub>.CH<sub>2</sub>Cl<sub>2</sub>, dppf, Et<sub>3</sub>N, CO, methanol/toluene, 100 °C; (f) MeMgCl, CeCl<sub>3</sub>, THF, rt; (g) NaH, O-(diphenylphosphoryl)hydroxylamine, DMF, 0 °C to rt; (h) 4-bromobenzoylchloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (i) NaOH, i-PrOH, 80 °C; (j) 4-bromobenzoylchloride, dioxane, 100 °C.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Pyrrolo[1,2-a]pyrazin-1-one Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,4′-dibromoacetophenone, K<sub>2</sub>CO<sub>3</sub>, DMF or acetone, rt; (b) K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O<sub>2</sub>, DMSO, MeOH, rt; (c) K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O<sub>2</sub>, DMSO, MeOH, rt; followed by TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) NH<sub>4</sub>OAc, AcOH, 110 °C; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (f) LiAlH<sub>4</sub>, THF, 0 °C to rt; (g) Pd(dppf)<sub>2</sub>Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, dppf, Et<sub>3</sub>N, CO, methanol/toluene, 100 °C; (h) MeMgCl, CeCl<sub>3</sub>, THF, rt; (i) ethylene glycole, TSA·H<sub>2</sub>O, rt; (j) Ti(Oi-Pr)<sub>4</sub>, EtMgCl, THF, rt; (k) oxetan-3-one, BuLi, THF, −75 °C; (l) 4,4,5,5-tetramethyl-2-(prop-1-en-2-yl)-1,3,2-dioxaborolane, K<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, dioxane/H<sub>2</sub>O, 90 °C; (m) BMIMPF<sub>6</sub>, DMAP, NMO, OsO<sub>4</sub>, t-BuOH/acetone, 60 °C; (n) Zn(CN)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, 100 °C; (o) MeMgCl, CuCl, THF, 60 °C; (p) Cp<sub>2</sub>TiCl<sub>2</sub>, Zn, ZnCl, dioxane, 90 °C; (q) LiAlH<sub>4</sub>, THF, rt.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding mode of <b>M2912</b> (<b>30g</b>) in complex with TNKS1 (PDB code 7OCV). The pyrrolo[1,2-<i>a</i>]pyrazin-1-one scaffold core makes three hydrogen bonds to Gly1185 and Ser1221 (highlighted by red dashed lines) and engages in π–π-stacking interactions with Tyr1224 (highlighted by orange dashed lines). The phenyl ring pointing toward the solvent forms π–π interactions with Tyr1224 (highlighted by orange dashed line) and van der Waals interactions with Tyr1203. The methyl group exhibits van der Waals interactions to surrounding tyrosine residues (indicated by yellow dashed lines).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Thermodynamic signature for the binding interaction of selected compounds with TNKS1 derived by ITC. Contributions from binding enthalpy represented by blue bars, entropic contributions represented by red bars, and over all free energy term depicted as green bar.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cellular mode of action of <b>M2912</b> (<b>30g</b>) in DLD1 cells. Treatment with increasing concentrations of <b>M2912</b> (<b>30g</b>) for 24 h induced an accumulation of tankyrase and axin2 protein levels and reduced cellular Wnt reporter activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>M2912</b> (<b>30g</b>) on softagar growth of colorectal cancer cell lines. Cells were seeded in softagar and treated with different concentrations of <b>M2912</b> (<b>30g</b>) for 14 days. Cell growth was determined by resazurin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Scaling of <i>in vivo</i> blood CL based on <i>in vitro</i> intrinsic CL data obtained in hepatocytes from mice, rats, dogs, and monkeys (dotted lines represent area within 2-fold prediction error; solid line represents 1:1 unity; predicted human value was correlated with the value predicted by allometric scaling).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <i>In vivo</i> pharmacodynamic biomarker modulation with <b>M2912</b> (<b>30g</b>) in the DLD1 xenograft model. DLD1 tumor-bearing mice received a single oral treatment with 10 or 30 mg/kg <b>M2912</b> (<b>30g</b>) and tumors were excised at 2, 8, and 18 h, respectively. Protein levels of (a) tankyrase, (b) axin2, and (c) active nuclear β-catenin were analyzed in <i>ex vivo</i> lysates and compared to untreated controls. Each group contained five mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/medium/jm1c00800_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <i>In vivo</i> antitumor activity of <b>M2912</b> (<b>30g</b>) in two colorectal cancer xenograft models, Colo320 (a) and HT55 (b). 20 mg/kg <b>M2912</b> (<b>30g</b>) given per os in bi-daily schedule achieved significant tumor growth inhibition compared to vehicle control in both models.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00800/20210716/images/large/jm1c00800_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00800&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i91">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50567" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50567" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fodde, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smits, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">APC, signal transduction and genetic instability in colorectal cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1038/35094067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1038%2F35094067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=11900252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A280%3ADC%252BD387mvVOhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=55-67&author=R.+Foddeauthor=R.+Smitsauthor=H.+Clevers&title=APC%2C+signal+transduction+and+genetic+instability+in+colorectal+cancer&doi=10.1038%2F35094067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">APC, signal transduction and genetic instability in colorectal cancer</span></div><div class="casAuthors">Fodde R; Smits R; Clevers H</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-67</span>
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    </div><div class="casAbstract">Colorectal cancer arises through a gradual series of histological changes, each of which is accompanied by a specific genetic alteration.  In general, an intestinal cell needs to comply with two essential requirements to develop into a cancer: it must acquire selective advantage to allow for the initial clonal expansion, and genetic instability to allow for multiple hits in other genes that are responsible for tumour progression and malignant transformation.  Inactivation of APC--the gene responsible for most cases of colorectal cancer--might fulfil both requirements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-LChZ0ggVnjMsgLhIoICsfW6udTcc2eYFhnQuzFKeV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387mvVOhtA%253D%253D&md5=854e24b3b614308fd84ce6af493a3e31</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F35094067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35094067%26sid%3Dliteratum%253Aachs%26aulast%3DFodde%26aufirst%3DR.%26aulast%3DSmits%26aufirst%3DR.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DAPC%252C%2520signal%2520transduction%2520and%2520genetic%2520instability%2520in%2520colorectal%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D55%26epage%3D67%26doi%3D10.1038%2F35094067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maricevich, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucherlapatiet, R.</span></span> <span> </span><span class="NLM_article-title">Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1565</span>– <span class="NLM_lpage">1570</span>, <span class="refDoi"> DOI: 10.1073/pnas.0908682107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1073%2Fpnas.0908682107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=20080688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslOrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=1565-1570&author=K.+E.+Hungauthor=M.+A.+Maricevichauthor=L.+G.+Richardauthor=W.+Y.+Chenauthor=M.+P.+Richardsonauthor=A.+Kuninauthor=R.+T.+Bronsonauthor=U.+Mahmoodauthor=R.+Kucherlapatiet&title=Development+of+a+mouse+model+for+sporadic+and+metastatic+colon+tumors+and+its+use+in+assessing+drug+treatment&doi=10.1073%2Fpnas.0908682107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment</span></div><div class="casAuthors">Hung, Kenneth E.; Maricevich, Marco A.; Richard, Larissa Georgeon; Chen, Wei Y.; Richardson, Michael P.; Kunin, Alexandra; Bronson, Roderick T.; Mahmood, Umar; Kucherlapati, Raju</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1565-1570, S1565/1-S1565/2</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Most genetically engineered mouse (GEM) models for colon cancer are based on tissue-wide or germline gene modification, resulting in tumors predominantly of the small intestine.  Several of these models involve modification of the adenomatous polyposis coli (Apc) gene and are excellent models for familial cancer predisposition syndromes.  We have developed a stochastic somatic mutation model for sporadic colon cancer that presents with isolated primary tumors in the distal colon and recapitulates the entire adenoma-carcinoma-metastasis axis seen in human colon cancer.  Using this model, we have analyzed tumors that are either solely mutant in the Apc gene or in combination with another colon cancer-assocd. mutant gene, the Kras G12D allele.  Because of the restricted location in the distal colon, the natural history of the tumors can be analyzed by serial colonoscopy.  As the mammalian target of rapamycin (mTOR) pathway is a crit. component of the complex signaling network in colon cancer, we used this model to assess the efficacy of mTOR blockade through rapamycin treatment of mice with established tumors.  After treatment, Apc mutant tumors were more than 80% smaller than control tumors.  However, tumors that possessed both Apc and Kras mutations did not respond to rapamycin treatment.  These studies suggest that mTOR inhibitors should be further explored as potential colorectal cancer therapies in patients whose tumors do not have activating mutations in KRAS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvKInIvqqMHLVg90H21EOLACvtfcHk0ljt96gZC4lZfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslOrs7g%253D&md5=64a0da835bca5b26274c0cf71fa773ee</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908682107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908682107%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DK.%2BE.%26aulast%3DMaricevich%26aufirst%3DM.%2BA.%26aulast%3DRichard%26aufirst%3DL.%2BG.%26aulast%3DChen%26aufirst%3DW.%2BY.%26aulast%3DRichardson%26aufirst%3DM.%2BP.%26aulast%3DKunin%26aufirst%3DA.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DMahmood%26aufirst%3DU.%26aulast%3DKucherlapatiet%26aufirst%3DR.%26atitle%3DDevelopment%2520of%2520a%2520mouse%2520model%2520for%2520sporadic%2520and%2520metastatic%2520colon%2520tumors%2520and%2520its%2520use%2520in%2520assessing%2520drug%2520treatment%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D1565%26epage%3D1570%26doi%3D10.1073%2Fpnas.0908682107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span> <span> </span><span class="NLM_article-title">APC mutations as a potential biomarker for sensitivity to tankyrase inhibitors in colorectal cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">752</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1158%2F1535-7163.MCT-16-0578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=28179481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltlOqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=752-762&author=N.+Tanakaauthor=T.+Mashimaauthor=A.+Mizutaniauthor=A.+Satoauthor=A.+Aoyamaauthor=B.+Gongauthor=H.+Yoshidaauthor=Y.+Muramatsuauthor=K.+Nakataauthor=M.+Matsuuraauthor=R.+Katayamaauthor=S.+Nagayamaauthor=N.+Fujitaauthor=Y.+Sugimotoauthor=H.+Seimiya&title=APC+mutations+as+a+potential+biomarker+for+sensitivity+to+tankyrase+inhibitors+in+colorectal+cancer&doi=10.1158%2F1535-7163.MCT-16-0578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer</span></div><div class="casAuthors">Tanaka, Noritaka; Mashima, Tetsuo; Mizutani, Anna; Sato, Ayana; Aoyama, Aki; Gong, Bo; Yoshida, Haruka; Muramatsu, Yukiko; Nakata, Kento; Matsuura, Masaaki; Katayama, Ryohei; Nagayama, Satoshi; Fujita, Naoya; Sugimoto, Yoshikazu; Seimiya, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">752-762</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In most colorectal cancers, Wnt/β-catenin signaling is activated by loss-of-function mutations in the adenomatous polyposis coli (APC) gene and plays a crit. role in tumorigenesis.  Tankyrases poly(ADP-ribosyl)ate and destabilize Axins, a neg. regulator of β-catenin, and upregulate β-catenin signaling.  Tankyrase inhibitors downregulate β-catenin and are expected to be promising therapeutics for colorectal cancer.  However, colorectal cancer cells are not always sensitive to tankyrase inhibitors, and predictive biomarkers for the drug sensitivity remain elusive.  Here we demonstrate that the short-form APC mutations predict the sensitivity of colorectal cancer cells to tankyrase inhibitors.  By using well-established colorectal cancer cell lines, we found that tankyrase inhibitors downregulated β-catenin in the drug-sensitive, but not resistant, colorectal cancer cells.  The drug-sensitive cells showed higher Tcf/LEF transcriptional activity than the resistant cells and possessed "short" truncated APCs lacking all seven β-catenin-binding 20-amino acid repeats (20-AARs).  In contrast, the drug-resistant cells possessed "long" APC retaining two or more 20-AARs.  Knockdown of the long APCs with two 20-AARs increased β-catenin, Tcf/LEF transcriptional activity and its target gene AXIN2 expression.  Under these conditions, tankyrase inhibitors were able to downregulate β-catenin in the resistant cells.  These results indicate that the long APCs are hypomorphic mutants, whereas they exert a dominant-neg. effect on Axin-dependent β-catenin degrdn. caused by tankyrase inhibitors.  Finally, we established 16 patient-derived colorectal cancer cells and confirmed that the tankyrase inhibitor-responsive cells harbor the short-form APC mutations.  These observations exemplify the predictive importance of APC mutations, the most common genetic alteration in colorectal cancers, for mol. targeted therapeutics.  Mol Cancer Ther; 16(4); 752-62. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9GIiKfM_5S7Vg90H21EOLACvtfcHk0ljt96gZC4lZfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltlOqtbk%253D&md5=05fb7d3731f714d6f7212f72f26707ab</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0578%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DMashima%26aufirst%3DT.%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DAoyama%26aufirst%3DA.%26aulast%3DGong%26aufirst%3DB.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DNakata%26aufirst%3DK.%26aulast%3DMatsuura%26aufirst%3DM.%26aulast%3DKatayama%26aufirst%3DR.%26aulast%3DNagayama%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DN.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DSeimiya%26aufirst%3DH.%26atitle%3DAPC%2520mutations%2520as%2520a%2520potential%2520biomarker%2520for%2520sensitivity%2520to%2520tankyrase%2520inhibitors%2520in%2520colorectal%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2017%26volume%3D16%26spage%3D752%26epage%3D762%26doi%3D10.1158%2F1535-7163.MCT-16-0578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schatoff, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zafra, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foronda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shusterman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, L. E.</span></span> <span> </span><span class="NLM_article-title">Distinct colorectal cancer-associated APC mutations dictate response to tankyrase inhibition</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1358</span>– <span class="NLM_lpage">1371</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-19-0289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1158%2F2159-8290.CD-19-0289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=31337618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFOmtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1358-1371&author=E.+M.+Schatoffauthor=S.+Goswamiauthor=M.+P.+Zafraauthor=M.+Forondaauthor=M.+Shustermanauthor=B.+I.+Leachauthor=A.+Kattiauthor=B.+J.+Diazauthor=L.+E.+Dow&title=Distinct+colorectal+cancer-associated+APC+mutations+dictate+response+to+tankyrase+inhibition&doi=10.1158%2F2159-8290.CD-19-0289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct colorectal cancer-associated APC mutations dictate response to tankyrase inhibition</span></div><div class="casAuthors">Schatoff, Emma M.; Goswami, Sukanya; Zafra, Maria Paz; Foronda, Miguel; Shusterman, Michael; Leach, Benjamin I.; Katti, Alyna; Diaz, Bianca J.; Dow, Lukas E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1358-1371</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The majority of colorectal cancers show hyperactivated WNT signaling due to inactivating mutations in the adenomatous polyposis coli (APC) tumor suppressor.  Genetically restoring APC suppresses WNT and induces rapid and sustained tumor regression, implying that reengaging this endogenous tumor-suppressive mechanism may be an effective therapeutic strategy.  Here, using new animal models, human cell lines, and ex vivo organoid cultures, we show that tankyrase (TNKS) inhibition can control WNT hyperactivation and provide long-term tumor control in vivo, but that effective responses are critically dependent on how APC is disrupted.  Mutant APC proteins truncated within the mutation cluster region phys. engage the destruction complex and suppress the WNT transcriptional program, while APC variants with early truncations (e.g., ApcMin) show limited interaction with AXIN1 and β-catenin, and do not respond to TNKS blockade.  Together, this work shows that TNKS inhibition, like APC restoration, can reestablish endogenous control of WNT/β-catenin signaling, but that APC genotype is a crucial determinant of this response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFx49qB-z9GbVg90H21EOLACvtfcHk0lir0cTE1iCN1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFOmtLrL&md5=c2b204d7f428b20b60c6b16b770065fb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-19-0289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-19-0289%26sid%3Dliteratum%253Aachs%26aulast%3DSchatoff%26aufirst%3DE.%2BM.%26aulast%3DGoswami%26aufirst%3DS.%26aulast%3DZafra%26aufirst%3DM.%2BP.%26aulast%3DForonda%26aufirst%3DM.%26aulast%3DShusterman%26aufirst%3DM.%26aulast%3DLeach%26aufirst%3DB.%2BI.%26aulast%3DKatti%26aufirst%3DA.%26aulast%3DDiaz%26aufirst%3DB.%2BJ.%26aulast%3DDow%26aufirst%3DL.%2BE.%26atitle%3DDistinct%2520colorectal%2520cancer-associated%2520APC%2520mutations%2520dictate%2520response%2520to%2520tankyrase%2520inhibition%26jtitle%3DCancer%2520Discovery%26date%3D2019%26volume%3D9%26spage%3D1358%26epage%3D1371%26doi%3D10.1158%2F2159-8290.CD-19-0289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palazzo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahel, I.</span></span> <span> </span><span class="NLM_article-title">PARPs in genome stability and signal transduction: implications for cancer therapy</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1681</span>– <span class="NLM_lpage">1695</span>, <span class="refDoi"> DOI: 10.1042/BST20180418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1042%2FBST20180418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=30420415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntVelsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=1681-1695&author=L.+Palazzoauthor=I.+Ahel&title=PARPs+in+genome+stability+and+signal+transduction%3A+implications+for+cancer+therapy&doi=10.1042%2FBST20180418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PARPs in genome stability and signal transduction: implications for cancer therapy</span></div><div class="casAuthors">Palazzo, Luca; Ahel, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1681-1695</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The poly(ADP-ribose) polymerase (PARP) superfamily of enzymes catalyzes the ADP-ribosylation (ADPr) of target proteins by using NAD (NAD+) as a donor.  ADPr reactions occur either in the form of attachment of a single ADP-ribose nucleotide unit on target proteins or in the form of ADP-ribose chains, with the latter called poly(ADP-ribosyl)ation.  PARPs regulate many cellular processes, including the maintenance of genome stability and signal transduction.  In this review, we focus on the PARP family members that possess the ability to modify proteins by poly(ADPribosyl) ation, namely PARP1, PARP2, Tankyrase-1, and Tankyrase-2.  Here, we detail the cellular functions of PARP1 and PARP2 in the regulation of DNA damage response and describe the function of Tankyrases in Wnt-mediated signal transduction.  Furthermore, we discuss how the understanding of these pathways has provided some major breakthroughs in the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGj0Tirya8TbVg90H21EOLACvtfcHk0lir0cTE1iCN1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntVelsb8%253D&md5=3904ef6d262be342a32b96f2f54f8a9f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1042%2FBST20180418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20180418%26sid%3Dliteratum%253Aachs%26aulast%3DPalazzo%26aufirst%3DL.%26aulast%3DAhel%26aufirst%3DI.%26atitle%3DPARPs%2520in%2520genome%2520stability%2520and%2520signal%2520transduction%253A%2520implications%2520for%2520cancer%2520therapy%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2018%26volume%3D46%26spage%3D1681%26epage%3D1695%26doi%3D10.1042%2FBST20180418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, P.</span></span> <span> </span><span class="NLM_article-title">New PARP targets for cancer therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1038/nrc3748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1038%2Fnrc3748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=24898058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptlKqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=502-509&author=S.+Vyasauthor=P.+Chang&title=New+PARP+targets+for+cancer+therapy&doi=10.1038%2Fnrc3748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">New PARP targets for cancer therapy</span></div><div class="casAuthors">Vyas, Sejal; Chang, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">502-509</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Poly(ADP-ribose) polymerases (PARPs) modify target proteins post-translationally with poly(ADP-ribose) (PAR) or mono(ADP-ribose) (MAR) using NAD+ as substrate.  The best-studied PARPs generate PAR modifications and include PARP1 and the tankyrase PARP5A, both of which are targets for cancer therapy with inhibitors in either clin. trials or preclin. development.  There are 15 addnl. PARPs, most of which modify proteins with MAR, and their biol. is less well understood.  Recent data identify potentially cancer-relevant functions for these PARPs, which indicates that we need to understand more about these PARPs to effectively target them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouf6CtI5GhsrVg90H21EOLACvtfcHk0lir0cTE1iCN1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptlKqsb0%253D&md5=24a3b64d2d0518e13c9540ee012e29ca</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrc3748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3748%26sid%3Dliteratum%253Aachs%26aulast%3DVyas%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DP.%26atitle%3DNew%2520PARP%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2014%26volume%3D14%26spage%3D502%26epage%3D509%26doi%3D10.1038%2Fnrc3748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickanin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlat, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, F.</span></span> <span> </span><span class="NLM_article-title">RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signaling</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1038/ncb2222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1038%2Fncb2222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=21478859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFGmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=623-629&author=Y.+Zhangauthor=S.+Liuauthor=C.+Mickaninauthor=Y.+Fengauthor=O.+Charlatauthor=G.+A.+Michaudauthor=M.+Schirleauthor=X.+Shiauthor=M.+Hildauthor=A.+Bauerauthor=V.+E.+Myerauthor=P.+M.+Finanauthor=J.+A.+Porterauthor=S.+M.+Huangauthor=F.+Cong&title=RNF146+is+a+poly%28ADP-ribose%29-directed+E3+ligase+that+regulates+axin+degradation+and+Wnt+signaling&doi=10.1038%2Fncb2222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling</span></div><div class="casAuthors">Zhang, Yue; Liu, Shanming; Mickanin, Craig; Feng, Yan; Charlat, Olga; Michaud, Gregory A.; Schirle, Markus; Shi, Xiaoying; Hild, Marc; Bauer, Andreas; Myer, Vic E.; Finan, Peter M.; Porter, Jeffery A.; Huang, Shih-Min A.; Cong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">623-629</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Wnt/β-catenin signalling pathway plays essential roles in embryonic development and adult tissue homeostasis, and deregulation of this pathway has been linked to cancer.  Axin is a concn.-limiting component of the β-catenin destruction complex, and its stability is regulated by tankyrase.  However, the mol. mechanism by which tankyrase-dependent poly(ADP-ribosyl)ation (PARsylation) is coupled to ubiquitylation and degrdn. of axin remains undefined.  Here, we identify RNF146, a RING-domain E3 ubiquitin ligase, as a pos. regulator of Wnt signalling.  RNF146 promotes Wnt signalling by mediating tankyrase-dependent degrdn. of axin.  Mechanistically, RNF146 directly interacts with poly(ADP-ribose) through its WWE domain, and promotes degrdn. of PARsylated proteins.  Using proteomics approaches, we have identified BLZF1 and CASC3 as further substrates targeted by tankyrase and RNF146 for degrdn.  Thus, identification of RNF146 as a PARsylation-directed E3 ligase establishes a mol. paradigm that links tankyrase-dependent PARsylation to ubiquitylation.  RNF146-dependent protein degrdn. may emerge as a major mechanism by which tankyrase exerts its function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgvUCNwxGZLrVg90H21EOLACvtfcHk0lgpxxM4fy8Ebg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFGmurk%253D&md5=0029be867466c74516f1a7fbab62369d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fncb2222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2222%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DMichaud%26aufirst%3DG.%2BA.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DMyer%26aufirst%3DV.%2BE.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DCong%26aufirst%3DF.%26atitle%3DRNF146%2520is%2520a%2520poly%2528ADP-ribose%2529-directed%2520E3%2520ligase%2520that%2520regulates%2520axin%2520degradation%2520and%2520Wnt%2520signaling%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2011%26volume%3D13%26spage%3D623%26epage%3D629%26doi%3D10.1038%2Fncb2222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callow, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bheddah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hongo, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span> <span> </span><span class="NLM_article-title">Ubiquitin ligase RNF146 regulates tankyrase and axin to promote Wnt signaling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e22595</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0022595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1371%2Fjournal.pone.0022595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=21799911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKgt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=M.+G.+Callowauthor=H.+Tranauthor=L.+Phuauthor=T.+Lauauthor=J.+Leeauthor=W.+N.+Sandovalauthor=P.+S.+Liuauthor=S.+Bheddahauthor=J.+Taoauthor=J.+R.+Lillauthor=J.-A.+Hongoauthor=D.+Davisauthor=D.+S.+Kirkpatrickauthor=P.+Polakisauthor=M.+Costa&title=Ubiquitin+ligase+RNF146+regulates+tankyrase+and+axin+to+promote+Wnt+signaling&doi=10.1371%2Fjournal.pone.0022595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling</span></div><div class="casAuthors">Callow, Marinella G.; Tran, Hoanh; Phu, Lilian; Lau, Ted; Lee, James; Sandoval, Wendy N.; Liu, Peter S.; Bheddah, Sheila; Tao, Janet; Lill, Jennie R.; Hongo, Jo-Anne; Davis, David; Kirkpatrick, Donald S.; Polakis, Paul; Costa, Mike</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e22595</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Canonical Wnt signaling is controlled intracellularly by the level of β-catenin protein, which is dependent on Axin scaffolding of a complex that phosphorylates β-catenin to target it for ubiquitylation and proteasomal degrdn.  This function of Axin is counteracted through relocalization of Axin protein to the Wnt receptor complex to allow for ligand-activated Wnt signaling.  AXIN1 and AXIN2 protein levels are regulated by tankyrase-mediated poly(ADP-ribosyl)ation (PARsylation), which destabilizes Axin and promotes signaling.  Mechanistically, how tankyrase limits Axin protein accumulation, and how tankyrase levels and activity are regulated for this function, are currently under investigation.  By RNAi screening, we identified the RNF146 RING-type ubiquitin E3 ligase as a pos. regulator of Wnt signaling that operates with tankyrase to maintain low steady-state levels of Axin proteins.  RNF146 also destabilizes tankyrases TNKS1 and TNKS2 proteins and, in a reciprocal relationship, tankyrase activity reduces RNF146 protein levels.  We show that RNF146, tankyrase, and Axin form a protein complex, and that RNF146 mediates ubiquitylation of all 3 proteins to target them for proteasomal degrdn.  RNF146 is a cytoplasmic protein that also prevents tankyrase protein aggregation at a centrosomal location.  Tankyrase auto-PARsylation and PARsylation of Axin is known to lead to proteasome-mediated degrdn. of these proteins, and we demonstrate that, through ubiquitylation, RNF146 mediates this process to regulate Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBK_DIvtiDN7Vg90H21EOLACvtfcHk0lgpxxM4fy8Ebg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKgt7vO&md5=df9dc5d0f0fc70e5d9c81783a34ee10c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0022595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0022595%26sid%3Dliteratum%253Aachs%26aulast%3DCallow%26aufirst%3DM.%2BG.%26aulast%3DTran%26aufirst%3DH.%26aulast%3DPhu%26aufirst%3DL.%26aulast%3DLau%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSandoval%26aufirst%3DW.%2BN.%26aulast%3DLiu%26aufirst%3DP.%2BS.%26aulast%3DBheddah%26aufirst%3DS.%26aulast%3DTao%26aufirst%3DJ.%26aulast%3DLill%26aufirst%3DJ.%2BR.%26aulast%3DHongo%26aufirst%3DJ.-A.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DCosta%26aufirst%3DM.%26atitle%3DUbiquitin%2520ligase%2520RNF146%2520regulates%2520tankyrase%2520and%2520axin%2520to%2520promote%2520Wnt%2520signaling%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0022595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishina, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlat, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiellette, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiessner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickanin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serluca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouwmeester, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, F.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition stabilizes axin and antagonizes Wnt signaling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1038/nature08356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1038%2Fnature08356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=19759537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=614-620&author=S.-M.+A.+Huangauthor=Y.+M.+Mishinaauthor=S.+Liuauthor=A.+Cheungauthor=F.+Stegmeierauthor=G.+A.+Michaudauthor=O.+Charlatauthor=E.+Wielletteauthor=Y.+Zhangauthor=S.+Wiessnerauthor=M.+Hildauthor=X.+Shiauthor=C.+J.+Wilsonauthor=C.+Mickaninauthor=V.+Myerauthor=A.+Fazalauthor=R.+Tomlinsonauthor=F.+Serlucaauthor=W.+Shaoauthor=H.+Chengauthor=M.+Shultzauthor=C.+Rauauthor=M.+Schirleauthor=J.+Schleglauthor=S.+Ghidelliauthor=S.+Fawellauthor=C.+Luauthor=D.+Curtisauthor=M.+W.+Kirschnerauthor=C.+Lengauerauthor=P.+M.+Finanauthor=J.+A.+Tallaricoauthor=T.+Bouwmeesterauthor=J.+A.+Porterauthor=A.+Bauerauthor=F.+Cong&title=Tankyrase+inhibition+stabilizes+axin+and+antagonizes+Wnt+signaling&doi=10.1038%2Fnature08356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span></div><div class="casAuthors">Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Kirschner, Marc W.; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Bouwmeester, Tewis; Porter, Jeffery A.; Bauer, Andreas; Cong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7264</span>),
    <span class="NLM_cas:pages">614-620</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The stability of the Wnt pathway transcription factor β-catenin is tightly regulated by the multi-subunit destruction complex.  Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies.  However, the development of targeted Wnt pathway inhibitors has been hampered by the limited no. of pathway components that are amenable to small mol. inhibition.  Here, we used a chem. genetic screen to identify a small mol., XAV939, which selectively inhibits β-catenin-mediated transcription.  XAV939 stimulates β-catenin degrdn. by stabilizing axin, the concn.-limiting component of the destruction complex.  Using a quant. chem. proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2.  Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degrdn. through the ubiquitin-proteasome pathway.  Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom3c1M4OoOarVg90H21EOLACvtfcHk0lisQx0Wh1RSGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP&md5=6a76dfa7ed2a57b29e0c1ee367bd652c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnature08356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08356%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.-M.%2BA.%26aulast%3DMishina%26aufirst%3DY.%2BM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DMichaud%26aufirst%3DG.%2BA.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DWiellette%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWiessner%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BJ.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DMyer%26aufirst%3DV.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DGhidelli%26aufirst%3DS.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DCurtis%26aufirst%3DD.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26atitle%3DTankyrase%2520inhibition%2520stabilizes%2520axin%2520and%2520antagonizes%2520Wnt%2520signaling%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D614%26epage%3D620%26doi%3D10.1038%2Fnature08356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariotti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guettler, S.</span></span> <span> </span><span class="NLM_article-title">Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">4611</span>– <span class="NLM_lpage">4636</span>, <span class="refDoi"> DOI: 10.1111/bph.14038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1111%2Fbph.14038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2017&pages=4611-4636&author=L.+Mariottiauthor=K.+Pollockauthor=S.+Guettler&title=Regulation+of+Wnt%2F%CE%B2-catenin+signalling+by+tankyrase-dependent+poly%28ADP-ribosyl%29ation+and+scaffolding&doi=10.1111%2Fbph.14038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fbph.14038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14038%26sid%3Dliteratum%253Aachs%26aulast%3DMariotti%26aufirst%3DL.%26aulast%3DPollock%26aufirst%3DK.%26aulast%3DGuettler%26aufirst%3DS.%26atitle%3DRegulation%2520of%2520Wnt%252F%25CE%25B2-catenin%2520signalling%2520by%2520tankyrase-dependent%2520poly%2528ADP-ribosyl%2529ation%2520and%2520scaffolding%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D74%26spage%3D4611%26epage%3D4636%26doi%3D10.1111%2Fbph.14038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riffell, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, A.</span></span> <span> </span><span class="NLM_article-title">Tankyrase-targeted therapeutics: expanding opportunities in the PARP family</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.1038/nrd3868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1038%2Fnrd3868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=23197039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCntbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=923-936&author=J.+L.+Riffellauthor=C.+J.+Lordauthor=A.+Ashworth&title=Tankyrase-targeted+therapeutics%3A+expanding+opportunities+in+the+PARP+family&doi=10.1038%2Fnrd3868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase-targeted therapeutics: expanding opportunities in the PARP family</span></div><div class="casAuthors">Riffell, Jenna L.; Lord, Christopher J.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">923-936</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The poly(ADP-ribose) polymerase (PARP) protein superfamily has wide-ranging roles in cellular processes such as DNA repair and WNT signalling.  Efforts to pharmacol. target PARP enzymes have largely focused on PARP1 and the closely related PARP2, but recent work highlighting the role of another family member, tankyrase 1 (TANK1; also known as PARP5A and ARTD5), in the control of WNT signalling has fuelled interest in the development of addnl. inhibitors to target this enzyme class.  Tankyrase function is also implicated in other processes such as the regulation of telomere length, lung fibrogenesis and myelination, suggesting that tankyrase inhibitors could have broad clin. utility.  Here, we discuss the biol. of tankyrases and the discovery of tankyrase-specific inhibitors.  We also consider the challenges that lie ahead for the clin. development of PARP family inhibitors in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6R0zBQ42UELVg90H21EOLACvtfcHk0lisQx0Wh1RSGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCntbvI&md5=510c523982433e4c22f06f8d1679e6f6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrd3868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3868%26sid%3Dliteratum%253Aachs%26aulast%3DRiffell%26aufirst%3DJ.%2BL.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DTankyrase-targeted%2520therapeutics%253A%2520expanding%2520opportunities%2520in%2520the%2520PARP%2520family%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D923%26epage%3D936%26doi%3D10.1038%2Fnrd3868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lehtiö, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Tankyrases as drug targets</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">3576</span>– <span class="NLM_lpage">3593</span>, <span class="refDoi"> DOI: 10.1111/febs.12320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1111%2Ffebs.12320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=23648170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A280%3ADC%252BC3snhtFOqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=3576-3593&author=L.+Lehti%C3%B6author=N.+Chiauthor=S.+Krauss&title=Tankyrases+as+drug+targets&doi=10.1111%2Ffebs.12320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrases as drug targets</span></div><div class="casAuthors">Lehtio Lari; Chi Nai-Wen; Krauss Stefan</div><div class="citationInfo"><span class="NLM_cas:title">The FEBS journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3576-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tankyrase 1 and tankyrase 2 are poly(ADP-ribosyl)ases that are distinguishable from other members of the enzyme family by the structural features of the catalytic domain, and the presence of a sterile α-motif multimerization domain and an ankyrin repeat protein-interaction domain.  Tankyrases are implicated in a multitude of cellular functions, including telomere homeostasis, mitotic spindle formation, vesicle transport linked to glucose metabolism, Wnt-β-catenin signaling, and viral replication.  In these processes, tankyrases interact with target proteins, catalyze poly(ADP-ribosyl)ation, and regulate protein interactions and stability.  The proposed roles of tankyrases in disease-relevant cellular processes have made them attractive drug targets.  Recently, several inhibitors have been identified.  The selectivity and potency of these small molecules can be rationalized by how they fit within the NAD(+)-binding groove of the catalytic domain.  Some molecules bind to the nicotinamide subsite, such as generic diphtheria toxin-like ADP-ribosyltransferase inhibitors, whereas others bind to a distinct adenosine subsite that diverges from other diphtheria toxin-like ADP-ribosyltransferases and confers specificity.  A highly potent dual-site inhibitor is also available.  Within the last few years, tankyrase inhibitors have proved to be useful chemical probes and potential lead compounds, especially for specific cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxqKZ7T5loVg20zIbnCCI3fW6udTcc2eZ0nU9SeBD6xLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snhtFOqug%253D%253D&md5=9643c0f2d7ee877400bffcdc8ad44c85</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12320%26sid%3Dliteratum%253Aachs%26aulast%3DLehti%25C3%25B6%26aufirst%3DL.%26aulast%3DChi%26aufirst%3DN.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DTankyrases%2520as%2520drug%2520targets%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D3576%26epage%3D3593%26doi%3D10.1111%2Ffebs.12320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtiö, L.</span></span> <span> </span><span class="NLM_article-title">Tankyrases: Structure, function and therapeutic implications in cancer</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6472</span>– <span class="NLM_lpage">6488</span>, <span class="refDoi"> DOI: 10.2174/1381612820666140630101525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.2174%2F1381612820666140630101525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=24975604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=6472-6488&author=T.+Haikarainenauthor=S.+Kraussauthor=L.+Lehti%C3%B6&title=Tankyrases%3A+Structure%2C+function+and+therapeutic+implications+in+cancer&doi=10.2174%2F1381612820666140630101525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrases: Structure, Function and Therapeutic Implications in Cancer</span></div><div class="casAuthors">Haikarainen, Teemu; Krauss, Stefan; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">6472-6488</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Several cellular signaling pathways are regulated by ADP-ribosylation, a posttranslational modification catalyzed by members of the ARTD superfamily.  Tankyrases are distinguishable from the rest of this family by their unique domain organization, notably the sterile alpha motif responsible for oligomerization and ankyrin repeats mediating protein-protein interactions.  Tankyrases are involved in various cellular functions, such as telomere homeostasis, Wnt/β -catenin signaling, glucose metab., and cell cycle progression.  In these processes, Tankyrases regulate the interactions and stability of target proteins by poly (ADP-ribosyl)ation.  Modified proteins are subsequently recognized by the E3 ubiquitin ligase RNF146, poly-ubiquitinated and predominantly guided to 26S proteasomal degrdn.  Several small mol. inhibitors have been described for Tankyrases; they compete with the co-substrate NAD+ for binding to the ARTD catalytic domain.  The recent, highly potent and selective inhibitors possess several properties of lead compds. and can be used for proof-of-concept studies in cancer and other Tankyrase linked diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotYUovVf-x6LVg90H21EOLACvtfcHk0lj0X_j5jxEIRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtLfN&md5=ced27d2889d245696043a8cfa891166c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1381612820666140630101525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666140630101525%26sid%3Dliteratum%253Aachs%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DLehti%25C3%25B6%26aufirst%3DL.%26atitle%3DTankyrases%253A%2520Structure%252C%2520function%2520and%2520therapeutic%2520implications%2520in%2520cancer%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D20%26spage%3D6472%26epage%3D6488%26doi%3D10.2174%2F1381612820666140630101525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riyaz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahim, A.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibitors as therapeutic targets for cancer</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1967</span>– <span class="NLM_lpage">1976</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.2174%2F1568026614666140929115831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=25262803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=1967-1976&author=A.+Kamalauthor=S.+Riyazauthor=A.+K.+Srivastavaauthor=A.+Rahim&title=Tankyrase+inhibitors+as+therapeutic+targets+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase Inhibitors as Therapeutic Targets for Cancer</span></div><div class="casAuthors">Kamal, Ahmed; Riyaz, S.; Srivastava, Ajay Kumar; Rahim, Abdul</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1967-1976</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tankyrase 1 and 2 belonging to the family of poly(ADP-ribosyl)ases play an important role in PARsylation by utilizing NAD+ as a substrate in order to generate ADP-ribose polymers.  Tankyrases are involved in a no. of cellular functions, that includes telomere homeostasis, mitotic spindle formation, vesicle transport linked to glucose metab., Wnt/β-catenin signalling, and viral replication.  These roles of tankyrases in disease-relevant cellular processes have made them attractive drug targets.  Recently, several inhibitors have been identified as potential clin. leads.  The current review covers the progress, mechanism and binding modes of recently known Tankyrase inhibitors and discusses the rational approaches that were used to identify the tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruFM_1i4ZP1LVg90H21EOLACvtfcHk0lj0X_j5jxEIRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgt7vP&md5=41cdf01744936fa538ef8e7307180feb</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F1568026614666140929115831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026614666140929115831%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DRiyaz%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DA.%2BK.%26aulast%3DRahim%26aufirst%3DA.%26atitle%3DTankyrase%2520inhibitors%2520as%2520therapeutic%2520targets%2520for%2520cancer%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D1967%26epage%3D1976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span> <span> </span><span class="NLM_article-title">RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">4003</span>– <span class="NLM_lpage">4014</span>, <span class="refDoi"> DOI: 10.1111/cas.13805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1111%2Fcas.13805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=30238564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFKju7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=4003-4014&author=A.+Mizutaniauthor=Y.+Yashirodaauthor=Y.+Muramatsuauthor=H.+Yoshidaauthor=T.+Chikadaauthor=T.+Tsumuraauthor=M.+Okueauthor=F.+Shiraiauthor=T.+Fukamiauthor=M.+Yoshidaauthor=H.+Seimiya&title=RK-287107%2C+a+potent+and+specific+tankyrase+inhibitor%2C+blocks+colorectal+cancer+cell+growth+in+a+preclinical+model&doi=10.1111%2Fcas.13805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model</span></div><div class="casAuthors">Mizutani, Anna; Yashiroda, Yoko; Muramatsu, Yukiko; Yoshida, Haruka; Chikada, Tsubasa; Tsumura, Takeshi; Okue, Masayuki; Shirai, Fumiyuki; Fukami, Takehiro; Yoshida, Minoru; Seimiya, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4003-4014</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tankyrase poly(ADP-ribosyl)ates (PARylates) Axin, a neg. regulator of β-catenin.  This post-translational modification causes ubiquitin-dependent degrdn. of Axin, resulting in β-catenin accumulation.  Tankyrase inhibitors downregulate β-catenin and suppress the growth of APC-mutated colorectal cancer cells.  Herein, we report a novel tankyrase-specific inhibitor RK-287107, which inhibits tankyrase-1 and -2 four- and eight-fold more potently, resp., than G007-LK, a tankyrase inhibitor that has been previously reported as effective in mouse xenograft models.  RK-287107 causes Axin2 accumulation and downregulates β-catenin, T-cell factor/lymphoid enhancer factor reporter activity and the target gene expression in colorectal cancer cells harboring the shortly truncated APC mutations.  Consistently, RK-287107 inhibits the growth of APC-mutated (β-catenin-dependent) colorectal cancer COLO-320DM and SW403 cells but not the APC-wild (β-catenin-independent) colorectal cancer RKO cells.  I.p. or oral administration of RK-287107 suppresses COLO-320DM tumor growth in NOD-SCID mice.  Rates of tumor growth inhibition showed good correlation with the behavior of pharmacodynamic biomarkers, such as Axin2 accumulation and MYC downregulation.  These observations indicate that RK-287107 exerts a proof-of-concept antitumor effect, and thus may have potential for tankyrase-directed mol. cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zgbenLgRqbVg90H21EOLACvtfcHk0ljcJPYJqQotkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFKju7zI&md5=4e7bae4fa3689bd43abe0ea399024686</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fcas.13805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13805%26sid%3Dliteratum%253Aachs%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DChikada%26aufirst%3DT.%26aulast%3DTsumura%26aufirst%3DT.%26aulast%3DOkue%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DF.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DSeimiya%26aufirst%3DH.%26atitle%3DRK-287107%252C%2520a%2520potent%2520and%2520specific%2520tankyrase%2520inhibitor%252C%2520blocks%2520colorectal%2520cancer%2520cell%2520growth%2520in%2520a%2520preclinical%2520model%26jtitle%3DCancer%2520Sci.%26date%3D2018%26volume%3D109%26spage%3D4003%26epage%3D4014%26doi%3D10.1111%2Fcas.13805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washizuka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, M.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shitara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, H.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of an orally efficacious spiroindolinone-based tankyrase inhibitor for the treatment of colon cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">4183</span>– <span class="NLM_lpage">4204</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltl2mt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4183-4204&author=F.+Shiraiauthor=A.+Mizutaniauthor=Y.+Yashirodaauthor=T.+Tsumuraauthor=Y.+Kanoauthor=Y.+Muramatsuauthor=T.+Chikadaauthor=H.+Yukiauthor=H.+Niwaauthor=S.+Satoauthor=K.+Washizukaauthor=Y.+Kodaauthor=Y.+Mazakiauthor=M.-K.+Jangauthor=H.+Yoshidaauthor=A.+Nagamoriauthor=M.+Okueauthor=T.+Watanabeauthor=K.+Kitamuraauthor=E.+Shitaraauthor=T.+Honmaauthor=T.+Umeharaauthor=M.+Shirouzuauthor=T.+Fukamiauthor=H.+Seimiyaauthor=M.+Yoshidaauthor=H.+Koyama&title=Design+and+discovery+of+an+orally+efficacious+spiroindolinone-based+tankyrase+inhibitor+for+the+treatment+of+colon+cancer&doi=10.1021%2Facs.jmedchem.0c00045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer</span></div><div class="casAuthors">Shirai, Fumiyuki; Mizutani, Anna; Yashiroda, Yoko; Tsumura, Takeshi; Kano, Yuko; Muramatsu, Yukiko; Chikada, Tsubasa; Yuki, Hitomi; Niwa, Hideaki; Sato, Shin; Washizuka, Kenichi; Koda, Yasuko; Mazaki, Yui; Jang, Myung-Kyu; Yoshida, Haruka; Nagamori, Akiko; Okue, Masayuki; Watanabe, Takashi; Kitamura, Kouichi; Shitara, Eiki; Honma, Teruki; Umehara, Takashi; Shirouzu, Mikako; Fukami, Takehiro; Seimiya, Hiroyuki; Yoshida, Minoru; Koyama, Hiroo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4183-4204</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases (TNKS/TNKS2) belong to the poly(ADP-ribose) polymerase family.  Inhibition of their enzymic activities attenuates the Wnt/β-catenin signaling, which plays an important role in cancer pathogenesis.  We previously reported the discovery of RK-287107, a spiroindoline-based, highly selective, potent tankyrase inhibitor.  Herein we describe the optimization process of RK-287107 leading to RK-582, which exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered.  In addn. to the dose-dependent elevation and attenuation of the levels of biomarkers AXIN2 and β-catenin, resp., results of the TCF reporter and cell proliferation studies on COLO-320DM are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnxMuxDScpWLVg90H21EOLACvtfcHk0ljcJPYJqQotkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltl2mt7g%253D&md5=8c55fd054daf7ccc91975379c2d8085b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00045%26sid%3Dliteratum%253Aachs%26aulast%3DShirai%26aufirst%3DF.%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DTsumura%26aufirst%3DT.%26aulast%3DKano%26aufirst%3DY.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DChikada%26aufirst%3DT.%26aulast%3DYuki%26aufirst%3DH.%26aulast%3DNiwa%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DWashizuka%26aufirst%3DK.%26aulast%3DKoda%26aufirst%3DY.%26aulast%3DMazaki%26aufirst%3DY.%26aulast%3DJang%26aufirst%3DM.-K.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DNagamori%26aufirst%3DA.%26aulast%3DOkue%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DK.%26aulast%3DShitara%26aufirst%3DE.%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DSeimiya%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DKoyama%26aufirst%3DH.%26atitle%3DDesign%2520and%2520discovery%2520of%2520an%2520orally%2520efficacious%2520spiroindolinone-based%2520tankyrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520colon%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D4183%26epage%3D4204%26doi%3D10.1021%2Facs.jmedchem.0c00045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quackenbush, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagby, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messersmith, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitts, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatchford, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capasso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcaroli, J. J.</span></span> <span> </span><span class="NLM_article-title">The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">28273</span>– <span class="NLM_lpage">28285</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.8626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.18632%2Foncotarget.8626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=27070088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A280%3ADC%252BC28fpt1KqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=28273-28285&author=K.+S.+Quackenbushauthor=S.+Bagbyauthor=W.+M.+Taiauthor=W.+A.+Messersmithauthor=A.+Schreiberauthor=J.+Greeneauthor=J.+Kimauthor=G.+Wangauthor=A.+Purkeyauthor=T.+M.+Pittsauthor=A.+Nguyenauthor=D.+Gaoauthor=P.+Blatchfordauthor=A.+Capassoauthor=A.+G.+Schullerauthor=S.+G.+Eckhardtauthor=J.+J.+Arcaroli&title=The+novel+tankyrase+inhibitor+%28AZ1366%29+enhances+irinotecan+activity+in+tumors+that+exhibit+elevated+tankyrase+and+irinotecan+resistance&doi=10.18632%2Foncotarget.8626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance</span></div><div class="casAuthors">Quackenbush Kevin S; Bagby Stacey; Tai Wai Meng; Messersmith Wells A; Schreiber Anna; Greene Justin; Kim Jihye; Wang Guoliang; Purkey Alicia; Pitts Todd M; Nguyen Anna; Gao Dexiang; Blatchford Patrick; Capasso Anna; Eckhardt S Gail; Arcaroli John J; Tai Wai Meng; Schuller Alwin G</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">28273-85</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Dysregulation of the canonical Wnt signaling pathway has been implicated in colorectal cancer (CRC) development as well as incipient stages of malignant transformation.  In this study, we investigated the antitumor effects of AZ1366 (a novel tankyrase inhibitor) as a single agent and in combination with irinotecan in our patient derived CRC explant xenograft models.  RESULTS:  Six out of 18 CRC explants displayed a significant growth reduction to AZ1366.  There was one CRC explant (CRC040) that reached the threshold of sensitivity (TGII ≤ 20%) in this study.  In addition, the combination of AZ1366 + irinotecan demonstrated efficacy in 4 out of 18 CRC explants.  Treatment effects on the WNT pathway revealed that tankyrase inhibition was ineffective at reducing WNT dependent signaling.  However, the anti-tumor effects observed in this study were likely a result of alternative tankyrase effects whereby tankyrase inhibition reduced NuMA levels.  MATERIALS AND METHODS:  Eighteen CRC explants were treated with AZ1366 single agent or in combination for 28 days and treatment responses were assessed.  Pharmacokinetic (AZ1366 drug concentrations) and pharmacodynamic effects (Axin2 levels) were investigated over 48 hours.  Immunohistochemistry of nuclear β-catenin levels as well as western blot was employed to examine the treatment effects on the WNT pathway as well as NuMA.  CONCLUSIONS:  Combination AZ1366 and irinotecan achieved greater anti-tumor effects compared to monotherapy.  Activity was limited to CRC explants that displayed irinotecan resistance and increased protein levels of tankyrase and NuMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRANi51pzsdW1QKX3ooHxWjfW6udTcc2eajADNIuLKklrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fpt1KqtQ%253D%253D&md5=bb51ae9892a3ec15cbb0f1f5a3e6ebca</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8626%26sid%3Dliteratum%253Aachs%26aulast%3DQuackenbush%26aufirst%3DK.%2BS.%26aulast%3DBagby%26aufirst%3DS.%26aulast%3DTai%26aufirst%3DW.%2BM.%26aulast%3DMessersmith%26aufirst%3DW.%2BA.%26aulast%3DSchreiber%26aufirst%3DA.%26aulast%3DGreene%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DPurkey%26aufirst%3DA.%26aulast%3DPitts%26aufirst%3DT.%2BM.%26aulast%3DNguyen%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DBlatchford%26aufirst%3DP.%26aulast%3DCapasso%26aufirst%3DA.%26aulast%3DSchuller%26aufirst%3DA.%2BG.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DArcaroli%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520novel%2520tankyrase%2520inhibitor%2520%2528AZ1366%2529%2520enhances%2520irinotecan%2520activity%2520in%2520tumors%2520that%2520exhibit%2520elevated%2520tankyrase%2520and%2520irinotecan%2520resistance%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D28273%26epage%3D28285%26doi%3D10.18632%2Foncotarget.8626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eide, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machonova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voronkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2822</span>– <span class="NLM_lpage">2832</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-3336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1158%2F0008-5472.CAN-11-3336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=22440753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2822-2832&author=J.+Waalerauthor=O.+Machonauthor=L.+Tumovaauthor=H.+Dinhauthor=V.+Korinekauthor=S.+R.+Wilsonauthor=J.+E.+Paulsenauthor=N.+M.+Pedersenauthor=T.+J.+Eideauthor=O.+Machonovaauthor=D.+Gradlauthor=A.+Voronkovauthor=J.+P.+von+Kriesauthor=S.+Krauss&title=A+novel+tankyrase+inhibitor+decreases+canonical+Wnt+signaling+in+colon+carcinoma+cells+and+reduces+tumor+growth+in+conditional+APC+mutant+mice&doi=10.1158%2F0008-5472.CAN-11-3336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice</span></div><div class="casAuthors">Waaler, Jo; Machon, Ondrej; Tumova, Lucie; Dinh, Huyen; Korinek, Vladimir; Wilson, Steven Ray; Paulsen, Jan Erik; Pedersen, Nina Marie; Eide, Tor J.; Machonova, Olga; Gradl, Dietmar; Voronkov, Andrey; von Kries, Jens Peter; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2822-2832</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This preclin. proof-of-concept study suggests a new strategy to treat colon cancer by increasing the degrdn. of β-catenin, which drives this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokQ3hrnF8gMLVg90H21EOLACvtfcHk0lgPgPuOAI5z4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D&md5=9814ad25dc1d5da6d9babaff8df19327</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-3336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-3336%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DTumova%26aufirst%3DL.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DPaulsen%26aufirst%3DJ.%2BE.%26aulast%3DPedersen%26aufirst%3DN.%2BM.%26aulast%3DEide%26aufirst%3DT.%2BJ.%26aulast%3DMachonova%26aufirst%3DO.%26aulast%3DGradl%26aufirst%3DD.%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DA%2520novel%2520tankyrase%2520inhibitor%2520decreases%2520canonical%2520Wnt%2520signaling%2520in%2520colon%2520carcinoma%2520cells%2520and%2520reduces%2520tumor%2520growth%2520in%2520conditional%2520APC%2520mutant%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2822%26epage%3D2832%26doi%3D10.1158%2F0008-5472.CAN-11-3336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anlauf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radtki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of 2-arylquinazolin-4-ones into a potent and selective tankyrase inhibitor modulating Wnt pathway activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7897</span>– <span class="NLM_lpage">7909</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7897-7909&author=H.-P.+Buchstallerauthor=U.+Anlaufauthor=D.+Dorschauthor=D.+Kuhnauthor=M.+Lehmannauthor=B.+Leuthnerauthor=D.+Musilauthor=D.+Radtkiauthor=C.+Ritzertauthor=F.+Rohdichauthor=R.+Schneiderauthor=C.+Esdar&title=Discovery+and+optimization+of+2-arylquinazolin-4-ones+into+a+potent+and+selective+tankyrase+inhibitor+modulating+Wnt+pathway+activity&doi=10.1021%2Facs.jmedchem.9b00656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity</span></div><div class="casAuthors">Buchstaller, Hans-Peter; Anlauf, Uwe; Dorsch, Dieter; Kuhn, Daniel; Lehmann, Martin; Leuthner, Birgitta; Musil, Djordje; Radtki, Daniela; Ritzert, Claudio; Rohdich, Felix; Schneider, Richard; Esdar, Christina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7897-7909</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. targets which recently gained interest for anticancer therapy in Wnt pathway dependent tumors.  2-Aryl-quinazolinones were identified and optimized into potent tankyrase inhibitors through SAR exploration around the quinazolinone core and the 4'-position of the Ph residue.  These efforts were supported by anal. of TNKS X-ray and Watermap structures and resulted in compd. 5k(I), a potent, selective tankyrase inhibitor with favorable pharmacokinetic properties.  The X-ray structure of I in complex with TNKS1 was solved and confirmed the design hypothesis.  Modulation of Wnt pathway activity was demonstrated with this compd. in a colorectal xenograft model in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl6p_xrETB-bVg90H21EOLACvtfcHk0lgPgPuOAI5z4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7bI&md5=7fcc6c91c6e614482386af2094675837</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00656%26sid%3Dliteratum%253Aachs%26aulast%3DBuchstaller%26aufirst%3DH.-P.%26aulast%3DAnlauf%26aufirst%3DU.%26aulast%3DDorsch%26aufirst%3DD.%26aulast%3DKuhn%26aufirst%3DD.%26aulast%3DLehmann%26aufirst%3DM.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DRadtki%26aufirst%3DD.%26aulast%3DRitzert%26aufirst%3DC.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DEsdar%26aufirst%3DC.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25202-arylquinazolin-4-ones%2520into%2520a%2520potent%2520and%2520selective%2520tankyrase%2520inhibitor%2520modulating%2520Wnt%2520pathway%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7897%26epage%3D7909%26doi%3D10.1021%2Facs.jmedchem.9b00656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dipietro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochala, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touré, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span> <span> </span><span class="NLM_article-title">Identification of NVP-TNKS656: The use of structure-efficiency relationships to generate a highly potent, selective, and orally active tankyrase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6495</span>– <span class="NLM_lpage">6511</span>, <span class="refDoi"> DOI: 10.1021/jm400807n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400807n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2msbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6495-6511&author=M.+D.+Shultzauthor=A.+K.+Cheungauthor=C.+A.+Kirbyauthor=B.+Firestoneauthor=J.+Fanauthor=C.+H.+Chenauthor=Z.+Chenauthor=D.+N.+Chinauthor=L.+Dipietroauthor=A.+Fazalauthor=Y.+Fengauthor=P.+D.+Fortinauthor=T.+Gouldauthor=B.+Laguauthor=H.+Leiauthor=F.+Lenoirauthor=D.+Majumdarauthor=E.+Ochalaauthor=M.+G.+Palermoauthor=L.+Phamauthor=M.+Puauthor=T.+Smithauthor=T.+Stamsauthor=R.+C.+Tomlinsonauthor=B.+B.+Tour%C3%A9author=M.+Visserauthor=R.+M.+Wangauthor=N.+J.+Watersauthor=W.+Shao&title=Identification+of+NVP-TNKS656%3A+The+use+of+structure-efficiency+relationships+to+generate+a+highly+potent%2C+selective%2C+and+orally+active+tankyrase+inhibitor&doi=10.1021%2Fjm400807n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of NVP-TNKS656: The Use of Structure-Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor</span></div><div class="casAuthors">Shultz, Michael D.; Cheung, Atwood K.; Kirby, Christina A.; Firestone, Brant; Fan, Jianmei; Chen, Christine Hiu-Tung; Chen, Zhouliang; Chin, Donovan N.; DiPietro, Lucian; Fazal, Aleem; Feng, Yun; Fortin, Pascal D.; Gould, Ty; Lagu, Bharat; Lei, Huangshu; Lenoir, Francois; Majumdar, Dyuti; Ochala, Etienne; Palermo, M. G.; Pham, Ly; Pu, Minying; Smith, Troy; Stams, Travis; Tomlinson, Ronald C.; Toure, B. Barry; Visser, Michael; Wang, Run Ming; Waters, Nigel J.; Shao, Wenlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6495-6511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase 1 and 2 have been shown to be redundant, druggable nodes in the Wnt pathway.  As such, there has been intense interest in developing agents suitable for modulating the Wnt pathway in vivo by targeting this enzyme pair.  By utilizing a combination of structure-based design and LipE-based structure efficiency relationships, the core of XAV939 was optimized into a more stable, more efficient, but less potent dihydropyran motif 7.  This core was combined with elements of screening hits 2, 19, and 33 and resulted in highly potent, selective tankyrase inhibitors that are novel three pocket binders.  NVP-TNKS656 (43) was identified as an orally active antagonist of Wnt pathway activity in the MMTV-Wnt1 mouse xenograft model.  With an enthalpy-driven thermodn. signature of binding, highly favorable physicochem. properties, and high lipophilic efficiency, NVP-TNKS656 is a novel tankyrase inhibitor that is well suited for further in vivo validation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDGWOimaJ0I7Vg90H21EOLACvtfcHk0lg6XhFebxG1cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2msbfE&md5=db3f1a471ca757e0219a5175c5017e9b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm400807n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400807n%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DCheung%26aufirst%3DA.%2BK.%26aulast%3DKirby%26aufirst%3DC.%2BA.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DDipietro%26aufirst%3DL.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DOchala%26aufirst%3DE.%26aulast%3DPalermo%26aufirst%3DM.%2BG.%26aulast%3DPham%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DTomlinson%26aufirst%3DR.%2BC.%26aulast%3DTour%25C3%25A9%26aufirst%3DB.%2BB.%26aulast%3DVisser%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DR.%2BM.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DShao%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520NVP-TNKS656%253A%2520The%2520use%2520of%2520structure-efficiency%2520relationships%2520to%2520generate%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520tankyrase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6495%26epage%3D6511%26doi%3D10.1021%2Fjm400807n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of 2-arylquinazolin-4-ones as potent and selective inhibitors of tankyrases</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.1021/ml400260b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400260b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aht7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1173-1177&author=A.+Nathubhaiauthor=P.+J.+Woodauthor=M.+D.+Lloydauthor=A.+S.+Thompsonauthor=M.+D.+Threadgill&title=Design+and+discovery+of+2-arylquinazolin-4-ones+as+potent+and+selective+inhibitors+of+tankyrases&doi=10.1021%2Fml400260b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Discovery of 2 Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases</span></div><div class="casAuthors">Nathubhai, Amit; Wood, Pauline J.; Lloyd, Matthew D.; Thompson, Andrew S.; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1173-1177</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases (TNKSs) are poly-(ADP-ribose)-polymerases (PARPs) that are overexpressed in several clin. cancers.  They regulate elongation of telomeres, regulate the Wnt system, and are essential for the function of the mitotic spindle.  A set of 2-arylquinazolin-4-ones has been designed and identified as potent and selective TNKS inhibitors, some being more potent and selective than the lead inhibitor XAV939, with IC50 = 3 nM vs.  TNKS-2.  Me was preferred at the 8-position and modest bulk at the 4-position of the 2-Ph group; electronic effects and H-bonding were irrelevant, but charge in the 4'-substituent must be avoided.  Mol. modeling facilitated initial design of the compds. and rationalization of the SAR of binding into the nicotinamide-binding site of the target enzymes.  These compds. have potential for further development into anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxfmX1o7LIsrVg90H21EOLACvtfcHk0lg6XhFebxG1cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aht7nM&md5=23eb9a910b7952c76392bb1ae3b1185b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fml400260b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400260b%26sid%3Dliteratum%253Aachs%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DP.%2BJ.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BS.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DDesign%2520and%2520discovery%2520of%25202-arylquinazolin-4-ones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520tankyrases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1173%26epage%3D1177%26doi%3D10.1021%2Fml400260b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukaiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oonota, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusama, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.10.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1016%2Fj.bmc.2006.10.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=17095233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtleisL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=868-885&author=H.+Mukaiyamaauthor=T.+Nishimuraauthor=S.+Kobayashiauthor=T.+Ozawaauthor=N.+Kamadaauthor=Y.+Komatsuauthor=S.+Kikuchiauthor=H.+Oonotaauthor=H.+Kusama&title=Synthesis+and+c-Src+inhibitory+activity+of+imidazo%5B1%2C5-a%5Dpyrazine+derivatives+as+an+agent+for+treatment+of+acute+ischemic+stroke&doi=10.1016%2Fj.bmc.2006.10.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke</span></div><div class="casAuthors">Mukaiyama, Harunobu; Nishimura, Toshihiro; Kobayashi, Satoko; Ozawa, Tomonaga; Kamada, Noboru; Komatsu, Yoshimitsu; Kikuchi, Shinji; Oonota, Hideki; Kusama, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">868-885</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We synthesized and evaluated a series of C-5 substituted imidazo[1,5-a]pyrazine derivs. to identify potent c-Src inhibitors as potential therapeutic agents for acute ischemic stroke.  Among these compds., compd. 14c (I) demonstrated remarkable central nervous system (CNS) penetration and significant neuroprotective efficacy in vivo in rat models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi4kukCwyq8LVg90H21EOLACvtfcHk0lhaLANsLYH1RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtleisL3O&md5=5a86ce3af0d088c9aefcb61080a4ac11</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.10.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.10.041%26sid%3Dliteratum%253Aachs%26aulast%3DMukaiyama%26aufirst%3DH.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DOzawa%26aufirst%3DT.%26aulast%3DKamada%26aufirst%3DN.%26aulast%3DKomatsu%26aufirst%3DY.%26aulast%3DKikuchi%26aufirst%3DS.%26aulast%3DOonota%26aufirst%3DH.%26aulast%3DKusama%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520c-Src%2520inhibitory%2520activity%2520of%2520imidazo%255B1%252C5-a%255Dpyrazine%2520derivatives%2520as%2520an%2520agent%2520for%2520treatment%2520of%2520acute%2520ischemic%2520stroke%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D868%26epage%3D885%26doi%3D10.1016%2Fj.bmc.2006.10.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, J. C.</span></span> <span> </span><span class="NLM_article-title">A concise and regioselective synthesis of 1-alkyl-4-imidazolecarboxylates</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">4133</span>– <span class="NLM_lpage">4134</span>, <span class="refDoi"> DOI: 10.1021/ol026892k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol026892k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFCnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=4133-4134&author=C.+J.+Helalauthor=J.+C.+Lucas&title=A+concise+and+regioselective+synthesis+of+1-alkyl-4-imidazolecarboxylates&doi=10.1021%2Fol026892k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A Concise and Regioselective Synthesis of 1-Alkyl-4-imidazolecarboxylates</span></div><div class="casAuthors">Helal, Christopher J.; Lucas, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4133-4134</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Reaction between Et 3-N,N-(dimethylamino)-2-isocyanoacrylate (I) and a primary amine regioselectively affords 1-alkyl-4-imidazolecarboxylates, e.g., II in good yields (52-89%).  The method is applicable to unhindered and hindered amine substrates, as well as those contg. reactive functionality such as alcs. and secondary and tertiary amines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs4Fz_aWB47rVg90H21EOLACvtfcHk0lhaLANsLYH1RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFCnur8%253D&md5=39b59fd4bbb930a5031c678d57241c90</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fol026892k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol026892k%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLucas%26aufirst%3DJ.%2BC.%26atitle%3DA%2520concise%2520and%2520regioselective%2520synthesis%2520of%25201-alkyl-4-imidazolecarboxylates%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D4133%26epage%3D4134%26doi%3D10.1021%2Fol026892k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H.-P.</span>; <span class="NLM_string-name">Dorsch, D.</span></span> <span> </span><span class="NLM_article-title">Imidazopyrazinone derivatives</span>. <span class="NLM_patent">WO 15096884</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.-P.+Buchstaller&author=D.+Dorsch&title=Imidazopyrazinone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBuchstaller%26aufirst%3DH.-P.%26atitle%3DImidazopyrazinone%2520derivatives%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heeran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandford, G.</span></span> <span> </span><span class="NLM_article-title">Fluorination of pyrrole derivatives by Selectfluor<sup>TM</sup></span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2456</span>– <span class="NLM_lpage">2463</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2016.03.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1016%2Fj.tet.2016.03.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVagur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2016&pages=2456-2463&author=D.+Heeranauthor=G.+Sandford&title=Fluorination+of+pyrrole+derivatives+by+SelectfluorTM&doi=10.1016%2Fj.tet.2016.03.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorination of pyrrole derivatives by Selectfluor</span></div><div class="casAuthors">Heeran, Darren; Sandford, Graham</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2456-2463</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Fluorination of a range of pyrrole substrates bearing various electron donating and withdrawing substituents at the 1-, 2- and 3-positions using Selectfluor was assessed in order to develop effective methodol. for the synthesis of corresponding fluoropyrrole derivs.  The synthesis of some novel fluorinated pyrrole derivs. were achieved in reasonable quantities although many pyrrole substrates were oxidatively polymd. by the fluorinating reagent, reducing the scope of a selective fluorination approach for the prepn. of fluoropyrrole products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhM4VzyaQiRbVg90H21EOLACvtfcHk0lhaLANsLYH1RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVagur4%253D&md5=24a342a6dc8da028a99dab08edeb76b5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2016.03.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2016.03.067%26sid%3Dliteratum%253Aachs%26aulast%3DHeeran%26aufirst%3DD.%26aulast%3DSandford%26aufirst%3DG.%26atitle%3DFluorination%2520of%2520pyrrole%2520derivatives%2520by%2520SelectfluorTM%26jtitle%3DTetrahedron%26date%3D2016%26volume%3D72%26spage%3D2456%26epage%3D2463%26doi%3D10.1016%2Fj.tet.2016.03.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gagliardi, S.</span>; <span class="NLM_string-name">Le Poul, E.</span>; <span class="NLM_string-name">Lingard, L.</span>; <span class="NLM_string-name">Palombi, G.</span>; <span class="NLM_string-name">Poli, S. M.</span>; <span class="NLM_string-name">Rocher, J.-P.</span></span> <span> </span><span class="NLM_article-title">Pyrrole derivatives as positive allosteric modulators of metabotropic receptors</span>. <span class="NLM_patent">WO 06123257</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=S.+Gagliardi&author=E.+Le+Poul&author=L.+Lingard&author=G.+Palombi&author=S.+M.+Poli&author=J.-P.+Rocher&title=Pyrrole+derivatives+as+positive+allosteric+modulators+of+metabotropic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGagliardi%26aufirst%3DS.%26atitle%3DPyrrole%2520derivatives%2520as%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520receptors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafiq, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa-Cabral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munkonge, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinidade, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, C. J.</span></span> <span> </span><span class="NLM_article-title">A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">201</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-36447-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1038%2Fs41598-018-36447-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=30655555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A280%3ADC%252BB3cjis1Gjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=201&author=M.+Menonauthor=R.+Elliottauthor=L.+Bowersauthor=N.+Balanauthor=R.+Rafiqauthor=S.+Costa-Cabralauthor=F.+Munkongeauthor=I.+Trinidadeauthor=R.+Porterauthor=A.+D.+Campbellauthor=E.+R.+Johnsonauthor=C.+Esdarauthor=H.-P.+Buchstallerauthor=B.+Leuthnerauthor=F.+Rohdichauthor=R.+Schneiderauthor=O.+Sansomauthor=D.+Wienkeauthor=A.+Ashworthauthor=C.+J.+Lord&title=A+novel+tankyrase+inhibitor%2C+MSC2504877%2C+enhances+the+effects+of+clinical+CDK4%2F6+inhibitors&doi=10.1038%2Fs41598-018-36447-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors</span></div><div class="casAuthors">Menon Malini; Elliott Richard; Bowers Leandra; Balan Nicolae; Rafiq Rumana; Costa-Cabral Sara; Munkonge Felix; Trinidade Ines; Ashworth Alan; Lord Christopher J; Porter Roderick; Campbell Andrew D; Johnson Emma R; Sansom Owen; Esdar Christina; Buchstaller Hans-Peter; Leuthner Birgitta; Rohdich Felix; Schneider Richard; Wienke Dirk; Ashworth Alan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">201</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inhibition of the PARP superfamily tankyrase enzymes suppresses Wnt/β-catenin signalling in tumour cells.  Here, we describe here a novel, drug-like small molecule inhibitor of tankyrase MSC2504877 that inhibits the growth of APC mutant colorectal tumour cells.  Parallel siRNA and drug sensitivity screens showed that the clinical CDK4/6 inhibitor palbociclib, causes enhanced sensitivity to MSC2504877.  This tankyrase inhibitor-CDK4/6 inhibitor combinatorial effect is not limited to palbociclib and MSC2504877 and is elicited with other CDK4/6 inhibitors and toolbox tankyrase inhibitors.  The addition of MSC2504877 to palbociclib enhances G1 cell cycle arrest and cellular senescence in tumour cells.  MSC2504877 exposure suppresses the upregulation of Cyclin D2 and Cyclin E2 caused by palbociclib and enhances the suppression of phospho-Rb, providing a mechanistic explanation for these effects.  The combination of MSC2504877 and palbociclib was also effective in suppressing the cellular hyperproliferative phenotype seen in Apc defective intestinal stem cells in vivo.  However, the presence of an oncogenic Kras p.G12D mutation in mice reversed the effects of the MSC2504877/palbociclib combination, suggesting one molecular route that could lead to drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsCECdrvD2BkewzGPswiWOfW6udTcc2eaue2p18cJYNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjis1Gjtg%253D%253D&md5=34ac002987c951a0ebd2f34f256ed21c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-36447-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-36447-4%26sid%3Dliteratum%253Aachs%26aulast%3DMenon%26aufirst%3DM.%26aulast%3DElliott%26aufirst%3DR.%26aulast%3DBowers%26aufirst%3DL.%26aulast%3DBalan%26aufirst%3DN.%26aulast%3DRafiq%26aufirst%3DR.%26aulast%3DCosta-Cabral%26aufirst%3DS.%26aulast%3DMunkonge%26aufirst%3DF.%26aulast%3DTrinidade%26aufirst%3DI.%26aulast%3DPorter%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DA.%2BD.%26aulast%3DJohnson%26aufirst%3DE.%2BR.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DBuchstaller%26aufirst%3DH.-P.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DSansom%26aufirst%3DO.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DAshworth%26aufirst%3DA.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26atitle%3DA%2520novel%2520tankyrase%2520inhibitor%252C%2520MSC2504877%252C%2520enhances%2520the%2520effects%2520of%2520clinical%2520CDK4%252F6%2520inhibitors%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D201%26doi%3D10.1038%2Fs41598-018-36447-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mouradov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloggett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorissen, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strausberg, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wormald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, L.</span></span> <span> </span><span class="NLM_article-title">Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">3238</span>– <span class="NLM_lpage">3247</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-0013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1158%2F0008-5472.CAN-14-0013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=24755471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1CmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=3238-3247&author=D.+Mouradovauthor=C.+Sloggettauthor=R.+N.+Jorissenauthor=C.+G.+Loveauthor=S.+Liauthor=A.+W.+Burgessauthor=D.+Arangoauthor=R.+L.+Strausbergauthor=D.+Buchananauthor=S.+Wormaldauthor=L.+O%E2%80%99Connor&title=Colorectal+cancer+cell+lines+are+representative+models+of+the+main+molecular+subtypes+of+primary+cancer&doi=10.1158%2F0008-5472.CAN-14-0013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer</span></div><div class="casAuthors">Mouradov, Dmitri; Sloggett, Clare; Jorissen, Robert N.; Love, Christopher G.; Li, Shan; Burgess, Antony W.; Arango, Diego; Strausberg, Robert L.; Buchanan, Daniel; Wormald, Samuel; O'Connor, Liam; Wilding, Jennifer L.; Bicknell, David; Tomlinson, Ian P. M.; Bodmer, Walter F.; Mariadason, John M.; Sieber, Oliver M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3238-3247</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Human colorectal cancer cell lines are used widely to investigate tumor biol., exptl. therapy, and biomarkers.  However, to what extent these established cell lines represent and maintain the genetic diversity of primary cancers is uncertain.  In this study, we profiled 70 colorectal cancer cell lines for mutations and DNA copy no. by whole-exome sequencing and SNP microarray analyses, resp.  Gene expression was defined using RNA-Seq.  Cell line data were compared with those published for primary colorectal cancers in The Cancer Genome Atlas.  Notably, we found that exome mutation and DNA copy-no. spectra in colorectal cancer cell lines closely resembled those seen in primary colorectal tumors.  Similarities included the presence of two hypermutation phenotypes, as defined by signatures for defective DNA mismatch repair and DNA polymerase ε proofreading deficiency, along with concordant mutation profiles in the broadly altered WNT, MAPK, PI3K, TGFβ, and p53 pathways.  Furthermore, we documented mutations enriched in genes involved in chromatin remodeling (ARID1A, CHD6, and SRCAP) and histone methylation or acetylation (ASH1L, EP300, EP400, MLL2, MLL3, PRDM2, and TRRAP).  Chromosomal instability was prevalent in nonhypermutated cases, with similar patterns of chromosomal gains and losses.  Although paired cell lines derived from the same tumor exhibited considerable mutation and DNA copy-no. differences, in silico simulations suggest that these differences mainly reflected a preexisting heterogeneity in the tumor cells.  In conclusion, our results establish that human colorectal cancer lines are representative of the main subtypes of primary tumors at the genomic level, further validating their utility as tools to investigate colorectal cancer biol. and drug responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEgggXY2lyLbVg90H21EOLACvtfcHk0ljnBEQRQ4G4zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1CmtLo%253D&md5=070b70d23cea1eaa4333d95df2f57245</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0013%26sid%3Dliteratum%253Aachs%26aulast%3DMouradov%26aufirst%3DD.%26aulast%3DSloggett%26aufirst%3DC.%26aulast%3DJorissen%26aufirst%3DR.%2BN.%26aulast%3DLove%26aufirst%3DC.%2BG.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DBurgess%26aufirst%3DA.%2BW.%26aulast%3DArango%26aufirst%3DD.%26aulast%3DStrausberg%26aufirst%3DR.%2BL.%26aulast%3DBuchanan%26aufirst%3DD.%26aulast%3DWormald%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DL.%26atitle%3DColorectal%2520cancer%2520cell%2520lines%2520are%2520representative%2520models%2520of%2520the%2520main%2520molecular%2520subtypes%2520of%2520primary%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D3238%26epage%3D3247%26doi%3D10.1158%2F0008-5472.CAN-14-0013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crenn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messing, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynober, L.</span></span> <span> </span><span class="NLM_article-title">Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction</span>. <i>Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1016/j.clnu.2008.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1016%2Fj.clnu.2008.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=18440672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1OqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=328-339&author=P.+Crennauthor=B.+Messingauthor=L.+Cynober&title=Citrulline+as+a+biomarker+of+intestinal+failure+due+to+enterocyte+mass+reduction&doi=10.1016%2Fj.clnu.2008.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction</span></div><div class="casAuthors">Crenn, Pascal; Messing, Bernard; Cynober, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Nutrition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">328-339</span>CODEN:
                <span class="NLM_cas:coden">CLNUDP</span>;
        ISSN:<span class="NLM_cas:issn">0261-5614</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In human, citrulline (plasma concn. about 40 μmol/L) is an amino acid involved in intermediary metab. and that is not incorporated in proteins.  Circulating citrulline is mainly produced by enterocytes of the small bowel.  For this reason plasma or serum citrulline concn. has been proposed as a biomarker of remnant small bowel mass and function.  This article reviews this concept and its metabolic basis.  Conditions in which there is a significantly reduced small bowel enterocyte mass and function and a plasma or serum citrulline were measured in adults and children.  These studies included patients with a short bowel syndrome, villous atrophy states, Crohn's disease, during monitoring of digestive toxicity of chemotherapy and radiotherapy or follow-up of patients after small bowel transplantation.  In all these situations, with more than 500 studied patients a decreased level of plasma citrulline correlated with the reduced enterocyte mass independently of nutritional and inflammatory status.  A close correlation between small bowel remnant length and citrullinemia was found.  In addn., diagnosis of intestinal failure was assessed through plasma citrulline levels in severe small bowel diseases in which there is a marked enterocyte mass redn.  The threshold for establishing a diagnosis of intestinal failure is lower in villous atrophy disease (10 μmol/L) than in short bowel syndrome (20 μmol/L).  Compromised renal function is an important factor when considering plasma citrulline levels as a marker of intestinal failure as this potentially can increase circulating citrulline values.  Reduced plasma citrulline levels are an innovative quant. biomarker of significantly reduced enterocyte mass and function in different disease states in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDSG-b8a5N2rVg90H21EOLACvtfcHk0lhkUHPCI_AN6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1OqsLg%253D&md5=3bcbcd6185d2fd15a5fbca6cb790335d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.clnu.2008.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clnu.2008.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DCrenn%26aufirst%3DP.%26aulast%3DMessing%26aufirst%3DB.%26aulast%3DCynober%26aufirst%3DL.%26atitle%3DCitrulline%2520as%2520a%2520biomarker%2520of%2520intestinal%2520failure%2520due%2520to%2520enterocyte%2520mass%2520reduction%26jtitle%3DClin.%2520Nutr.%26date%3D2008%26volume%3D27%26spage%3D328%26epage%3D339%26doi%3D10.1016%2Fj.clnu.2008.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jäckel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pipp, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanschke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddharta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czasch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, M. W.</span></span> <span> </span><span class="NLM_article-title">L-citrulline: A preclinical safety biomarker for the small intestine in rats and dogs in repeat dose toxicity studies</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">107068</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1016%2Fj.vascn.2021.107068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=33940165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A280%3ADC%252BB3sbpsFeitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2021&pages=107068&author=S.+J%C3%A4ckelauthor=F.+C.+Pippauthor=B.+Emdeauthor=S.+Weigtauthor=E.+Vignaauthor=B.+Hanschkeauthor=L.+Kasperauthor=A.+Siddhartaauthor=J.+Hellmannauthor=S.+Czaschauthor=M.+W.+Schmitt&title=L-citrulline%3A+A+preclinical+safety+biomarker+for+the+small+intestine+in+rats+and+dogs+in+repeat+dose+toxicity+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">l-citrulline: A preclinical safety biomarker for the small intestine in rats and dogs in repeat dose toxicity studies</span></div><div class="casAuthors">Jackel Sven; Pipp Frederic Christian; Emde Barbara; Weigt Stefan; Kasper Lena; Hellmann Jurgen; Czasch Stephanie; Schmitt Michael W; Vigna Enrico; Hanschke Bettina; Siddharta Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107068</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Gastrointestinal (GI) toxicity is still an issue within drug development, especially for novel oncology drugs.  The identification of GI mucosal damage at an early stage with high sensitivity and specificity across preclinical species and humans remains difficult.  To date, in preclinical studies, no qualified mechanistic, diagnostic or prognostic biomarkers exist for GI mucosal toxicity. l-citrulline is one of the most promising biomarker candidates used in clinical settings to quantify enterocyte integrity in various small intestinal diseases. l-citrulline is an intermediate metabolic amino acid produced mainly by functional enterocytes of the small intestine, whereby enterocyte loss will cause a drop in circulating l-citrulline.  METHODS:  In several repeat-dose toxicity studies, plasma l-citrulline has been evaluated as a potential safety biomarker for intestinal toxicity in beagle dogs and Wistar (Han) rats treated with different oncological drug candidates in drug development.  Clinical observations and body weight determinations were performed during the pretreatment, treatment and treatment-free recovery period as well as toxicokinetic, gross and histopathology examinations.  The quantitative determination of plasma l-citrulline levels during the pretreatment (only dogs), treatment and treatment-free recovery period were performed using an HPLC MS/MS assay.  In cynomolgus monkeys, the first investigations on baseline l-citrulline levels were performed.  RESULTS:  In dogs, a dose- and exposure-dependent decrease of up to 50% in plasma l-citrulline was seen without histopathological alterations.  However, a decrease of more than 50% in comparison to the individual animal pretreatment value of l-citrulline correlated very well with histopathological findings (intestinal crypt necrosis, villus atrophy, enterocyte loss) and clinical signs (bloody faeces and diarrhoea).  During a treatment-free recovery period, a trend of increasing levels was observed in dogs.  In rats, absolute l-citrulline plasma levels of treated animals decreased compared to the values of the concurrent control group.  This decrease also correlated with the histopathological findings in the small intestine (single cell necrosis and mucosa atrophy).  Because of a large physiological variation in l-citrulline plasma levels in dogs and rats, a clear cut-off value for absolute l-citrulline levels predictive of intestinal mucosal toxicity was difficult to establish.  However, a > 50% decrease in l-citrulline plasma levels during the treatment period strongly correlated with histopathological findings.  DISCUSSION:  Based on the performed analysis, a longitudinal investigation of l-citrulline plasma levels for individual animals in the control and treatment groups is essential and pretreatment values of l-citrulline levels in rodents would be highly informative.  Overall, further cross-species comparison (Cynomolgus monkey, mouse) and implementation in clinical trials as exploratory biomarker is essential to foster the hypothesis and to understand completely the clinical relevance of l-citrulline as a small intestine biomarker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnvm1YrGpJ1Ebxh97K6Vt6fW6udTcc2eZpoPPNDPrjHbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3sbpsFeitw%253D%253D&md5=588202c50174e81604e0f574e53d08d2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2021.107068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2021.107068%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25A4ckel%26aufirst%3DS.%26aulast%3DPipp%26aufirst%3DF.%2BC.%26aulast%3DEmde%26aufirst%3DB.%26aulast%3DWeigt%26aufirst%3DS.%26aulast%3DVigna%26aufirst%3DE.%26aulast%3DHanschke%26aufirst%3DB.%26aulast%3DKasper%26aufirst%3DL.%26aulast%3DSiddharta%26aufirst%3DA.%26aulast%3DHellmann%26aufirst%3DJ.%26aulast%3DCzasch%26aufirst%3DS.%26aulast%3DSchmitt%26aufirst%3DM.%2BW.%26atitle%3DL-citrulline%253A%2520A%2520preclinical%2520safety%2520biomarker%2520for%2520the%2520small%2520intestine%2520in%2520rats%2520and%2520dogs%2520in%2520repeat%2520dose%2520toxicity%2520studies%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2021%26volume%3D110%26spage%3D107068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsworth, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span> <span> </span><span class="NLM_article-title">A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3132</span>– <span class="NLM_lpage">3144</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-4562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1158%2F0008-5472.CAN-12-4562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=23539443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3132-3144&author=T.+Lauauthor=E.+Chanauthor=M.+Callowauthor=J.+Waalerauthor=J.+Boggsauthor=R.+A.+Blakeauthor=S.+Magnusonauthor=A.+Sambroneauthor=M.+Schuttenauthor=R.+Firesteinauthor=O.+Machonauthor=V.+Korinekauthor=E.+Chooauthor=D.+Diazauthor=M.+Merchantauthor=P.+Polakisauthor=D.+D.+Holsworthauthor=S.+Kraussauthor=M.+Costa&title=A+novel+tankyrase+small-molecule+inhibitor+suppresses+APC+mutation-driven+colorectal+tumor+growth&doi=10.1158%2F0008-5472.CAN-12-4562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation-Driven Colorectal Tumor Growth</span></div><div class="casAuthors">Lau, Ted; Chan, Emily; Callow, Marinella; Waaler, Jo; Boggs, Jason; Blake, Robert A.; Magnuson, Steven; Sambrone, Amy; Schutten, Melissa; Firestein, Ron; Machon, Ondrej; Korinek, Vladimir; Choo, Edna; Diaz, Dolores; Merchant, Mark; Polakis, Paul; Holsworth, Daniel D.; Krauss, Stefan; Costa, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3132-3144</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Most colorectal cancers (CRC) are initiated by mutations of APC, leading to increased β-catenin-mediated signaling.  However, continued requirement of Wnt/P-catenin signaling for tumor progression in the context of acquired KRAS and other mutations is less well-established.  To attenuate Wnt/β-catenin signaling in tumors, we have developed potent and specific small-mol. tankyrase inhibitors, G007-LK and G244-LM, that reduce Wnt./p-catenin signaling by preventing poly(ADP-ribosyl)ation-dependent AXIN degrdn., thereby promoting β-catenin destabilization.  We show that novel tankyrase inhibitors completely block ligand-driven Wnt/β-catenin signaling in cell culture and display approx. 50% inhibition of APC mutation-driven signaling in most CRC cell lines.  It was previously unknown whether the level of AXIN protein stabilization by tankyrase inhibition is sufficient to impact tumor growth in the absence of normal APC activity.  Compd. G007-LK displays favorable pharmacokinetic properties and inhibits in vivo tumor growth in a subset of APC-mutant CRC xenograft models.  In the xenograft model most sensitive to tankyrase inhibitor, COLO-320DM, G007-LK inhibits cell-cycle progression, reduces colony formation, and induces differentiation, suggesting that β-catenin-dependent maintenance of an undifferentiated state may be blocked by tankyrase inhibition.  The full potential of the antitumor activity of G007-LK may be limited by intestinal toxicity assocd. with inhibition of Wnt/β-catenin signaling and cell proliferation in intestinal crypts.  These results establish proof-of-concept antitumor efficacy for tankyrase inhibitors in APC-mutant CRC models and uncover potential diagnostic and safety concerns to be overcome as tankyrase inhibitors are advanced into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbDZ01XGjOaLVg90H21EOLACvtfcHk0lhkUHPCI_AN6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D&md5=9f1d7b05b92ba8df593ccca9e7ea2cdf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-4562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-4562%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DCallow%26aufirst%3DM.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DSchutten%26aufirst%3DM.%26aulast%3DFirestein%26aufirst%3DR.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DM.%26atitle%3DA%2520novel%2520tankyrase%2520small-molecule%2520inhibitor%2520suppresses%2520APC%2520mutation-driven%2520colorectal%2520tumor%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D3132%26epage%3D3144%26doi%3D10.1158%2F0008-5472.CAN-12-4562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katavolos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harstad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutten, M.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition causes reversible intestinal toxicity in mice with a therapeutic index < 1</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1177/0192623315621192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1177%2F0192623315621192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=26692561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWgsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=267-278&author=Y.+Zhongauthor=P.+Katavolosauthor=T.+Nguyenauthor=T.+Lauauthor=J.+Boggsauthor=A.+Sambroneauthor=D.+Kanauthor=M.+Merchantauthor=E.+Harstadauthor=D.+Diazauthor=M.+Costaauthor=M.+Schutten&title=Tankyrase+inhibition+causes+reversible+intestinal+toxicity+in+mice+with+a+therapeutic+index+%3C+1&doi=10.1177%2F0192623315621192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition causes reversible intestinal toxicity in mice with a therapeutic index < 1</span></div><div class="casAuthors">Zhong, Yu; Katavolos, Paula; Nguyen, Trung; Lau, Ted; Boggs, Jason; Sambrone, Amy; Kan, David; Merchant, Mark; Harstad, Eric; Diaz, Dolores; Costa, Mike; Schutten, Melissa</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-278</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Activated Wnt/β-catenin signaling is frequently assocd. with colorectal cancer.  Wnt inhibitors, including tankyrase inhibitors, are being explored as potential anticancer agents.  Wnt signaling is also crit. for intestinal tissue homeostasis, and Wnt inhibitors have been shown to cause intestinal toxicity in mice by affecting intestinal stem cells.  This study sought to characterize the intestinal toxicity of tankyrase inhibitors, including reversibility, and to assess their therapeutic index.  Novel tankyrase inhibitor G-631 caused dose-dependent intestinal toxicity with a therapeutic index < 1 after 14 days of dosing in mice.  At a tolerated subtherapeutic dose level, the intestinal toxicity was composed of enteritis characterized by villus blunting, epithelial degeneration, and inflammation, which fully reversed after 14 days of recovery.  Doubled exposure showed weak antitumor activity in a xenograft colorectal cancer model but also caused more severe intestinal toxicity characterized by multifocal-regionally extensive necrotizing and ulcerative enteritis leading to morbidity or moribundity in some animals.  This toxicity was only partially reversed after 14 days of recovery, with evidence of crypt and villus regeneration, mildly blunted villi, and/or scarring in assocn. with chronic inflammation of the submucosa.  Therefore, the clin. utility of tankyrase inhibitors is likely limited by the on-target intestinal toxicity and a therapeutic index < 1 in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE6KF-WKDKTrVg90H21EOLACvtfcHk0lie7-Iw-P9KnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWgsLvF&md5=b4276e4b15fae2aa0bbc53d0f9f1f680</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1177%2F0192623315621192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623315621192%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DY.%26aulast%3DKatavolos%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DLau%26aufirst%3DT.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DKan%26aufirst%3DD.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DCosta%26aufirst%3DM.%26aulast%3DSchutten%26aufirst%3DM.%26atitle%3DTankyrase%2520inhibition%2520causes%2520reversible%2520intestinal%2520toxicity%2520in%2520mice%2520with%2520a%2520therapeutic%2520index%2520%253C%25201%26jtitle%3DToxicol.%2520Pathol.%26date%3D2016%26volume%3D44%26spage%3D267%26epage%3D278%26doi%3D10.1177%2F0192623315621192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veeman, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusarski, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaykas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span> <span> </span><span class="NLM_article-title">Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">680</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1016/S0960-9822(03)00240-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=10.1016%2FS0960-9822%2803%2900240-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=12699626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtVKhu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=680-685&author=M.+T.+Veemanauthor=D.+C.+Slusarskiauthor=A.+Kaykasauthor=S.+H.+Louieauthor=R.+T.+Moon&title=Zebrafish+prickle%2C+a+modulator+of+noncanonical+Wnt%2FFz+signaling%2C+regulates+gastrulation+movements&doi=10.1016%2FS0960-9822%2803%2900240-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements</span></div><div class="casAuthors">Veeman, Michael T.; Slusarski, Diane C.; Kaykas, Ajamete; Louie, Sarah Hallagan; Moon, Randall T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">680-685</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In addn. to the canonical Wnt/β-catenin signaling pathway, at least two noncanonical Wnt/Fz pathways have been described: the planar cell polarity (PCP) pathway in Drosophila and the Wnt/calcium pathway in vertebrate embryos.  Recent work suggests that a vertebrate pathway homologous to the PCP pathway acts to regulate the convergent extension movements of gastrulation.  To further test this hypothesis, we have identified two zebrafish homologs of the Drosophila PCP gene prickle (pk) , both of which show discrete and dynamic expression patterns during gastrulation.  Both gain and loss of pk1 function cause defects in convergent extension.  Pk1 localizes to both the cytoplasm and the cell membrane, and its normal localization is partially dependent on its C-terminal prenylation motif.  At the cell membrane, Pk1 is frequently localized asym. around the cell and can colocalize with the signaling mol. Dishevelled (Dsh).  In overexpression assays, Pk1 is able to activate AP-1-mediated transcription and inhibit activation of Wnt/β-catenin signaling.  Like noncanonical Wnts , overexpression of Pk1 increases the frequency of calcium transients in zebrafish blastulae.  Our results support the idea that a vertebrate PCP pathway regulates gastrulation movements and suggest that there is overlap between the PCP and Wnt/calcium pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCHsICitWVAbVg90H21EOLACvtfcHk0lie7-Iw-P9KnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtVKhu7s%253D&md5=9f4718000ceeb7fb5958e0f0679fa61c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2803%2900240-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252803%252900240-9%26sid%3Dliteratum%253Aachs%26aulast%3DVeeman%26aufirst%3DM.%2BT.%26aulast%3DSlusarski%26aufirst%3DD.%2BC.%26aulast%3DKaykas%26aufirst%3DA.%26aulast%3DLouie%26aufirst%3DS.%2BH.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26atitle%3DZebrafish%2520prickle%252C%2520a%2520modulator%2520of%2520noncanonical%2520Wnt%252FFz%2520signaling%252C%2520regulates%2520gastrulation%2520movements%26jtitle%3DCurr.%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D680%26epage%3D685%26doi%3D10.1016%2FS0960-9822%2803%2900240-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i87"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00800">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_07675"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00800?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00800</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Assay protocols: activity ELISA of TNKS1 and TNKS2 and PARP-1 biochemical activity assay; PARP family biochemical assays; protocol for determination of microsomal stability (intrinsic clearance); protocol for the determination of Kv11.1 (hERG) ion channel activity; procedure for Caco-2 Papp determination; determination of thermodynamic solubility; information about cell lines; protocol for axin2 and tankyrase cellular assay; description of crystallization procedure and structure determination; description of WaterMap analysis; description of the Glide & WaterMap method; description of isothermal titration calorimetry with binding isotherms and tabulated binding parameters; prediction of human PK by 4 species allometric scaling; scaling of <i>in vivo</i> blood CL based on hepatocyte data; determination of the maximum tolerated dose (MTD); PK simulation (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_001.pdf">jm1c00800_si_001.pdf (1.19 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00800/suppl_file/jm1c00800_si_002.csv">jm1c00800_si_002.csv (1.17 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors are deposited at the Protein Data Bank with code 7OCV (<b>30g</b>). The authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00800&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00800%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-14" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00800" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c1ef08d71239","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
